id,dataset,question,ground_truth_answer,nvidia_model,nvidia_parsed_answer,nvidia_raw_response,nvidia_outcome
21645374,pubmedqa_pqa_l,Do mitochondria play a role in remodelling lace plant leaves during programmed cell death?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if mitochondria play a role in remodeling lace plant leaves during programmed cell death (PCD). The context provided is a study on the lace plant, Aponogeton madagascariensis, which uses PCD to create perforations in its leaves.

First, I need to recall the details from the context. The paper mentioned that mitochondrial dynamics were studied in different stages of PCD: NPCD (no PCD), EPCD (early PCD), and LPCD (late PCD). They used MitoTracker Red to examine mitochondria, categorizing their dynamics into M1-M4 based on distribution, motility, and membrane potential. The TUNEL assay showed fragmented DNA correlating with mitochondrial stages. Also, when they treated with cyclosporine A (CsA), which affects the mitochondrial permeability transition pore (PTP), there were fewer perforations, and mitochondrial dynamics resembled non-PCD cells.

So, the key points here are that mitochondrial characteristics change during PCD stages, and inhibiting PTP (a mitochondrial structure) with CsA reduced PCD (fewer perforations). This suggests that mitochondria are involved in the PCD process that remodels the leaves. In animals, mitochondrial involvement in PCD (like apoptosis) is well-known, but this study shows it's also important in plants. The results imply that mitochondrial dynamics and PTP are part of the mechanism driving PCD in lace plants, leading to leaf perforation. Therefore, mitochondria do play a role in remodeling the leaves during PCD.
</think>

[Yes]",Correct
16418930,pubmedqa_pqa_l,Landolt C and snellen e acuity: differences in strabismus amblyopia?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if there are differences in visual acuity measurements between Landolt C and Snellen E in patients with strabismus amblyopia.

Looking at the context provided, the study compared these two optotypes in various patients, including those with amblyopia due to strabismus. The results mention that in the entire group, the mean decimal values for Landolt C (LR) were 0.25 and Snellen E (SE) 0.29. For the strabismus amblyopia group specifically, LR was 0.14 and SE 0.16. The mean difference between LR and SE was 0.55 lines in both the entire group and the amblyopia group, with SE being higher. The study states that differences were small and similar across groups.

So, even though there's a slight difference (0.55 lines), the conclusion is that the differences are small. The question is whether there are differences in strabismus amblyopia. The answer would be yes, but the differences are small. However, the study found that SE was higher, so technically there is a difference. The answer should be yes, but the user might be looking for whether the difference is significant. The context says ""differences were small,"" but they do exist. So the answer is yes, there are differences, albeit small ones.
</think>

[Yes]",Incorrect
9488747,pubmedqa_pqa_l,"Syncope during bathing in infants, a pediatric form of water-induced urticaria?",yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if syncope during bathing in infants is a pediatric form of water-induced urticaria.

First, I need to recall the context provided. The study describes eight infants who had life-threatening events during baths. When immersed, they became pale, hypotonic, unresponsive, and recovered quickly after removal. The initial considered diagnoses were seizures or gastroesophageal reflux, but those were doubtful. Then they considered aquagenic urticaria, noting family histories of dermographism or reactions to water/sun. All six tested infants had dermographism, and two showed increased blood histamine after a bath trial. The infants improved when baths were stopped, but some had ongoing issues with sun or water.

Aquagenic urticaria typically presents with hives upon water contact. However, the infants here didn't have urticaria but syncope-like symptoms. The study suggests a possible link due to histamine release (as seen in urticaria) and family history of similar conditions. The term ""equivalent of aquagenic urticaria"" is used, implying it's not classic urticaria but a related reaction. The favorable response to avoiding baths and histamine increase supports a water-induced mechanism, possibly a variant presentation in infants. However, the symptoms (syncope, pallor, hypotonia) differ from typical urticaria. The authors propose it as a pediatric form, so maybe a unique manifestation. The answer hinges on whether syncope in this context is considered a form of water-induced urticaria. Given the histamine involvement and family history, the authors link it, but it's a non-classical presentation. So the answer would be yes, according to the study's hypothesis.
</think>

[Yes]",Correct
17208539,pubmedqa_pqa_l,Are the long-term results of the transanal pull-through equal to those of the transabdominal pull-through?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether the long-term results of the transanal pull-through (TERPT) are equal to those of the transabdominal (ABD) pull-through for Hirschsprung disease.

Looking at the context: The study compared TERPT and ABD in 41 patients. The total scores from the questionnaire were similar between the two groups. However, there were differences in specific areas: continence was better in ABD, and stool pattern was better in TERPT. They also mentioned that age at interview was different between groups, but after controlling for age, the overall long-term scores weren't significantly affected. The conclusion from the study seems to be that overall outcomes are similar, even though some specific aspects differ. The question is about equality in long-term results. Since the overall scores are similar after adjusting for age, the answer would lean towards yes, but there are nuances. But the question is asking if they are equal. The study says overall scores were similar, so maybe the answer is yes. But the continence and stool differences might suggest they aren't exactly equal. However, the main conclusion is that when age is controlled, the long-term outcomes (as per total score) don't differ. So the answer is yes, they are equal in terms of overall long-term results, even if specific components differ. The question is about the long-term results being equal, and the study's main finding supports that.
</think>

[Yes]",Incorrect
10808977,pubmedqa_pqa_l,Can tailored interventions increase mammography use among HMO women?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if tailored interventions can increase mammography use among HMO women based on the provided context.

First, I need to recall the study details. The study compared three groups: usual care, tailored print, and tailored telephone counseling. The outcome was adherence to mammography screening over three years. 

The results showed that telephone counseling had a higher percentage (71%) compared to usual care (61%) after the first year. Tailored print was 67% vs 61%. So both interventions had higher rates than usual care. However, the effect was more pronounced in the first year for telephone counseling. Also, telephone counseling was more effective than print for women who were off-schedule previously.

The question is whether tailored interventions (which include both telephone and print) increase mammography use. Since both tailored methods had higher rates than usual care, even if the effect varied over time, the answer would be yes. The study supports that tailored interventions do increase use compared to usual care.
</think>

[Yes]",Correct
23831910,pubmedqa_pqa_l,Double balloon enteroscopy: is it efficacious and safe in a community setting?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if double balloon enteroscopy (DBE) is efficacious and safe in a community setting based on the provided context.

First, I need to recall what DBE is. It's a procedure used to examine the small intestine, which is hard to reach with standard endoscopy. The context gives data from a study conducted between 2007 and 2011 involving 66 patients. The key points here are the number of procedures, indications, use of VCE prior to DBE, procedure details, and outcomes.

Looking at efficacy: The study mentions that VCE was used before DBE in 43 patients, and in 32 cases (74.4%), the findings were confirmed by DBE. Additionally, in 3 cases, DBE found things that VCE missed. This suggests that DBE is effective in both confirming VCE findings and detecting additional issues. Also, therapeutic interventions like electrocautery, biopsies, and stricture dilation were performed, which indicates that DBE isn't just diagnostic but also therapeutic. The mean distances reached during antegrade and retrograde procedures show that DBE can access significant portions of the small bowel, which is important for efficacy.

Regarding safety: The context doesn't explicitly mention complications like perforation, bleeding, or adverse events. However, the fact that therapeutic procedures were done (like electrocautery and dilation) without reported complications might imply safety, but absence of data on complications doesn't confirm safety. Typically, studies would report complication rates if they were significant. Since this isn't mentioned, maybe the authors considered it safe, but the user might need more info. However, the question is about whether the provided data supports efficacy and safety. Since the study performed multiple interventions without noting complications, it leans towards safe, but maybe the user is expecting a 'Yes' here.

Community setting: The study was conducted in a community hospital? The context doesn't specify, but the question is whether it's efficacious and safe in such a setting. If the procedures were done in a community hospital, then the results support that. The mean procedure times and technical details (like distance reached) are comparable to what's expected in specialized centers? Maybe. The fact that they could perform these procedures and achieve these results suggests that with proper training, it's feasible in a community setting.

But wait, the study doesn't mention the setting explicitly. However, the user is asking in a community setting, so the answer should be based on the data provided. The data shows that DBE was used effectively for diagnosis and treatment, with a good confirmation rate from VCE and therapeutic interventions. No complications reported, so assuming safety. Therefore, the answer would be Yes.
</think>

[Yes]",Correct
26037986,pubmedqa_pqa_l,30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking whether the 30-day and 1-year mortality rates in emergency general surgery laparotomies are an area of concern and if there's a need for improvement.

Looking at the context provided, the study found a 30-day mortality rate of 12.4% for patients under 70 and 22% for those over 70. The 1-year mortality was 25.15% and 38% respectively. Both these rates are statistically significant (p<0.001), which suggests that the differences are not due to chance. The authors mention that their aim is to encourage better data collection, improve care, and establish best practices. 

High mortality rates, especially in older patients, indicate that outcomes are suboptimal. The fact that the study is retrospective might mean there's a need for more prospective studies to track outcomes in real-time. The authors themselves state a desire to improve care, which implies that current practices might be lacking. The 30-day mortality rates mentioned (14-15% in recent studies) are in line with the study's findings, showing that this is a consistent issue. The significant difference in mortality between age groups also highlights a potential area where targeted interventions could help. 

Since the study's conclusion points to the need for better strategies and care improvements, the answer should reflect that there is indeed a concern and a need for action. The mortality rates are high enough to warrant attention, especially in older populations. Therefore, the answer should be yes.
</think>

[Yes]",Incorrect
26852225,pubmedqa_pqa_l,Is adjustment for reporting heterogeneity necessary in sleep disorders?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if adjusting for reporting heterogeneity is necessary in sleep disorders, based on the provided context.

First, I need to understand what reporting heterogeneity means here. From the context, it seems to refer to differences in how individuals interpret and use response categories when self-reporting. The study used anchoring vignettes to adjust for this. 

The study compared results from the ordered probit model (without adjustment) and the CHOPIT model (with adjustment). Before adjustment, factors like age, sex, and comorbidities were significant. After adjustment using CHOPIT, sex was no longer significant, while regular exercise became significant. This suggests that the adjustment changed which variables were associated with sleep problems. 

The key point is that the adjustment altered the results, indicating that some associations (like sex) might have been influenced by how people report their symptoms rather than actual differences. Therefore, the study implies that adjusting for reporting heterogeneity is necessary to get a more accurate understanding of the true factors associated with sleep disorders. The answer should be Yes because the adjustment led to different, presumably more valid, results.
</think>

[Yes]",Incorrect
17113061,pubmedqa_pqa_l,Do mutations causing low HDL-C promote increased carotid intima-media thickness?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether mutations that cause low HDL-C (high-density lipoprotein cholesterol) promote increased carotid intima-media thickness (cIMT). 

First, I need to recall the context provided. The study mentioned looked at individuals with mutations in LCAT, ABCA1, and APOA1 genes, which are known to affect HDL levels. They compared these cases with controls matched for sex and age. The key findings were that despite significantly lower HDL cholesterol and apolipoprotein A-I levels in the cases, the cIMT measurements were nearly the same between the two groups. The mean cIMT for cases was 0.66 cm and for controls 0.65 cm, which is a very small difference, and the standard deviations are similar too. The P-value for the HDL and apolipoprotein differences was significant (<0.05), but the cIMT difference wasn't mentioned as significant.

The question is whether these mutations causing low HDL-C lead to increased cIMT. The study's results show that even with lower HDL, the cIMT isn't higher in the cases. This suggests that, at least in these genetic conditions, low HDL doesn't correlate with increased atherosclerosis as measured by cIMT. Observational studies usually find an inverse relationship between HDL and CHD, but genetic deficiencies sometimes don't show the same link. This study supports the idea that low HDL due to these specific mutations doesn't promote increased cIMT. Therefore, the answer would be No, since the cIMT was similar despite lower HDL.
</think>

[No]",Correct
10966337,pubmedqa_pqa_l,A short stay or 23-hour ward in a general and academic children's hospital: are they effective?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if short stay or 23-hour wards in general and academic children's hospitals are effective. The context provided is a study comparing two hospitals, Westmead and New Children's Hospital.

First, I need to look at the outcome measures mentioned. The study looked at length of stay, appropriateness, admission rates to in-hospital beds, unscheduled visits after discharge, adverse events, and cost savings. 

At both hospitals, the short stay wards handled a significant percentage of admissions (10.3% and 14.7%). The average stays were around 17.5 to 20.5 hours, which is under 23 hours for most cases. Only 1% stayed longer. That suggests efficiency in bed usage. 

The rate of moving to an in-hospital bed was low (4% and 6%), and unscheduled visits were under 1%. No adverse events were reported, and parents were satisfied. Plus, there were cost savings due to better bed usage. 

All these points indicate that the short stay wards were effective in managing patients without compromising care, reducing the need for longer admissions, and saving money. The answer should be yes because the outcomes measured show positive results across efficiency, safety, and cost.
</think>

[Yes]",Correct
25432938,pubmedqa_pqa_l,Did Chile's traffic law reform push police enforcement?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if Chile's traffic law reform pushed police enforcement. The context provided is a study analyzing the reduction in traffic fatalities and injuries from 2000-2012, particularly after the 2005 traffic law reform. The study uses variables like the presence of the new law, police officers per population, traffic tickets per officer, and their interaction.

The key points here are the independent variables. The reform itself (variable 1) and the interaction between the number of tickets per officer and the law reform (variable 4) are significant. The results mention that the interaction effect is associated with decreased fatalities and injuries. Additionally, the piecewise regression for 2007-2012 shows that police enforcement (tickets per officer) led to reductions. 

So, the law reform's interaction with enforcement (tickets per officer) is significant. This suggests that the reform may have led to increased enforcement, as the interaction term's effect is part of what caused the decrease. The study's findings imply that the reform either enabled or motivated police to issue more tickets, thus increasing enforcement. Therefore, the answer is likely yes because the interaction term's significance indicates that the reform's presence combined with enforcement actions (tickets) contributed to the outcomes.
</think>

[Yes]",Correct
18847643,pubmedqa_pqa_l,Therapeutic anticoagulation in the trauma patient: is it safe?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if therapeutic anticoagulation is safe for trauma patients. The context provided is a study that looked into complications from using anticoagulants like heparin in trauma patients.

First, the study found that 21% of patients had complications, which is a significant number. The most common issue was a drop in hemoglobin requiring transfusions, and there were a few deaths linked to bleeding from anticoagulation. That suggests there are risks involved.

Then, the analysis identified factors like COPD, use of unfractionated heparin (UH), and lower platelet counts as being associated with higher complications. UH had a higher odds ratio compared to fractionated heparin (FH), so maybe the type of heparin matters. Also, patients on UH vs. FH had different characteristics, which might influence outcomes.

But the study is retrospective, which has limitations. They can't control for all variables, so there might be confounding factors. Also, the sample size is 114 patients, which isn't huge. The fact that 21% had complications is concerning, but maybe in some cases, the benefits of anticoagulation outweigh the risks. The study doesn't say if the anticoagulation was effective, just the complications.

The question is about safety. If 21% had complications, including some deaths, the answer might lean towards ""No"" it's not safe. But the study also shows that certain factors increase risk, so maybe it's safe in some patients but not others. The abstract's conclusion might be that it's not universally safe, but depends on patient factors. However, the user's question is a general ""is it safe?"" Based on the complications reported, the answer would be ""No"" because there's a significant risk. But since some patients didn't have complications, maybe ""Maybe"" is appropriate. Wait, the study's conclusion might say that it's associated with complications, especially in those with certain factors. So the answer would be that it's not safe overall, but the presence of certain factors increases risk. The user's question is a yes/no/maybe. The study shows complications in 21%, so it's not entirely safe. But maybe the answer is ""No"" because there are significant risks. Alternatively, ""Maybe"" because it depends on patient factors. The study's abstract might conclude that it's not safe in certain populations. The user's question is general, so the answer would be ""No"" because the study found a notable complication rate. However, the presence of associated factors might mean that in some cases it's safer. But the question is a general ""is it safe?"" So the answer is [No] because the study shows a significant risk of complications. Alternatively, if the answer is ""Maybe"" because it's safe in some but not others. The study's results indicate that complications are common enough to question safety, but the answer might be ""No"" given the 21% complication rate. The abstract's purpose was to determine incidence and factors. The conclusion might state that therapeutic anticoagulation in trauma patients is associated with a high complication rate, especially with certain factors. Therefore, the answer would be [No], it's not safe. But maybe the authors suggest caution rather than outright unsafe. Hmm. The user is asking for a yes/no/maybe. The study found 21% complications, including deaths. So the answer is [No], because the complications are significant. But maybe the answer is [Maybe] because it's safe in some patients. The study's factors like COPD, UH use, and low platelets are predictors. So if those factors are absent, maybe it's safer. But the question is general. Since the study shows a notable risk, the answer is [No]. But the options are only yes, no, maybe. The study's conclusion might not state it's unsafe, but the data shows risks. So the answer is [No].
</think>

[No]",Correct
18239988,pubmedqa_pqa_l,Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if routine laboratory markers are useful for differentiating between nonalcoholic steatohepatitis (NASH) and alcoholic steatohepatitis (ASH). 

First, I need to look at the context provided. The study reviewed 95 patients with steatohepatitis, split into NASH and ASH based on biopsy and alcohol consumption. They looked at various lab parameters.

The key findings mentioned are that high-grade fibrosis was more common in ASH (59% vs. 19%), and an AST/ALT ratio >1 was also more common in ASH (54.1% vs 20.7%). MCV was elevated in 53% of ASH patients but normal in all NASH patients. Multivariate analysis identified MCV, AST/ALT ratio, and sex as relevant factors with a high aROC of 0.92, which suggests good predictive ability. Additionally, AST/ALT ratio and age predicted high-grade fibrosis.

So, the study is showing that certain routine lab markers (MCV, AST/ALT ratio) along with sex and age can help differentiate NASH from ASH. The high aROC value indicates that these markers are useful in combination. The answer should be yes because the study demonstrates that these routine lab parameters are statistically significant in distinguishing the two conditions.
</think>

[Yes]",Correct
25957366,pubmedqa_pqa_l,Prompting Primary Care Providers about Increased Patient Risk As a Result of Family History: Does It Work?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether prompting primary care providers about a patient's increased risk due to family history works. The context provided is a study that implemented automated, tailored prompts for PCPs regarding familial risks for certain diseases. The main outcomes measured were changes in PCP behavior, documentation of risk in problem lists, and patient screening status.

First, I need to understand the study's findings. The study found that when prompts were present (excluding visits without documentation), PCPs reviewed family history in 53.5% of visits and discussed it in 22.9%. However, in 22.3% of cases, the prompt wasn't addressed. Only a tiny fraction (0.7%) led to tests or referrals. Importantly, there was no significant change in documenting the risk in problem lists or in screening interventions for the diseases studied.

The question is whether these prompts work. The key here is to determine what ""work"" means. If the goal is to get PCPs to review or discuss family history, then there's some effect, as over half the visits had the family history reviewed. But if the goal is to lead to concrete actions like updating problem lists or increasing screenings, then the study shows no significant improvement. The answer hinges on the definition of ""work."" Since the main outcome measures (documentation and screening) didn't improve, the prompts didn't achieve those objectives. However, there was some change in behavior (reviewing/discussing), but maybe not enough to be considered effective overall. The study's conclusion seems to suggest that the prompts didn't lead to the desired outcomes, so the answer would be No.
</think>

[No]",Correct
24866606,pubmedqa_pqa_l,Do emergency ultrasound fellowship programs impact emergency medicine residents' ultrasound education?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether emergency ultrasound (EUS) fellowship programs impact emergency medicine (EM) residents' ultrasound education. The context provided is a study that compared EM residency programs with and without EUS fellowships.

First, I need to recall the key points from the study. The primary outcomes measured were the number of US exams performed, the scope of bedside US applications, barriers to education, and US use in the ED. Secondary outcomes were factors impacting education. The study found that residents in programs with EUS fellowships performed more scans (statistically significant, P=0.04). There were also significant differences in the scope of applications and barriers between the two groups (P<0.05).

The question is whether these findings indicate an impact. The study's conclusion seems to suggest that EUS fellowships do have an impact because residents in those programs performed more scans and had broader applications. The P-values indicate that these differences are not due to chance. However, the abstract mentions that there's no prior evidence supporting that EUS fellowships enhance education, but this study's results show a positive association. 

I need to check if the answer is directly supported. The primary outcome showed more scans in fellowship programs, and the secondary outcomes showed differences in barriers and applications. The authors' purpose was to determine the impact, and their results support that there is an impact. Therefore, the answer should be yes. But wait, the user might be looking for a confirmation based on the study's results. The study's conclusion would likely state that EUS fellowships do impact residents' education, given the findings. So the answer is yes.
</think>

[Yes]",Correct
26578404,pubmedqa_pqa_l,Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether patient-controlled therapy (PCT) for breathlessness in palliative care is a new therapeutic concept for opioid administration.

First, I need to look at the context provided. The study mentioned is a pilot observational study with 18 inpatients. The results showed that using intravenous opioid PCT reduced breathlessness scores over three days. The authors also looked at feasibility and acceptance, which were positive. 

Now, the key here is determining if PCT is a ""new"" concept. The context states that oral, buccal, and parenteral routes are already used, but it's unclear if PCT is an additional option. The study's aim was to investigate if PCT could be effective. Since this is a pilot study, it suggests that PCT might not be widely established yet. However, the question is whether it's a new concept. If existing literature already discusses PCT for breathlessness in palliative care, then maybe it's not entirely new. But the context here presents it as something they're exploring as an additional option, implying it might be a novel approach in this specific application. The conclusion from the study supports its effectiveness, but the question is about the concept's novelty. The answer hinges on whether PCT for breathlessness is established or newly proposed. Given that the study is a pilot and the authors are investigating its viability, it's likely presenting PCT as a new therapeutic concept in this context. So the answer would be Yes.
</think>

[Yes]",Correct
11729377,pubmedqa_pqa_l,Is there still a need for living-related liver transplantation in children?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if there's still a need for living-related liver transplantation (LRT) in children, given the context provided.

First, I need to look at the data from the study. The study compares split-liver transplantation (SLT) and LRT. The results show that patient survival rates are 82% for SLT and 88% for LRT. Graft survival is 76% vs. 81%. So LRT has slightly better outcomes here. 

Then there's the incidence of primary nonfunction: 12% in SLT vs. 2.3% in LRT. That's a big difference. Primary nonfunction is a serious complication, so lower rates in LRT are a plus. 

Liver function parameters like prothrombin time, factor V, and bilirubin clearance didn't differ significantly. So both methods are similar in that aspect. Surgical complication rates are also not significantly different. 

Cold ischemic time is longer in SLT, which could contribute to issues like higher alanine aminotransferase levels post-op. That might indicate more initial liver damage in SLT. 

However, LRT had more grafts with fatty degeneration. Fatty liver might affect graft quality, but the study doesn't mention if this led to worse outcomes. 

The context also mentions that combining SLT and LRT abolished deaths on the waiting list. So maybe the availability of both methods helps prevent deaths. But the question is whether LRT is still necessary. 

Even though SLT (especially in situ) is a good option, LRT has better survival rates and lower primary nonfunction. The higher incidence of fatty degeneration in LRT doesn't seem to negate the survival benefits. Also, the study period ended in 2000, so maybe techniques have improved since then, but based on the given data, LRT still offers advantages. 

But the conclusion in the context raises the question of whether LRT is still needed. However, the data presented here suggests that LRT has some superior outcomes. Unless there are other factors not mentioned, like donor availability or risks to the living donor, the answer might lean towards yes. But the study's own conclusion is questioning the necessity, so maybe there's a maybe here. Wait, the user is asking based on the provided context, not real-world updates. The context says the combination abolished deaths, but the data shows LRT has better outcomes. So the answer would be yes, there's still a need because LRT has better survival and lower complications. But the question is phrased as ""is still necessary,"" and the context mentions that the combination raised the question. However, the data supports that LRT has benefits. So the answer is yes.
</think>

[Yes]",Correct
17096624,pubmedqa_pqa_l,Do patterns of knowledge and attitudes exist among unvaccinated seniors?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether there are patterns of knowledge and attitudes among unvaccinated seniors based on the provided context.

First, I need to recall the context. The study surveyed Medicare beneficiaries over 65 who were unvaccinated for influenza. They clustered these seniors into four groups based on their knowledge and attitudes. The clusters are Potentials, Fearful Uninformeds, Doubters, and Misinformeds. Each group has different beliefs: Potentials are willing to get vaccinated to prevent disease, Fearful Uninformeds are unsure if the vaccine causes illness, Doubters question the vaccine's efficacy, and Misinformeds believe the vaccine causes illness. The percentages also show that some clusters had higher past vaccination rates than others.

The question is whether these clusters represent patterns of knowledge and attitudes. Since the study explicitly clustered them based on these factors and identified distinct groups with varying beliefs and past behaviors, the answer should be yes. The existence of these clusters demonstrates that there are indeed patterns in their knowledge and attitudes towards the influenza vaccine.
</think>

[Yes]",Correct
22694248,pubmedqa_pqa_l,Is there a model to teach and practice retroperitoneoscopic nephrectomy?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if there's a model to teach and practice retroperitoneoscopic nephrectomy. The context provided is a study where they used piglets to develop a training model for retroperitoneoscopy. They performed 15 procedures, divided into two groups, and found that after eight cases (group A), there were significant improvements in operative time, blood loss, and fewer peritoneal openings. The conclusion mentions that the porcine model simulates the entire procedure and that the learning curve was established as eight cases.

So the study's main aim was to create a training model, and they used piglets for that. The results showed that with practice (eight cases), performance improved. Therefore, the answer should be yes because they developed a model using piglets for training purposes. The question is specifically about the existence of such a model, which the study addresses directly.
</think>

[Yes]",Correct
22990761,pubmedqa_pqa_l,Cardiovascular risk in a rural adult West African population: is resting heart rate also relevant?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if resting heart rate (RHR) is relevant as a cardiovascular risk factor in a rural adult West African population. The context provided is a study from Ghana.

First, I need to check what the study found. The study mentions that elevated RHR (>90 bpm) was present in 19% of participants. They also found that RHR was significantly associated with age, waist circumference, and blood pressure. The odds ratio for high BP with elevated RHR was 1.94, which is statistically significant. Additionally, the study states that 79% had at least one CVD risk factor, and RHR's association with BP remained even after adjusting for other risk factors.

The question is whether RHR is relevant here. The study's results indicate that elevated RHR is associated with higher odds of high BP, which is a known CVD risk factor. The authors also mention that RHR is a neglected marker in these populations, implying that their findings suggest it should be considered. Since the study found a significant association, the answer is likely yes. But I need to make sure there's no conflicting info. The regression dilution ratio is 0.75, which might indicate some variability, but the confidence intervals for the OR don't cross 1, so the association is still valid. Therefore, the answer should be yes.
</think>

[Yes]",Correct
19394934,pubmedqa_pqa_l,Israeli hospital preparedness for terrorism-related multiple casualty incidents: can the surge capacity and injury severity distribution be better predicted?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if Israeli hospital preparedness for terrorism-related multiple casualty incidents can have better predictions for surge capacity and injury severity distribution. 

First, I need to look at the context provided. The study evaluated the current readiness guidelines which set 20% of bed capacity as the surge capacity. They found that in 95% of HMCIs, the casualty load was â‰¤52. The mean number of casualties per hospital was around 20.8, with a median of 16.5. Also, 79.2% of casualties didn't need immediate treatment.

The current guideline uses 20% of bed capacity, but the data shows that most incidents have fewer casualties than that. However, the study's data is from 2000-2003. The question is about whether predictions can be improved. Since the study's data might be outdated, maybe newer data or different models could refine the surge capacity. Also, the injury severity distribution showed that a significant portion didn't need immediate care, which could mean resources are being overallocated. So, adjusting based on actual severity data might help. Therefore, the answer is likely yes because there's room for improvement based on more recent or detailed data analysis.
</think>

[Yes]",Correct
11481599,pubmedqa_pqa_l,Acute respiratory distress syndrome in children with malignancy--can we predict outcome?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if we can predict the outcome of acute respiratory distress syndrome (ARDS) in children with malignancy based on the provided study.

First, I need to look at the context given. The study's purpose was to find early respiratory predictors of mortality in these children. They reviewed data from 17 children over a 10-year period. The key findings mention that by day 3, certain parameters like peak inspiratory pressure, PEEP, and ventilation index could distinguish outcomes. Additionally, oxygenation efficiency (PaO2/FIO2 and P(A-a)O2) was significant from day 8.

The question is whether outcome prediction is possible. The study identifies specific respiratory metrics that correlate with survival or mortality. Since they found predictors by day 3 and day 8, that suggests that yes, there are indicators that can help predict outcomes. The answer should be yes because the study provides evidence of measurable factors linked to survival rates.
</think>

[Yes]",Correct
21669959,pubmedqa_pqa_l,Secondhand smoke risk in infants discharged from an NICU: potential for significant health disparities?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether there's potential for significant health disparities related to secondhand smoke (SHS) risk in infants discharged from the NICU.

First, I need to recall the context provided. The study looked at families with high-risk infants in a Houston NICU, focusing on smoking practices. They found that 26% of these families had a household smoker. Almost half of those with a smoker had an income under $25k. The presence of total smoking bans (both home and car) was 46.2% overall. But when breaking it down by income, only 27.8% of lower-income families had bans compared to nearly 60% in higher-income families. That's a big difference and statistically significant (p<0.01). 

Then, race/ethnicity: African American and Caucasian families were less likely to have bans than Hispanics (p<0.05). Also, mothers without bans were more depressed. 

So, health disparities typically refer to differences in health outcomes linked to social, economic, or environmental disadvantages. Here, lower-income families and certain racial groups have lower rates of smoking bans, which would increase SHS exposure for their infants. Since these infants are already high-risk (very low birth weight, ventilated), SHS could worsen their respiratory issues. 

The income and racial differences in smoking bans suggest that these groups might have higher SHS exposure, leading to worse health outcomes. This creates a disparity because the risk isn't evenly distributed; it's concentrated in lower-income and non-Hispanic families. The link to maternal depression adds another layer, as mental health can affect the ability to implement bans. 

Therefore, the data points to significant health disparities based on socioeconomic status and race, which could lead to unequal health outcomes for these infants. The answer should be yes.
</think>

[Yes]",Correct
23806388,pubmedqa_pqa_l,Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether nomograms designed to predict biochemical recurrence (BCR) are better at predicting more clinically relevant outcomes like prostate cancer-specific mortality (PCSM) than they are at predicting BCR itself.

First, I need to recall the context provided. The study looked at four postoperative nomograms (DPC, Kattan, JHH, CPDR/CaPSURE) in the SEARCH database. They used Cox analyses and calculated c-index values to assess predictive accuracy for BCR, aggressive BCR (PSADT <9 months), and PCSM.

The key findings mentioned are that all nomograms could predict aggressive BCR and PCSM significantly. Moreover, they predicted PCSM more accurately than BCR, as indicated by higher c-index values. The question is about whether these nomograms, designed for BCR, perform better for more relevant outcomes like PCSM.

The study's conclusion directly states that the nomograms predicted PCSM more accurately than BCR. Since PCSM is a more definitive and clinically relevant endpoint compared to BCR, this suggests that the answer is yes. The nomograms' higher c-index for PCSM implies better performance for that outcome. Therefore, the answer should be yes.
</think>

[Yes]",Correct
17919952,pubmedqa_pqa_l,Are reports of mechanical dysfunction in chronic oro-facial pain related to somatisation?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's try to figure out if the reports of mechanical dysfunction in chronic oro-facial pain are related to somatisation based on the given context.

First, the study's objectives were to look at the association between self-reported mechanical factors (like teeth grinding, facial trauma, etc.) and chronic oro-facial pain. They also wanted to see if psychological factors or other unexplained syndromes could explain this relationship.

The results showed that even after adjusting for psychological factors, teeth grinding and facial trauma were still independently associated with chronic oro-facial pain. However, these same mechanical factors were also linked to other unexplained syndromes. The study mentions that these syndromes are ""frequently unexplained,"" which might imply that they are related to somatisation, where psychological distress manifests as physical symptoms.

Somatisation often involves reporting physical symptoms that can't be fully explained by medical conditions, and these symptoms might be associated with psychological factors. The fact that the mechanical factors (teeth grinding and facial trauma) are associated with other unexplained syndromes suggests that there might be an underlying tendency to report various physical symptoms, possibly due to somatisation. Additionally, even though psychological factors were adjusted for, the presence of other syndromes might indicate a broader pattern of somatisation influencing the reporting of mechanical dysfunction.

So, the connection between mechanical factors and other unexplained syndromes points towards somatisation being a factor. Therefore, the answer is likely yes.
</think>

[Yes]",Correct
10966943,pubmedqa_pqa_l,Amblyopia: is visual loss permanent?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if visual loss from amblyopia is permanent. The context provided is a study on patients with age-related macular degeneration. They found 12 cases where the unaffected eye (the one without macular disease) showed improved visual acuity without other treatments. Nine of these had a history of amblyopia. The mean improvement was 3.3 lines for distance and 1.9 for near vision, occurring between 1-12 months and remaining stable.

So, amblyopia is often called ""lazy eye,"" and traditionally, it's thought that if not treated early in childhood, the visual loss becomes permanent. But this study shows that in some adults with amblyopia, there was improvement in vision even without treating the amblyopia directly. The improvement happened over months and stayed stable. That suggests that maybe amblyopia-related visual loss isn't always permanent, at least in some cases. However, the sample size here is small (9 eyes), and the patients were part of a macular degeneration study. Also, the improvement was in the eye without macular disease, which was the amblyopic eye. So maybe the other eye's condition (macular degeneration) led to the brain relying more on the amblyopic eye, thus improving its acuity. That could be a form of visual therapy. The study's results challenge the notion of permanence, indicating possible plasticity in the adult visual system. But the answer depends on whether this improvement is a common occurrence or a rare case. The study shows it's possible, so the answer might be ""No"" or ""Maybe,"" but traditional teaching says ""Yes."" However, the context here provides evidence against permanence, so the answer should be ""No"" based on the given data.
</think>

[No]",Correct
23690198,pubmedqa_pqa_l,Implementation of epidural analgesia for labor: is the standard of effective analgesia reachable in all women?,yes,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether the standard of effective analgesia is reachable in all women with the implementation of epidural analgesia for labor.

First, I need to look at the context provided. The study was an audit over two years evaluating the implementation of epidural analgesia. The standards they set included effectiveness of labor analgesia as one of the four criteria. 

The results showed that epidural use increased from 15.5% to 51% over the study period. Satisfaction levels were good. The VAS scores decreased significantly in both clusters. Cluster 1 had a reduction from 8.5 to 4.1, while Cluster 2 went from 8.12 to 0.76. The study mentions that in Cluster 2, the reduction was more substantial and statistically significant compared to Cluster 1. However, there were no other differences between the clusters. 

The key point here is that while effectiveness was achieved in terms of reducing pain (since both clusters showed significant decreases), Cluster 1's post-epidural VAS was still 4.1, which might not be considered as effective as Cluster 2's 0.76. The question is whether effective analgesia is reachable in *all* women. The data shows that there's variability in outcomes. Some women (Cluster 2) achieved almost complete pain relief, while others (Cluster 1) had moderate relief. 

The study doesn't mention why there's a difference between the clusters. Possible factors could be individual variations in pain perception, technical aspects of epidural administration, or other unmeasured variables. Since the standard is about effectiveness, and effectiveness is demonstrated in both clusters but to varying degrees, the answer might hinge on how ""effective"" is defined. If the standard requires a VAS reduction to near zero, then not all women reached that. If the standard is a significant reduction, then yes. The study states effectiveness as one of the standards, but the clusters show different levels of effectiveness. Therefore, the answer might be that while effective analgesia is achievable, it's not uniformly achieved in all women to the same extent. Hence, the answer could be ""No"" because not all reached the highest effectiveness, or ""Maybe"" if the standard allows for some variability. However, the study's own conclusion might consider the standard met if there's a significant reduction, but the question is about reachable in *all* women. Since Cluster 1 still had a VAS of 4.1, which is moderate pain, maybe the standard isn't fully met for all. So the answer is likely [No] because not all women achieved the same level of effectiveness.
</think>

[No]",Incorrect
17940352,pubmedqa_pqa_l,Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether HER2 immunoreactivity gives prognostic information for patients with locally advanced urothelial carcinoma who received adjuvant M-VEC chemotherapy.

First, I need to look at the context provided. The study examined 114 patients who either had surgery alone or adjuvant M-VEC. They looked at HER2 immunoreactivity using immunohistochemistry and analyzed its impact on progression-free survival (PFS) and disease-specific overall survival (OS) using univariate and multivariate Cox analyses.

In the results, HER2 immunoreactivity was significantly associated with PFS and OS in advanced urothelial carcinoma overall. But when focusing specifically on the adjuvant M-VEC group, HER2 was a significant prognostic factor in univariate analysis for both PFS (p=0.03) and OS (p=0.02). However, in multivariate analysis, it wasn't significant. Also, it wasn't prognostic for the watchful waiting group.

The key here is that the question is about adjuvant M-VEC patients. The study found significance in univariate but not multivariate analysis. Since multivariate adjusts for other variables like nodal status (which was a strong independent prognostic factor), HER2's effect might not hold when considering other factors. But the question is whether HER2 provides prognostic information. Even if it's only in univariate, that still suggests some prognostic value, but maybe not independent. However, the answer might depend on whether the user considers univariate results sufficient. The study's conclusion for the M-VEC group is that HER2 was significant in univariate but not multivariate. So the answer would be yes, it provides prognostic info in univariate, but not when adjusted. The question is phrased as ""provide prognostic information"" without specifying multivariate. So maybe the answer is yes, but with caveats. However, the options are Yes, No, Maybe. The answer here is Maybe, because in univariate it's yes, but multivariate no. But the question is whether it provides any prognostic info. Since univariate shows significance, the answer would be Yes. Wait, but the study says ""not for patients receiving watchful waiting,"" but for M-VEC, it was significant in univariate. So the answer is Yes. But the user might be confused because multivariate wasn't significant. However, the question is about providing prognostic information, which univariate analysis does. So the answer is Yes. But the study's conclusion might be that it's not an independent factor. But the question is whether it provides any prognostic info. So the answer is Yes. Wait, the original answer in the context says ""HER2 immunoreactivity was a significant prognostic factor for PFS and OS using univariate analysis, but not multivariate analysis."" So in the context of the study, for M-VEC patients, HER2 is prognostic in univariate. Therefore, the answer is Yes. But the user might think multivariate is required. However, the question doesn't specify. So according to the data, the answer is Yes. But the study's conclusion might say that it's not independent. But the question is about providing prognostic information, which univariate shows. So the answer is Yes. But the options are Yes, No, Maybe. The answer is Yes. Wait, but the study says ""not multivariate analysis, and not for patients receiving watchful waiting."" So for M-VEC, univariate yes, multivariate no. The question is whether HER2 provides prognostic info in M-VEC patients. Since univariate shows significance, the answer is Yes. Therefore, the answer is [Yes].
</think>

[Yes]",Incorrect
20537205,pubmedqa_pqa_l,Is halofantrine ototoxic?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether halofantrine is ototoxic, which means toxic to the ears, specifically the structures involved in hearing. The context provided is a study on guinea pigs. The control group showed no changes. The therapeutic dose group had damage to inner hair cells, inner phalangeal cells, and loss of spiral ganglia cells. The double dose group had even more damage, affecting both inner and outer hair cells plus spiral ganglia loss.

Since ototoxicity typically refers to damage to the cochlea or auditory structures leading to hearing loss, and the study found structural damage in the cochlea of the treated groups, that suggests ototoxicity. Even though there's no direct hearing test mentioned, structural damage in the cochlea (like hair cell loss) is a strong indicator. The control group was fine, so the changes are likely due to the drug. The dose-dependent effect (worse with higher dose) also supports a causal relationship. However, the study is on animals, not humans, so there's some uncertainty. But based on the given info, the answer is probably yes.
</think>

[Yes]",Correct
28707539,pubmedqa_pqa_l,Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is asking if measuring visceral adipose tissue (VAT) area at a single level on a CT scan can represent the entire VAT volume. The study they mentioned used 60 CT images from 30 men, looking at different slice locations. They found that the slice 3 cm above L3's lower margin had the strongest correlation with VAT volume and body weight changes, with r values of 0.853 and 0.902. 

Hmm, high correlation coefficients, especially 0.902 for body weight. But the question is about representing VAT volume. An r of 0.853 is strong but not perfect. So even though it's a single slice, the high correlation suggests that this specific slice's area is a good indicator of the overall volume. But does a strong correlation mean it can fully represent the volume? Maybe not entirely, since it's still a single slice and volume is a 3D measure. However, the study's results imply that this particular slice is the best single-level measurement for tracking changes. So the answer would probably be yes, based on the study's findings. But I should check if the question is about whether it can represent it, not if it's perfect. Since the correlation is strong, the answer is likely yes.
</think>

[Yes]",Correct
7482275,pubmedqa_pqa_l,Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether necrotizing fasciitis (NF) is an indication for hyperbaric oxygenation (HBO) therapy. The context provided is a study comparing outcomes between patients treated with HBO plus standard care (surgery and antibiotics) versus those with standard care alone.

First, I need to recall what the study found. The HBO group had a higher mortality rate (36% vs. 25%) and required more surgical debridements (3.3 vs. 1.5). The hospitalization length was shorter for HBO survivors, but not statistically significant. The groups were similar in other factors like age, APACHE II scores, etc. The conclusion here seems to suggest that HBO didn't improve mortality and actually required more surgeries. However, the study mentions HBO is controversial as an adjuvant therapy. 

The question is whether HBO is indicated for NF. Indications usually require evidence of benefit. The study's results don't support HBO reducing mortality; in fact, mortality was higher in the HBO group. More surgeries might indicate more severe cases, but the study says the groups were similar in severity. The lack of statistical significance in hospitalization stay also doesn't help. 

But the context says HBO has been recommended as adjuvant therapy despite controversy. The study's results might not show a benefit, but maybe other studies do? However, based solely on the provided data, the answer leans towards no. However, the user might be looking for a ""maybe"" because the recommendation exists but the evidence here is conflicting. But the study's own results here don't support HBO, so the answer would be no. Wait, but the question is whether it's an indication. If the study's results are negative, but some guidelines still recommend it, maybe the answer is maybe. But the user is asking based on this study. Since the study shows higher mortality and more surgeries with HBO, the answer would be no. But the context says HBO is recommended but controversial. So maybe the answer is maybe. Hmm. The study's results don't support HBO, but the controversy exists. The question is whether it's an indication. If the study's conclusion is that HBO isn't beneficial, then the answer would be no. But the study's own conclusion isn't stated here. The user provided the study's results. So based on the data given, HBO didn't improve mortality and required more surgeries, so the answer would be no. But the initial context says HBO has been recommended. So maybe the answer is maybe. But the study here doesn't support it. The user is asking if it's an indication based on this study. So the answer would be no. But the user might want maybe because the recommendation exists. But the study's data here doesn't support it. So the answer is no. But the user might expect maybe. Wait, the study is retrospective, which is not as strong as a randomized trial. The higher mortality in HBO could be because they were sicker, but the study says the groups were similar. So the answer is no. So the answer is [No].
</think>

[No]",Correct
24183388,pubmedqa_pqa_l,Is the Hawkins sign able to predict necrosis in fractures of the neck of the astragalus?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if the Hawkins sign can predict avascular necrosis (AVN) in astragalus (talus) neck fractures.

First, I need to recall what the Hawkins sign is. From what I remember, the Hawkins sign is a radiographic finding seen in the talus. It's a subchondral lucency in the talar dome that appears 6-8 weeks after a fracture. Its presence suggests preserved blood flow, so it's a good prognostic indicator that AVN might not develop. If the sign is absent, there's a higher risk of AVN.

Looking at the context provided: The study had 23 talar neck fractures. They classified them using the Hawkins classification (types I-IV). Out of these, 4 cases developed AVN. The Hawkins sign was observed in 12 cases, none of which developed necrosis. Conversely, 4 cases with a negative Hawkins sign did develop AVN. The statistical analysis showed a significant p-value of 0.03 when comparing the presence of Hawkins sign with AVN development. 

The study also looked at other factors like fracture displacement, soft tissue injury, and treatment delay, but none of those were statistically significant. So the key finding here is that the Hawkins sign was a significant predictor. 

The question is asking if the Hawkins sign can predict AVN. The results here show that when the Hawkins sign was present (positive), none developed AVN. When it was absent (negative), 4 did. The p-value is 0.03, which is below the typical 0.05 threshold, indicating statistical significance. 

Therefore, based on this study, the Hawkins sign does seem to be a predictor. The answer should be yes. But wait, the study is retrospective and has a small sample size (23 cases, 4 AVN). However, the results are statistically significant. The conclusion here aligns with existing literature that the Hawkins sign is a useful predictor. So the answer is yes.
</think>

[Yes]",Incorrect
9645785,pubmedqa_pqa_l,Is a mandatory general surgery rotation necessary in the surgical clerkship?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether a mandatory general surgery rotation is necessary in the surgical clerkship based on the provided context.

First, I need to understand the context. The study mentioned tested if students could achieve the same mastery of objectives with or without a general surgery rotation. Students chose any two surgical rotations and were assessed through various methods: written exams, OSCE, ward evaluations, self-assessment, and satisfaction surveys. The data from 54 students showed no differences in scores between the groups. Also, there were no specific concerns noted about not having a general surgery rotation.

So the key points here are that when students weren't required to do general surgery (they could choose any two rotations), their performance was the same across all assessment parameters. The study's hypothesis was supported, suggesting that the mandatory rotation might not be necessary. The absence of general surgery didn't lead to any issues in the outcomes measured.

The question is whether the mandatory rotation is necessary. The study's results imply that it might not be, since there was no difference in mastery. However, I should check if there are any limitations. The sample size is 54 students, which might be small, but the results are clear. Also, the assessments covered various aspects, so it's comprehensive. The conclusion from the data is that the mandatory rotation isn't needed for achieving the clerkship objectives. Therefore, the answer would be No.
</think>

[No]",Correct
26298839,pubmedqa_pqa_l,Is Acupuncture Efficacious for Treating Phonotraumatic Vocal Pathologies?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The study is about whether acupuncture is effective for treating phonotraumatic vocal fold lesions. The design includes three groups: genuine acupuncture, sham acupuncture, and no treatment. The genuine group had needles in specific acupoints, sham used blunted needles on the same points, and the control had no treatment.

The results showed that both genuine and sham groups improved in vocal function and quality of life, but only the genuine group had structural improvements in lesion size. The no-treatment group didn't improve. 

Now, the question is whether acupuncture is efficacious. The key here is to differentiate between specific effects of acupuncture (due to the actual technique) and non-specific effects (like placebo). The sham acupuncture here is a good control because it mimics the procedure without the actual needling. Both genuine and sham groups improved similarly in function and QoL, which suggests that the improvement might be due to placebo effects or other non-specific factors. However, the genuine group had structural improvements that the sham didn't. So, for structural changes, acupuncture seems effective. But for functional and QoL outcomes, since both groups improved, it's unclear if it's the acupuncture itself. 

Efficacy usually refers to the specific effect of the treatment beyond placebo. Since structural improvements are only in the genuine group, that supports efficacy for that aspect. But the functional and QoL improvements are present in both, so maybe not. The answer might be ""Yes"" because there's some efficacy in structural terms, but the question is general. Alternatively, maybe ""Maybe"" because the results are mixed. But the study does show that genuine acupuncture leads to structural changes, which sham doesn't. So, considering the structural part, which is a direct measure of the lesion, the answer could be Yes. However, the functional improvements are not different between genuine and sham. The question is about efficacy overall. If the structural improvement is a key outcome, then yes. But if the main outcomes are functional and QoL, then maybe not. The study's conclusion might be that acupuncture has some efficacy, especially for structural changes. So the answer is Yes.
</think>

[Yes]",Correct
24153338,pubmedqa_pqa_l,Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if aneurysm repair is justified for patients aged 80 or older after aSAH. The study they provided compared surgical treatments (clipping or coiling) versus conservative treatment in this age group.

First, the study excluded inoperable cases like those dead-on-arrival or with both pupils dilated, so the remaining patients were likely candidates where surgery was feasible. The results showed that those who had aneurysm repair (either clipping or coiling) had significantly better clinical outcomes compared to the conservative group. Importantly, factors like WFNS grade and premorbid Rankin Scale were similar between groups, which suggests that the groups were comparable in terms of initial severity and pre-existing conditions. 

The sample size is 69, which isn't huge but still provides some evidence. The age range up to 98 is notable, as very elderly patients are often understudied. The fact that outcomes were better with intervention suggests that repair could be beneficial. However, the study is retrospective and non-randomized, so there might be selection bias. For example, families choosing conservative treatment might have had other unmeasured factors influencing their decision, like comorbidities not accounted for. Also, the study doesn't mention complications or quality of life post-treatment, which are important in elderly populations. 

But based purely on the data presentedâ€”better outcomes without differences in baseline severityâ€”it seems to support the justification. The answer would lean towards yes, but with caveats about study limitations. The user might be a medical professional considering treatment options for elderly patients. They need a concise answer based on the study's findings. The study's conclusion is that repair is feasible and beneficial, so the answer is likely yes.
</think>

[Yes]",Correct
18534072,pubmedqa_pqa_l,Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether general practice characteristics influence the uptake of an IT innovation in primary care. The context provided is a study evaluating the association between structural characteristics of general practices and their use of a web-based clinical information system for diabetes care.

First, I need to recall the key findings from the study. The researchers looked at variables like practice list size, training status, number of GPs, GP age, number of female GPs, deprivation level, and whether staff had advanced diabetes training. They used regression analysis to see if these factors were linked to the system's use.

The results mentioned that overall use became more evenly spread over time, especially among nurses. However, GP use was high in only a few practices and decreased over the years. The regression analysis found that none of the practice variables were associated with online use except for the number of diabetes-educated staff. This factor was consistently linked to increased use by both nurses and GPs.

So, the question is whether practice characteristics influence uptake. The study found that most structural characteristics (like list size, training status, etc.) didn't have an effect. The only exception was the number of staff with advanced diabetes training. Since this is a characteristic related to the staff's training (a structural aspect of the practice), it does count as a practice characteristic influencing uptake. Therefore, the answer should be yes, but only in the case of diabetes-educated staff. However, the question is phrased generally about practice characteristics. Since the majority of the variables tested didn't show an association, but one did, the answer is that there is an influence, but only from that specific characteristic. The study's conclusion is that except for diabetes-educated staff, other variables didn't matter. So the answer is yes, but with the caveat. However, the question is a yes/no/maybe. The presence of at least one characteristic (diabetes-trained staff) that influenced uptake means the answer is yes. The other variables didn't, but the question isn't asking if all characteristics do, just if any do. Therefore, the answer is yes.
</think>

[Yes]",Incorrect
8847047,pubmedqa_pqa_l,Prognosis of well differentiated small hepatocellular carcinoma--is well differentiated hepatocellular carcinoma clinically early cancer?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether well-differentiated small hepatocellular carcinoma (HCC) is considered clinically early cancer based on the study provided.

First, I need to understand the context. The study compared well-differentiated (w-d) HCCs (grade I) with less differentiated (l-d) HCCs (grades I-II, II-III, III) in 76 patients. The main findings were that w-d HCCs had lower fibrous capsule formation but no significant differences in intrahepatic metastasis, portal vein invasion, or disease-free survival compared to l-d HCCs. Also, the transparent specimen showed intact portal veins in w-d HCC, but microscopic infiltration was present. The tumor doubling time analysis suggested that recurrent foci might have been present at the time of surgery.

The question is about prognosis and whether w-d HCC is early-stage cancer. The study's conclusion seems to indicate that even though w-d HCCs are less aggressive in some features (like capsule formation), the recurrence rates and survival outcomes are similar to l-d HCCs. The presence of microscopic infiltration and possible existing minute foci at surgery suggests that even these well-differentiated tumors might not be truly early stage, as they could already have micrometastases. However, the study's sample size for w-d HCC is small (10 patients), which might affect the statistical power. The lack of difference in survival and recurrence despite differentiation status could imply that differentiation alone doesn't determine early stage. But the study's title and purpose aim to examine if w-d HCC is early cancer, and the findings don't strongly support that it is, given the similar outcomes. So the answer might be No, but maybe there's uncertainty due to the small sample. Alternatively, Maybe if the evidence is inconclusive. However, the study's results lean towards no significant difference in prognosis, suggesting that w-d HCC isn't necessarily early cancer. So the answer is likely [No].
</think>

[No]",Correct
10575390,pubmedqa_pqa_l,Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether follow-up recommendations for abnormal Pap smears influence patient adherence.

First, I need to look at the context provided. The study compared adherence between colposcopy and repeated Pap smears. The main outcome was adherence rates. The results showed that the type of follow-up (colposcopy vs. Pap) didn't have a significant difference in adherence (OR 1.40, CI 0.80-2.46). However, the number of reminders (up to 3) improved adherence. Also, factors like not having insurance and the specific clinic affected adherence.

The question is about whether the recommendations themselves (i.e., the type of follow-up) influence adherence. The study found no significant difference between the two types, suggesting that the specific recommendation (colposcopy vs. Pap) doesn't affect adherence. But other factors like reminders and insurance do. So the answer might be no, since the type of recommendation didn't matter, but the reminders (which are part of follow-up protocols) did. Wait, but the question is about follow-up recommendations influencing adherence. The study's conclusion mentions that reminders (part of the follow-up process) improved adherence. So maybe the answer is yes, because the number of attempts (reminders) influenced adherence. But the original question is about the recommendations (colposcopy vs. Pap), not the reminders. The study found that the type of recommendation didn't affect adherence, but the follow-up attempts (reminders) did. So the answer depends on interpreting ""follow-up recommendations"" as the type (colposcopy vs. Pap) or the process (including reminders). The study's conclusion says that reminders improved adherence, so if the recommendations include the reminder protocols, then yes. But the main comparison between colposcopy and Pap showed no difference. The question is a bit ambiguous. The study's conclusion states that adherence wasn't different between the two types, but reminders (part of follow-up) did help. So the answer might be yes, because the follow-up process (including reminders) affects adherence, even if the type of test doesn't. But the question specifically asks if the recommendations (presumably the type) influence adherence. The study's result says the type doesn't, but the number of reminders does. So maybe the answer is yes, because the follow-up process (including reminders) is part of the recommendations. Alternatively, if the recommendations are just the test type, then no. The study's abstract mentions that the protocols (reminders) were applied regardless of the test type. So the adherence was influenced by the number of reminders, not the test type. Therefore, the follow-up recommendations (as in the protocols including reminders) do influence adherence. But the main comparison between colposcopy and Pap didn't. The question is a bit ambiguous. The answer might be yes, because the study found that reminders (part of follow-up recommendations) improved adherence. But if the question is strictly about the type of recommendation (colposcopy vs. Pap), then no. The user's question is phrased as ""follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?"" The study's conclusion is that the type of follow-up (colposcopy vs. Pap) didn't affect adherence, but the number of reminders did. So the answer is yes, because the follow-up process (including reminders) does influence adherence, even if the specific test type doesn't. Therefore, the answer is yes.
</think>

[Yes]",Incorrect
20084845,pubmedqa_pqa_l,Biomolecular identification of allergenic pollen: a new perspective for aerobiological monitoring?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether biomolecular identification of allergenic pollen offers a new perspective for aerobiological monitoring. 

First, I need to recall the context provided. The study aimed to test a real-time PCR approach as an alternative to traditional optical methods for pollen detection. The traditional method is time-consuming and limits expanding the sampling network. The researchers modified DNA extraction from pollen, identified taxon-specific sequences, developed primers and probes, and tested the accuracy on three species. They found that their PCR method could identify pollen taxa accurately, even from routine samples, and did preliminary quantification successfully.

So, the question is whether this biomolecular approach (using PCR) presents a new perspective. The study shows that PCR can be faster and more automated, which addresses the limitations of the current methods. The results were positive in terms of accuracy and feasibility. Since the conclusion is that this method works and could enhance monitoring networks by being quicker and allowing automation, it does suggest a new approach. Therefore, the answer should be yes. But wait, maybe I should check if the study's results are conclusive enough. They tested on three species and in mixes, which is a start but maybe limited. However, the question is about a ""new perspective,"" not full validation. The fact that they demonstrated feasibility and some successful applications indicates that it's a promising direction. So yes, this does offer a new perspective.
</think>

[Yes]",Correct
15703931,pubmedqa_pqa_l,Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether diabetes mellitus (DM) affects the efficacy of FDG-PET in diagnosing cervical cancer.

First, I need to recall the context provided. The study compared FDG-PET's diagnostic ability in cervical cancer patients with and without DM. They categorized patients into hyperglycemic DM, euglycemic DM, and non-DM groups. The key metric here is the area under the curve (AUC) from ROC analysis, which measures how well the test distinguishes between diseased and non-diseased.

The results showed that for both metastatic lesions and primary/local recurrence, the AUC values across the three groups (hyperglycemic DM, euglycemic DM, non-DM) were not significantly different. The P-values were greater than 0.05, indicating no statistical difference. However, when all DM patients (both hyperglycemic and euglycemic) were considered together, PET had a higher AUC compared to MRI/CT for metastatic lesions, which was significant (P=0.012). 

The question is specifically about DM's influence on PET's efficacy. The study's conclusion here is that the diagnostic power (AUC) of PET didn't differ significantly between the DM subgroups and non-DM group. Even though hyperglycemia can influence FDG uptake, the results here suggest that in this study, DM (whether controlled or not) didn't significantly affect PET's diagnostic efficacy for cervical cancer. The part where PET was better than MRI/CT in DM patients overall is a separate comparison and doesn't directly address whether DM affects PET's efficacy compared to non-DM cases. 

So, based on the provided data, the answer would be that DM does not significantly influence the efficacy of FDG-PET in diagnosing cervical cancer, hence the answer is No.
</think>

[No]",Correct
18269157,pubmedqa_pqa_l,Biomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman's keratomileusis?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether there's a difference in biomechanical and wound healing characteristics between Advanced Surface Ablation (ASA) and Sub-Bowman's Keratomileusis (SBK) after excimer laser surgery.

First, I need to recall the context provided. The study compared various procedures, including ASA and SBK. The key points mentioned are:

1. **Biomechanical Safety**: PRK and ASA are considered biomechanically safer than LASIK because they preserve more of the anterior stromal tissue, which is stronger. SBK is mentioned as being secondarily safer than conventional LASIK but not as much as PRK/ASA. The cohesive tensile strength tests showed the anterior cornea is stronger, so procedures that spare this area (like ASA) are better.

2. **Wound Healing**: 
   - ASA (a type of surface ablation like PRK) can lead to corneal haze or breakthrough haze due to hypercellular fibrotic scarring. This is a disadvantage because the healing is more active but can cause opacity.
   - SBK, similar to LASIK, creates an interface with a hypocellular primitive scar. This leads to potential interface complications both short and long-term, but less haze compared to ASA.

So, the differences are:
- **Biomechanically**, ASA is safer (less risk of ectasia) than SBK because it preserves more anterior stroma.
- **Wound Healing**: ASA has issues with haze due to more active healing, while SBK has interface complications but less haze.

The study directly compares these two (ASA and SBK) in terms of both biomechanics and wound healing. The answer should be Yes, there are differences in both aspects.
</think>

[Yes]",Correct
25489696,pubmedqa_pqa_l,Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether radiotherapy for the primary rectal cancer affects the prognosis after pelvic exenteration for recurrent rectal cancer. 

First, I need to look at the context provided. The study compared patients who had radiotherapy as part of their primary treatment with those who didn't. The outcomes measured included resection margins, overall survival, disease-free survival, and surgical complications.

From the results, the group that received radiotherapy had more radical exenterations needed, lower clear resection margins (63% vs 87%), higher surgical complications, and lower disease-free survival. Even when margins were clear, overall and disease-free survival were still lower in the irradiated group. The multivariate analysis also supported these findings after adjusting for T and N stages.

The limitations mentioned are the retrospective design and varied radiotherapy regimens, but the results consistently show negative impacts on several key prognosis indicators. So, the answer should be yes because the study demonstrates that radiotherapy for the primary cancer is associated with worse outcomes after exenteration for recurrence.
</think>

[Yes]",Correct
14599616,pubmedqa_pqa_l,Can a practicing surgeon detect early lymphedema reliably?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's try to figure out the answer to the question. The question is whether a practicing surgeon can detect early lymphedema reliably based on the information provided.

First, I need to understand the context. The study involved 90 breast cancer patients who were monitored for three years with quarterly measurements of seven upper arm circumferences. The criteria for identifying lymphedema were a 10% volume increase or a greater than 1 cm increase in arm circumference, verified by a specialist. The study compared different criteria's sensitivity and specificity.

The results showed that using a 10% increase at two sites had a sensitivity of 37%, meaning only 37% of actual cases were detected. When using a 10% increase at any site, sensitivity went up to 49%. But when they used a 5% increase at any site, sensitivity jumped to 91%. 

So, the key here is sensitivity. High sensitivity means that the test correctly identifies most of the true cases. If a 5% increase at any site gives 91% sensitivity, that's pretty good. However, the question is about a practicing surgeon's ability to detect early lymphedema reliably. The study's method uses circumference measurements, which are simpler than volume measurements. 

But wait, the study's standard is the academic trial, which uses these circumference criteria verified by a specialist. The different criteria's sensitivities are compared against this standard. The 5% criterion has high sensitivity, so if the surgeon uses that, they might detect most cases. However, specificity isn't mentioned here. High sensitivity might come with lower specificity, meaning more false positives. But the question is about reliable detection, which might prioritize sensitivity for early detection, even if some false positives occur. 

However, the question is whether the surgeon can detect early lymphedema ""reliably."" If the method with 91% sensitivity is considered reliable, then maybe yes. But reliability also depends on specificity. If the specificity is low, there could be many false positives, making it less reliable. But the context doesn't provide specificity numbers. The answer might hinge on the high sensitivity. Since the 5% criterion catches 91% of cases, perhaps that's reliable enough for early detection, even if some cases are missed. But the question is about the surgeon's ability. If they use the 5% method, then maybe they can. But the study's verification was by a specialist, so maybe the surgeon can use the same method. 

Alternatively, maybe the answer is no because even with 91% sensitivity, there's still 9% missed. But ""reliably"" might not require 100%, just sufficiently high. The answer could be maybe if there's uncertainty, but the data shows 91% sensitivity with the 5% criterion, which is quite high. So perhaps the answer is yes, but the options are yes, no, maybe. The study shows that using a 5% increase in circumference at any site has high sensitivity, so a surgeon using that criterion could detect most cases. Therefore, the answer might be yes. But wait, the original detection method in the academic trial was the 10% volume or 1 cm increase. The 5% circumference method is compared against that. If the academic trial is the standard, then the 5% method is more sensitive but maybe less specific. However, the question is about the surgeon's ability to detect early cases. If the 5% method is more sensitive, then using that could allow reliable detection. So the answer would be yes. But maybe the answer is maybe because the context doesn't mention specificity, and reliability requires both sensitivity and specificity. But the question is about detecting early cases, which might prioritize sensitivity. The answer could be yes because the 5% criterion has 91% sensitivity, which is high. So the surgeon can detect early lymphedema reliably using that method. Therefore, the answer is [Yes].
</think>

[Yes]",Incorrect
22537902,pubmedqa_pqa_l,Colorectal cancer with synchronous liver metastases: does global management at the same centre improve results?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user wants to know if global management (GM) at the same center improves results for colorectal cancer with synchronous liver metastases compared to separate management (SM). 

First, I need to look at the study details. The study is retrospective, covering 2000-2006, with 45 GM and 66 SM patients. The groups had similar morphologic characteristics and types of resections, so baseline comparability might be okay.

Looking at outcomes: For delayed liver resection, SM had more chemotherapy prior to liver surgery (92% vs 38%, significant p-value). The delay between procedures was longer in SM (212 vs 182 days, p=0.04). GM did more liver resections during the initial colorectal surgery (62% vs 6%, p<0.0001) and had fewer total procedures (1.6 vs 2.3, p=0.003). 

Mortality at 3 months was 3% GM vs 0% SM, but not significant. Survival rates at 3 and 5 years were similar between groups. However, disease-free survival at 5 years was higher in SM (14% vs 11%, p=0.009), which is statistically significant. 

So, the main points are that GM allows more combined procedures, fewer total surgeries, but SM had better disease-free survival. The overall survival wasn't different. The study doesn't show a clear improvement in survival with GM, but there are some procedural benefits. However, the better disease-free survival in SM complicates things. Since the question is about improving results, and the primary survival outcomes aren't significant, but disease-free is better in SM, the answer might lean towards no. But maybe there's a nuance. The study is retrospective, so there could be confounders. Also, maybe the GM approach has other benefits not captured here. But based on the data provided, the answer is Maybe or No. Wait, the disease-free survival is better in SM, which is a key result. The study doesn't show GM improves results. So the answer is No. But the abstract says ""does global management... improve results?"" The results here show similar overall survival but worse disease-free in GM. So the answer would be No. But the user might consider that GM has some benefits (fewer procedures) but not better survival. Since the question is about improving results (which could include survival and disease-free), the answer is No. But the abstract's conclusion might not be definitive. Wait, the p-value for disease-free is 0.009, which is significant. So SM has better disease-free survival. Therefore, GM does not improve results compared to SM. So the answer is No. But the user might have to consider that. So the answer is [No].
</think>

[No]",Correct
19054501,pubmedqa_pqa_l,Is motion perception deficit in schizophrenia a consequence of eye-tracking abnormality?,yes,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's try to figure this out. The question is whether the motion perception deficit in schizophrenia is a consequence of eye-tracking abnormality. The context provided talks about two experiments.

In Experiment 1, they used a short stimulus duration (150 msec) to minimize eye-tracking. Here, there was no difference in speed discrimination thresholds between patients and controls. But in Experiment 2, with a longer duration (300 msec) where eye movements are more likely, the patients had higher thresholds (worse performance). Also, in controls, eye-tracking frequency during the 300 msec task correlated with better discrimination, but not in patients. However, regular eye-tracking performance (from Experiment 3) didn't relate to the speed discrimination results.

So, the initial thought was that motion perception deficits cause eye-tracking issues. But the study suggests that when eye movements are possible (longer stimulus), patients perform worse. The correlation in controls implies that eye-tracking helps them, but not the patients. But the lack of correlation between regular eye-tracking and task performance complicates things. 

If the deficit were a consequence of eye-tracking problems, then when eye-tracking is prevented (Experiment 1), the deficit should disappear, which it does. But when eye-tracking is possible (Experiment 2), the deficit appears. This suggests that the motion perception deficit in patients might be exacerbated by their inability to use eye-tracking effectively. However, the original hypothesis was that motion perception deficits cause eye-tracking issues. The study's results might indicate that the interaction is more complex. The fact that patients don't benefit from eye-tracking (since their eye-tracking doesn't correlate with performance) might mean that their eye-tracking abnormality contributes to the motion perception deficit in situations where eye movements are involved. But the initial deficit in motion perception (when eye-tracking is minimized) wasn't present, so maybe the main issue is the interaction during longer stimuli. Therefore, the motion perception deficit in schizophrenia might not be a direct consequence of eye-tracking abnormality, but rather that the eye-tracking abnormality doesn't allow them to compensate as controls do. So the answer might be No, because the deficit only appears when eye-tracking is possible, suggesting that the eye-tracking issue contributes to the deficit in those cases, but isn't the root cause. Alternatively, Maybe, since the interaction exists. Hmm.
</think>

[No]",Incorrect
16432652,pubmedqa_pqa_l,Transgastric endoscopic splenectomy: is it possible?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is asking if transgastric endoscopic splenectomy is possible. The context provided is a study where they performed this procedure on pigs. They used a flexible endoscope inserted through the mouth into the stomach, made an incision in the gastric wall to enter the peritoneal cavity, then visualized and removed the spleen using endoscopic tools.

The study mentions that they did this on six pigs with no complications during the initial steps. They were able to ligate the splenic vessels and dissect the mesentery. The results suggest that it's technically feasible. Since they successfully did it in a porcine model, even though it's not human trials, the answer would be yes. The study's goal was to determine feasibility, and they achieved that in their model. So the answer should be yes.
</think>

[Yes]",Correct
19504993,pubmedqa_pqa_l,It's Fournier's gangrene still dangerous?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if Fournier's gangrene is still dangerous. The context provided is a study from 1997 to 2006 with 14 patients. The mortality rate was 5 out of 14, which is about 35.7%. The study mentions that despite antibiotics and aggressive treatment, mortality remains high. The survivors had lower leukocyte counts compared to those who died. The conclusion here seems to be that even with treatment, there's a significant mortality rate. However, the study is from 1997-2006, which is over a decade old. I wonder if more recent advancements have improved outcomes. But based solely on the provided data, the answer would be yes because the mortality rate in the study is high. The question is present tense, so ""still"" implies current danger. The study's data is old, but the user hasn't provided newer data, so within the context given, the answer is yes.
</think>

[Yes]",Correct
20571467,pubmedqa_pqa_l,Is it appropriate to implant kidneys from elderly donors in young recipients?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether it's appropriate to use kidneys from elderly donors (over 60) in young recipients (under 60). The study compares 91 such transplants with a control group where both donors and recipients are under 60.

Looking at the survival rates: patient survival at 1,5,10 years are similar between the groups (97.6% vs 98.8%, etc.), and the p-values are not significant (0.642). Graft survival also shows no significant difference (P=0.980). Even when censoring for death, the graft survival is comparable (P=0.747). So the main outcomes are not worse in the elderly donor group. 

However, creatinine levels are higher in the elderly donor group at all time points (172 vs 139 at 1 year, etc.), and the p-value is <0.05, which is significant. Higher creatinine suggests lower kidney function. But despite this, the graft survival isn't worse. Maybe the higher creatinine is manageable, or the difference isn't clinically significant enough to affect survival outcomes. 

The study concludes that there's no significant difference in patient or graft survival between the two groups over 10 years. Even though the elderly donor kidneys have higher creatinine, the overall outcomes are similar. So, in terms of survival, it seems appropriate. But the higher creatinine might indicate some functional differences, but the study doesn't report complications related to that. Since the main metrics (survival) are comparable, the answer would lean towards yes. But maybe there are other factors not considered here, like quality of life or long-term complications. However, based on the data provided, the answer is yes.
</think>

[Yes]",Correct
24237112,pubmedqa_pqa_l,Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether provider service networks (PSNs) result in lower expenditures compared to HMOs or primary care case management (PCCM) in Florida's Medicaid program.

First, I need to look at the context provided. The study analyzed data from Florida Medicaid claims before and after the implementation of the Medicaid Demonstration. They used a difference-in-differences approach comparing Demonstration counties (with HMOs and PSNs) to non-Demonstration counties. The data includes SSI and TANF enrollees.

The key finding mentioned is that among SSI enrollees, the Demonstration led to lower increases in PMPM expenditures over time compared to non-Demonstration counties. Specifically, Demonstration PSNs lowered PMPM expenditures by $7 more than HMOs. There were also savings among TANF enrollees, but less so.

The question is whether PSNs result in lower expenditures than HMOs or PCCM. The context directly states that PSNs had $7 more in savings compared to HMOs. However, the context doesn't mention PCCM. The non-Demonstration counties might be using PCCM, but the comparison here is between Demonstration (HMOs and PSNs) and non-Demonstration (possibly PCCM). The results show that the Demonstration counties (with HMOs and PSNs) had lower expenditure increases than non-Demonstration. But within the Demonstration, PSNs were better than HMOs by $7. However, the comparison to PCCM (non-Demonstration) isn't directly addressed in the results provided. The $40 vs. $186 increase is between Demonstration and non-Demonstration overall, not specifically PSN vs PCCM. So, while PSNs are better than HMOs within the Demonstration, the comparison to PCCM (if non-Demonstration uses PCCM) would require looking at the overall $40 vs $186. But the question is about PSNs vs HMOs or PCCM. The answer for HMOs is yes (PSNs better), but for PCCM, the data isn't clear. The study might not have compared PSNs directly to PCCM, only the Demonstration (HMO/PSN) vs non-Demonstration (PCCM). So the answer might be a partial yes for HMOs, but maybe not enough info on PCCM. However, the user's question groups HMOs and PCCM, so if the answer is that PSNs are better than HMOs, but the comparison to PCCM isn't clear, the answer would still be yes for part of the question. But the context says ""compared with HMOs or primary care case management"". Since the non-Demonstration counties (possibly PCCM) had higher increases ($186 vs $40), but that's the entire Demonstration (HMO and PSN) vs non-Demonstration. So within the Demonstration, PSNs are better than HMOs, but the overall Demonstration (including both HMOs and PSNs) is better than non-Demonstration (PCCM). Therefore, PSNs are better than HMOs, and the Demonstration (which includes PSNs and HMOs) is better than PCCM. So combining these, PSNs result in lower expenditures compared to both HMOs and PCCM. But wait, the $7 difference is within the Demonstration (PSN vs HMO), and the $40 vs $186 is Demonstration vs non-Demonstration. So if non-Demonstration is PCCM, then the Demonstration (HMO/PSN) is better than PCCM. But within the Demonstration, PSNs are better than HMOs. Therefore, PSNs are better than HMOs and better than PCCM (since the Demonstration as a whole is better than non-Demonstration, and PSNs are the best within the Demonstration). Therefore, the answer is yes. The answer should be [Yes].
</think>

[Yes]",Correct
21402341,pubmedqa_pqa_l,Assessment of carotid artery stenosis before coronary artery bypass surgery. Is it always necessary?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether assessing carotid artery stenosis before coronary artery bypass surgery (CABG) is always necessary.

First, I need to recall the context provided. The study compared selective vs. non-selective preoperative carotid screening. They stratified patients into high-risk and low-risk groups based on factors like PVD, carotid bruit, diabetes, age over 70, or history of cerebrovascular disease. The high-risk group had a significantly higher prevalence of carotid stenosis (9.1% vs. 1.2%) and all strokes and carotid procedures were in the high-risk group. The conclusion seems to support selective screening since the low-risk group had very few cases of stenosis and no strokes. 

So, the question is if it's always necessary. The study's results suggest that in low-risk patients, the prevalence is very low (1.2%), and none of them had strokes. Therefore, maybe screening isn't necessary for everyone, only high-risk patients. The answer would be that it's not always necessary, hence ""No."" But wait, the study's aim was to test if selective is as effective as non-selective. The results showed that high-risk groups had all the cases needing intervention and strokes. So, maybe selective screening is sufficient, implying that non-selective (i.e., screening everyone) isn't necessary. Therefore, the answer would be No, it's not always necessary. But I need to check if the data supports that. The low-risk group had 1.2% stenosis, but no strokes. So even if there's some stenosis, maybe it's not significant enough to cause strokes. The study's conclusion would support selective screening, so the answer is No, it's not always necessary. Hence, the answer should be [No].
</think>

[No]",Correct
20082356,pubmedqa_pqa_l,Should direct mesocolon invasion be included in T4 for the staging of gastric cancer?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether direct mesocolon invasion should be included in the T4 category for gastric cancer staging. The context provided is a study that looked at patients with advanced gastric carcinoma, specifically those with mesocolon invasion.

First, I need to recall the UICC (Union for International Cancer Control) staging system for gastric cancer. T4 typically refers to tumors invading adjacent structures. The context mentions that UICC doesn't list the mesocolon as an adjacent structure. The study found that patients with mesocolon invasion had worse outcomes in terms of curability, nodal metastasis, and survival compared to T3, but better survival after curative resection than those with incurable factors.

The key points here are that mesocolon invasion is associated with more aggressive features (like worse nodal metastasis) and poorer survival than T3, which is a lower T category. However, after curative surgery, their survival was better than non-curative cases. Since T4 is for tumors invading adjacent structures, and the study argues that mesocolon invasion behaves more like T4 (worse than T3), the implication is that it should be classified as T4. The answer would likely be Yes, based on the study's findings suggesting mesocolon invasion has a significant impact similar to other T4 factors.
</think>

[Yes]",Incorrect
26606599,pubmedqa_pqa_l,Do Surrogates of Injury Severity Influence the Occurrence of Heterotopic Ossification in Fractures of the Acetabulum?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether surrogates of injury severity influence the occurrence of heterotopic ossification (HO) in acetabular fractures.

First, I need to recall the context provided. The study looked at factors associated with HO development after surgery for acetabular fractures via a posterior approach. They used a multivariate model to assess various factors.

The key findings mentioned are that ICU length of stay (LOS) categories (1-2 days, 3-6 days, >6 days) and non-ICU LOS >10 days were significantly associated with higher odds of HO. Also, HO prophylaxis with XRT reduced the odds. Other variables like injury severity score, age, gender, etc., were not significant in the multivariate model.

The question is about surrogates of injury severity. The study mentions ""injury severity surrogates"" in the objective. The surrogates here might include ICU LOS and non-ICU LOS, which are used as indicators of how severe the injury or the patient's condition was. Since these were significant predictors, the answer would be yes. However, the injury severity score itself was not significant. But the question is about surrogates, not the actual injury severity score. So the surrogates (like LOS) do influence HO occurrence. Therefore, the answer should be yes.
</think>

[Yes]",Incorrect
11340218,pubmedqa_pqa_l,Does pretreatment with statins improve clinical outcome after stroke?,no,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user wants to know if pretreatment with statins improves clinical outcomes after a stroke. The context provided is a study that looked into this.

First, the study is observational and case-referent, which means they compared patients on statins at stroke onset with matched controls not on statins. The sample size is 125 cases and 250 referents. The main outcome was early discharge to home versus late discharge or death.

The unadjusted odds ratio was 1.41, but the confidence interval includes 1 (0.91 to 2.17), so it's not statistically significant. Then they adjusted for prognostic factors, which were more unfavorable in the statin group. After adjustment, the odds ratio was 1.42, still with a CI crossing 1 (0.90 to 2.22). So even after adjusting, the result isn't statistically significant.

The key points here are that the study found a positive association (OR >1) but the confidence intervals are wide and include 1, meaning we can't rule out chance. Also, the study is observational, so there might be confounding factors even after adjustment. The authors mention that statin users had more unfavorable prognostic factors, which might mean they were sicker to begin with, possibly leading to worse outcomes. But even after adjusting, the effect isn't significant.

So the answer isn't clear-cut. The data suggests a possible benefit, but without statistical significance, we can't be sure. The study is preliminary, so more research is needed. Therefore, the answer should be Maybe.
</think>

[Maybe]",Incorrect
25481573,pubmedqa_pqa_l,Processing fluency effects: can the content and presentation of participant information sheets influence recruitment and participation for an antenatal intervention?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether processing fluency effects, specifically the content and presentation of participant information sheets (PISs), can influence recruitment and participation for an antenatal intervention. 

First, I need to recall what processing fluency is. From what I remember, processing fluency refers to how easily information is processed. When something is easier to process (like a clear title and readable font), people tend to have more positive reactions towards it.

Looking at the context provided, the study manipulated both the title and font of PISs into four conditions. They measured perceptions like attractiveness, complexity, risk, and effort. The results showed that pregnant women found the Double Awkward condition (both title and font awkward) more complex than others. 

Now, the question is about recruitment and participation. The study's dependent variables are perceptions, not actual recruitment numbers. However, if participants perceive the intervention as more complex or risky, they might be less likely to enroll. The study found significant differences in complexity ratings, which could imply that higher complexity might deter participation. 

But wait, the study didn't measure actual recruitment rates, just perceptions. So while there's an effect on perception (which is related to processing fluency), the direct impact on recruitment isn't measured here. However, it's reasonable to infer that perceptions could influence decisions to participate. 

The answer hinges on whether the effects on perceptions (like complexity) are enough to suggest an impact on recruitment. Since processing fluency is known to affect decision-making, and the study shows that fluency manipulations affect perceived complexity, it's plausible that this could influence recruitment. But without direct evidence, it's a maybe. However, the context does provide evidence that fluency affects perceptions which are factors in recruitment decisions. So maybe the answer is yes, but the study doesn't directly show it. But the question is asking if the content and presentation CAN influence, not does it. Since the study shows an effect on perceptions that are relevant to participation decisions, the answer is yes.
</think>

[Yes]",Correct
25277731,pubmedqa_pqa_l,Sternal fracture in growing children : A rare and often overlooked fracture?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if sternal fractures in growing children are rare and often overlooked. The context provided mentions that these fractures are rare in childhood. The study found only 4 cases over two years, which seems like a small number, supporting the rarity. Also, since they are rare, they might not be the first thing doctors look for, leading to possible oversight. The study also talks about investigating accident mechanisms and detection methods, which implies that detection might be challenging. So, combining rarity and potential difficulty in detection, the answer is likely yes.
</think>

[Yes]",Incorrect
25475395,pubmedqa_pqa_l,Is there a correlation between androgens and sexual desire in women?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if there's a correlation between androgens and sexual desire in women based on the provided study.

First, I need to recall the context. The study mentions that previous findings on this correlation are inconclusive. However, they did find that androgen substitution helps women with certain conditions like surgical menopause. The aim was to check if serum androgens and ADT-G correlate with sexual desire.

Looking at the methods: cross-sectional study with 560 women divided into age groups. They measured various androgens and ADT-G using mass spectrometry. Sexual desire was measured via the FSFI score.

The results: In the total cohort, FT and androstenedione correlated with sexual desire. In the 25-44 subgroup without hormonal contraception, TT, FT, androstenedione, and DHEAS were correlated. In the 45-65 group, only androstenedione. ADT-G didn't show any correlation.

So, the answer hinges on whether any correlations were found. The study did find some correlations in specific groups, even though overall conclusions might be mixed. The question is general, not asking about ADT-G specifically. Since some androgens did correlate in certain groups, the answer should be yes. But wait, the initial context says the correlation is inconclusive. However, the study's own results show significant correlations in subgroups, so maybe the answer is yes. But the user's question is about the study's findings, not the general state of research. The study found some correlations, so the answer is yes.
</think>

[Yes]",Correct
23177368,pubmedqa_pqa_l,Does immediate breast reconstruction compromise the delivery of adjuvant chemotherapy?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether immediate breast reconstruction (IBR) compromises the delivery of adjuvant chemotherapy. The context provided is a study comparing patients who had IBR with those who had mastectomy alone.

First, I need to look at the key findings. The study mentions that overall complication rates were similar between the two groups, though there were some differences in specific complications. The IBR group had more returns to surgery, mainly due to tissue expander removal, while the mastectomy group had more seromas. However, the crucial point here is the time to chemotherapy. The study states there was no significant difference in the median time to chemotherapy between the two groups. 

Since the main concern is whether IBR affects chemotherapy delivery, the time to starting chemotherapy is a critical factor. If there were delays, that could indicate a compromise. But the results show no significant difference, meaning IBR didn't delay chemotherapy. Additionally, even though there were more returns to surgery in the IBR group, the overall complication rates were comparable, and the time to chemo wasn't affected. 

The study also notes that IBR patients were younger, had lower BMI, and better prognoses. These factors might influence outcomes, but the analysis adjusted for them, and still found no difference in chemotherapy timing. Therefore, based on the data presented, IBR doesn't compromise the delivery of adjuvant chemotherapy.
</think>

[No]",Correct
17179167,pubmedqa_pqa_l,Human papillomavirus and pterygium. Is the virus a risk factor?,maybe,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether human papillomavirus (HPV) is a risk factor for pterygium based on the provided study.

First, I need to recall the study details. The study examined 100 pterygium specimens and 20 normal conjunctival samples using PCR for HPV detection. They used beta-globin primers to check DNA quality, and HPV primers MY09/11 and GP5+/6+. Out of 90 suitable pterygium samples (since 10 were excluded due to beta-globin issues), 4 tested positive for HPV type 6. The normal samples were all HPV negative. However, when they did DNA in situ hybridization (ISH) on the HPV-positive pterygia, all were negative.

Now, the question is whether HPV is a risk factor. The study found a low prevalence (4/90, ~4.4%) of HPV in pterygium samples, and none in controls. But the fact that ISH didn't confirm the presence of HPV DNA in the tissue might suggest that the PCR results could be false positives or that HPV isn't actively present in the tissue. The authors mention previous studies have inconclusive results, and their findings with low detection rate and lack of confirmation by ISH might indicate that HPV isn't a significant risk factor. However, since some samples were positive, albeit a small number, there's a maybe. But considering the controls were all negative and the low prevalence, maybe leaning towards no. But the presence in some cases could mean it's a possible co-factor in rare instances. However, the study's conclusion would likely be that there's no strong association, hence the answer might be No. But since there's a small number of positives, maybe the answer is Maybe. Wait, the study's aim was to clarify the association. They found HPV in 4 out of 90, but the controls were all negative. However, the ISH didn't confirm, which is a more specific test. So PCR might have detected contamination or non-active HPV. Therefore, the study suggests HPV is not a significant risk factor. So answer is No.
</think>

[No]",Incorrect
14612308,pubmedqa_pqa_l,Can PRISM predict length of PICU stay?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether PRISM can predict the length of PICU stay. From the context, they did correlation and regression analyses. The Spearman and Pearson coefficients for PRISM and LOS were 0.2 and 0.08, both statistically significant but the values are low. That suggests a weak correlation. Then they used an ANN, which had a Pearson's coefficient of 0.21, which is still low but slightly better. The fact that the correlations are significant but low might mean that PRISM has some predictive ability, but it's not strong. The study's conclusion might be that PRISM has a small impact, but the ANN performed a bit better. However, the question is specifically about PRISM, not the ANN. So even though the correlations are weak, they are statistically significant. So maybe the answer is yes, but with the caveat that the predictive power is weak. But the question is just asking if it can predict, not how well. Since there's a significant correlation, even if weak, the answer would be yes.
</think>

[Yes]",Incorrect
27491658,pubmedqa_pqa_l,Can predilatation in transcatheter aortic valve implantation be omitted?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether predilatation can be omitted in TAVI. The study they mentioned randomized 60 patients into two groups: one with the standard procedure (which includes balloon predilatation) and one without. The results showed no significant differences in early hemodynamic results or complications. So, if both groups had similar outcomes, that suggests that skipping the predilatation didn't cause worse results. Therefore, the answer would be yes, it can be omitted. But wait, maybe the sample size is small? Only 60 patients. But the answer is based on the study provided, so according to that, yes.
</think>

[Yes]",Correct
19822586,pubmedqa_pqa_l,Autoerotic asphyxiation: secret pleasure--lethal outcome?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether autoerotic asphyxiation (AEA) is a secret pleasure that can lead to lethal outcomes. From the context provided, the study discusses AEA among young people, noting it's a clandestine practice. The key points are that it's done to enhance sexual excitement, is often hidden, and can result in unintended death due to miscalculations. The study mentions both fatal and nonfatal cases, and the aim is to help pediatricians recognize and prevent tragedies. The answer should confirm that AEA is both a secretive activity (secret pleasure) and can result in death (lethal outcome). The context supports this with phrases like ""clandestine and elusive practice"" and ""inept practitioners... lose their gamble with death."" So the answer is yes.
</think>

[Yes]",Correct
27643961,pubmedqa_pqa_l,Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether having both major depression (MD) and alcohol use disorder (AUD) during adolescence leads to worse outcomes for depression later on. 

First, I need to look at the context provided. The study used longitudinal data from ages 15-18 and looked at MD outcomes up to age 35. They categorized participants into four groups: neither disorder, MD-only, AUD-only, and comorbid MD/AUD. The results showed that all three disorder groups had higher rates of adult MD compared to the no-disorder group. Importantly, the comorbid group had significantly higher rates than the AUD-only group and marginally higher than the MD-only group. However, after adjusting for confounders like gender, childhood behavior problems, and abuse, the difference between the comorbid and MD-only groups became non-significant.

So the key points here are that initially, comorbidity seemed to lead to worse MD outcomes, but after controlling for certain factors, that effect was explained away. The study's data were self-reported, which might introduce bias, but the question is about whether comorbidity leads to poorer outcomes. The answer hinges on the adjusted results. Since after adjustment, the difference between comorbid and MD-only groups wasn't significant, the comorbidity's effect is confounded by those factors. Therefore, the answer would be that comorbidity doesn't independently lead to worse outcomes once those confounders are considered. But the initial analysis (unadjusted) did show a marginal effect. The question is phrased as ""Does comorbidity lead..."" and the study's adjusted analysis says no, the effect isn't significant when confounders are accounted for. So the answer would be ""Yes"" before adjustment, but ""No"" after. However, the question doesn't specify adjustment. The study's conclusion is that the association is explained by confounding factors, implying that comorbidity itself may not be the cause. So the answer is that comorbidity is associated with worse outcomes, but this is due to other factors. Therefore, the answer would be ""Yes"" in unadjusted terms, but the study's adjusted analysis suggests that the comorbidity's effect isn't independent. The user's question is whether comorbidity leads to poorer outcomes. The answer based on the adjusted analysis is that it's not the comorbidity itself but the confounding factors. However, the study's initial findings showed higher rates in the comorbid group. The question is whether comorbidity leads to poorer outcomes, and the answer would depend on whether confounders are considered. Since the study's conclusion after adjustment negates the significance, the answer might be ""No"" when adjusted, but the question doesn't specify. The user is likely asking in general terms. The study shows that comorbidity is associated with worse outcomes, but this is due to confounders. Therefore, the answer would be ""Maybe"" because without considering confounders, yes, but with them, no. However, the answer options are Yes, No, Maybe. The study's adjusted results remove the significance, so the answer would be that comorbidity doesn't independently lead to worse outcomes. But the initial analysis shows a marginal effect. The user's question is whether comorbidity leads to poorer outcomes. The answer based on the study's adjusted analysis is that the association is explained by other factors, so comorbidity itself doesn't lead to worse outcomes. Therefore, the answer is No. Wait, but the initial unadjusted analysis showed higher rates. The question is whether comorbidity leads to poorer outcomes. The study's conclusion is that after adjustment, the difference isn't significant, so the answer is that comorbidity doesn't lead to worse outcomes when confounders are considered. But the question is general. The answer would be that comorbidity is associated with worse outcomes, but this is due to confounding factors, so the comorbidity itself may not be the cause. Therefore, the answer is Maybe. Wait, the options are Yes, No, Maybe. The study found that in unadjusted models, comorbid had higher rates than MD-only (marginally), but after adjustment, the difference wasn't significant. So the answer is that comorbidity is associated with worse outcomes, but this is explained by confounders, so the answer would be No when adjusted. But the question is phrased as ""Does comorbidity lead to poorer outcomes?"" The study's adjusted analysis suggests that the comorbidity's effect is not significant when confounders are accounted for. Therefore, the answer would be No. However, the initial analysis showed a marginal effect, so maybe the answer is Maybe. But the options are Yes, No, Maybe. The study's conclusion is that the association is explained by confounding factors, so the answer would be No. Because after adjustment, the effect isn't there. So the answer is No. But wait, the question is whether comorbidity leads to poorer outcomes. The study shows that in the unadjusted model, yes, but after adjustment, no. So the answer depends on whether you consider confounders. The user's question doesn't specify, but the study's conclusion is that the association is due to confounders. Therefore, the answer would be No. But the initial analysis showed a marginal effect. Hmm. The answer is that comorbidity is associated with worse outcomes, but this is due to confounding factors. Therefore, the answer is No, because the comorbidity itself isn't the cause. So the answer is No.
</think>

[Yes] 

**Note:** The initial analysis suggested comorbidity was associated with poorer MD outcomes (marginally higher rates than MD-only). However, after adjusting for confounders (gender, childhood behavior problems, abuse), the difference between comorbid and MD-only groups became non-significant. The answer ""[Yes]"" reflects the unadjusted association (as the question does not specify adjustment), but the adjusted results imply confounding factors explain the link. If the question had explicitly asked about *independent* effects of comorbidity, the answer would be ""[No].""",Correct
23539689,pubmedqa_pqa_l,Cold preparation use in young children after FDA warnings: do concerns still exist?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The study is about the use of cough and cold medicines in kids under 6 after the 2007 FDA warnings. The main findings are that 82% of caregivers in the study said they would use these medicines, and 72% of those dosed incorrectly. The question is asking if concerns still exist regarding the use of these preparations in young children post-FDA warnings.

So, the FDA warnings were likely about the risks of using these medicines in young children, maybe due to side effects or dosing errors. The study was done in 2010, a few years after the warnings. The high percentage of caregivers still willing to use them suggests that usage hasn't dropped as much as hoped. Plus, the majority of those who would use them are dosing incorrectly, which is a big safety concern. Even if the FDA issued warnings, the fact that so many are still using them and making mistakes indicates that the warnings might not have been effective enough, or that there's a lack of awareness. Therefore, the answer would be yes, concerns still exist because usage is high and incorrect dosing is prevalent despite the warnings.
</think>

[Yes]",Correct
22453060,pubmedqa_pqa_l,Does a 4 diagram manual enable laypersons to operate the Laryngeal Mask SupremeÂ®?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether a 4-diagram manual enables laypersons to operate the Laryngeal Mask SupremeÂ® (LMAS). 

First, I need to look at the context provided. The study was a pilot where laypersons were given an instruction manual with four diagrams and speech bubbles. They had to use the LMAS on a manikin. The results showed that 96.7% inserted it in the right direction, though some had issues with inversion or twisting. However, 79.3% managed to insert it and provide adequate tidal volumes within two minutes. The time taken was about 83 seconds.

The key points here are the success rates. Most participants could insert the LMAS correctly, and a majority achieved the required ventilation. The study mentions that there was no significant difference based on prior training, education, or gender, which suggests that the manual alone was effective across different groups. 

But wait, 8.7% had insertion issues, and only 5.3% corrected them. Does that affect the conclusion? The main measure of success here is whether they could operate it sufficiently, which the majority did. The question is about enabling them to operate it, not necessarily perfect operation. Since over 79% achieved effective ventilation, the answer seems to lean towards yes. The study's conclusion supports that the manual was effective for laypersons. So the answer should be yes.
</think>

[Yes]",Correct
22227642,pubmedqa_pqa_l,Can we measure mesopic pupil size with the cobalt blue light slit-lamp biomicroscopy method?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if the cobalt blue light slit-lamp biomicroscopy method (SLBM) can measure mesopic pupil size.

Looking at the context provided, the study compares SLBM to Colvard infrared pupillometry (CIP). The results mention that the mean pupil diameter measured with SLBM was 5.81 Â± 0.70 mm, which is slightly lower than CIP's 6.26 Â± 0.68 mm. The p-value here is 0.01, indicating a statistically significant difference between the two methods. 

The study also discusses the agreement between SLBM and CIP, along with intraobserver and interobserver repeatability. The intraobserver reproducibility for SLBM had ICCs of 0.97 and 0.92, which are quite high, suggesting good consistency when the same examiner repeats measurements. However, the 95% LoA (limits of agreement) widths are around 1.79 to 2.30 mm, which might indicate some variability. 

The sensitivity and specificity of SLBM for detecting pupils larger than 6 mm are moderate, ranging from 55.56% to 73.68% and 76.19% to 95.45%, respectively. The best trade-off cutoff values are between 5.4 and 6.2 mm. 

The key point here is whether mesopic conditions are addressed. Mesopic refers to intermediate lighting conditions, neither fully dark (scotopic) nor fully lit (photopic). The context doesn't explicitly mention mesopic conditions, but since they're comparing to CIP, which is commonly used in such settings, and the study is about pupil diameter measurement methods, it's possible that the measurements were taken under mesopic conditions. However, the abstract doesn't specify the lighting conditions used during the measurements. 

But the fact that SLBM is being used to measure pupil size and compared to CIP, which is a standard method, suggests that SLBM is being evaluated under similar conditions. The results show that SLBM can measure pupil diameters, albeit with some differences compared to CIP. The study's conclusion might imply that SLBM is a viable method, but with noted limitations in agreement and repeatability. 

Since the question is about the ability to measure mesopic pupil size with SLBM, and the study's context involves measuring pupil diameter using SLBM, even if mesopic isn't explicitly stated, the answer would hinge on whether the methods used in the study align with mesopic conditions. If the study's environment was mesopic, then yes. But without explicit mention, it's a bit uncertain. However, the fact that they measured pupil sizes (which are typically assessed under mesopic conditions in clinical settings) suggests that the answer is yes, but the method has some variability compared to CIP. The answer would be yes, but with caveats. However, the user is asking if it's possible, not about its accuracy. The study shows that they did measure pupil size using SLBM, so the answer is yes.
</think>

[Yes]",Incorrect
12380309,pubmedqa_pqa_l,Should circumcision be performed in childhood?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's see. The user is asking whether circumcision should be performed in childhood based on the provided study. The study evaluated 400 boys aged 0-16. For infants under 1 year, most (71.5%) had non-retractile prepuce (type I), and only 5.5% had completely retractile (type V). By adolescence, type I was rare (1.6%), and type V was common (82.3%). This suggests that natural development improves retractibility over time without intervention.

The study also mentions that 106 boys who had forced dilation earlier had adhesions again, indicating that forced dilation might not be effective long-term. Only 11 boys (2.7%) needed circumcision for medical reasons like stenosis, constrictive rings, infections, or balanitis. 

So, the data shows that most cases resolve naturally, and forced dilation doesn't prevent issues. Only a small percentage required circumcision for medical reasons. Therefore, routine childhood circumcision might not be necessary unless specific medical issues arise. The answer would lean towards ""No"" unless medically indicated, which is a small percentage. The study's conclusion probably supports not performing circumcision routinely in childhood but only when necessary.
</think>

[No]",Correct
22186742,pubmedqa_pqa_l,Does a colonoscopy after acute diverticulitis affect its management?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user wants to know if a colonoscopy after acute diverticulitis affects management.

First, I need to look at the context provided. The study reviewed 220 patients, but 15 were excluded. So, 205 patients. Out of these, 100 had an early colonoscopy 4-6 weeks after discharge. The others didn't. The key points here are the findings from the colonoscopies.

The study says no colonic malignancy was detected in the colonoscopy group. That's important because if cancer was found, that would definitely change management. But here, none were found. However, 32 patients (32%) had at least one polyp, and only one was an advanced adenoma. Advanced adenomas are more concerning because they can turn into cancer, so removing them is part of management. But only one case here. The rest were presumably non-advanced polyps, which are less urgent.

Also, the study mentions that there were no significant differences in survival between the groups with or without colonoscopy. The follow-up period was about 4 years. So, even though some polyps were found, it didn't impact survival. Additionally, no new or different diagnoses were made after colonoscopy. That suggests that the colonoscopy didn't reveal any conditions that weren't already considered, which would have changed treatment plans.

So, the main findings are that colonoscopy didn't find cancer, found some polyps (mostly non-advanced), and didn't lead to different diagnoses. Since the management of diverticulitis typically involves treating the acute episode, possibly antibiotics, and sometimes surgery for complications. If colonoscopy found something that requires a change in treatment, like cancer or advanced polyps, then it would affect management. But in this study, only one advanced adenoma was found. The rest were non-advanced polyps, which might be removed during the colonoscopy but don't necessarily change the management of diverticulitis itself. The survival rates were the same, so even with polyps, the outcome wasn't different.

Therefore, based on this study, colonoscopy after acute diverticulitis didn't significantly affect management because it didn't lead to new diagnoses that would alter treatment plans, except in a very small number of cases. The answer would likely be No, since the majority didn't have findings that changed management, and the study didn't report any changes in treatment based on colonoscopy results.
</think>

[No]",Correct
22188074,pubmedqa_pqa_l,Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether instrumental activities of daily living (IADL) can predict dementia at 1- and 2-year follow-up.

First, I need to look at the context provided. The study is a multicenter prospective cohort study conducted in European memory clinics with participants aged 55+ without dementia. They measured IADL using informant-based questionnaires and used structural equation modeling (SEM) to see how IADL relates to dementia, controlling for other variables like age, sex, education, depression, and cognitive measures.

The results show that at 1-year follow-up, 13% of the 531 participants developed dementia, and at 2 years, 20.8% of 481 did. The key finding here is that participants with IADL disabilities at baseline had a higher conversion rate (24.4%) compared to those without (16.7%), which was statistically significant (p=0.04). The SEM analysis gave odds ratios of 2.20 at 1 year and 2.11 at 2 years, both with confidence intervals that don't cross 1, indicating significance.

So, the study's conclusion is that IADL disabilities add predictive value beyond conventional clinical measures. The question is whether IADL predicts dementia at these follow-ups. The answer seems to be yes based on the ORs and significance. But I need to make sure there's no conflicting info. The SEM results specifically state that IADL helps predict dementia in addition to other variables. Therefore, the answer should be yes.
</think>

[Yes]",Correct
27989969,pubmedqa_pqa_l,Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user wants to know if using a neuroendoscope during VPS procedures affects the infection rate. The study they provided compared groups with and without an endoscope. The overall infection rates were 22.4% vs. 18%, but the p-value was 0.449, which isn't statistically significant. Then they broke it down into first-time and revision surgeries. For first-time (group 1A vs. 1B), the rates were 28.6% vs. 16.2%, p=0.27. For revisions (group 2A vs. 2B), 20% vs. 19.8%, p=0.977. Both of these p-values are also not significant. So even though the numbers look higher in the endoscope groups, the lack of statistical significance means we can't say there's a real difference. The answer should be No, since the study didn't find a significant effect.
</think>

[No]",Correct
18607272,pubmedqa_pqa_l,"Body perception: do parents, their children, and their children's physicians perceive body image differently?",yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if parents, children, and physicians perceive body image differently based on the study described.

First, I'll look at the context provided. The study involved children aged 12-18 and their parents, with the children being patients in a Pediatric Gastroenterology Clinic. They used a Likert scale with body image figures. The children's BMI was categorized into underweight, normal, overweight, and obese. The key findings were the percentages of underestimation by each group.

Parents underestimated children's body size 44% using descriptions and 47% with figures. Children underestimated themselves 40% with descriptions and 43% with figures. Physicians had a higher correct estimation rate but still underestimated 33% of patients. Also, some obese children weren't recognized, and some average kids were seen as underweight.

The question is whether these groups perceive body image differently. The data shows varying rates of underestimation. Parents and children have similar underestimation rates, but physicians are better yet still underestimate a third. The fact that each group's accuracy differs (physicians more correct, parents and children less so) suggests differing perceptions. Additionally, the study compared their estimates statistically, which likely showed significant differences. The mention of some misclassifications (obese not recognized, average as underweight) further indicates discrepancies in perception among the groups.

So, the answer should be yes because each group's estimation accuracy varies, and the study found statistical differences in their perceptions.
</think>

[Yes]",Correct
18235194,pubmedqa_pqa_l,Is a specialised training of phonological awareness indicated in every preschool child?,maybe,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The study involved 218 preschool kids split into two training programs: one specialized for phonological awareness to prevent dyslexia, and another for general perception. After first grade, 131 were compared. Overall, there was only a slight difference in writing abilities between the two groups. But for kids with hearing loss or ear issues, the specialized training was more beneficial for reading.

The question is whether specialized phonological training is needed for every preschooler. The study shows that the specialized program didn't make a big difference overall except in writing, which was slight. However, it did help a specific subgroupâ€”those with hearing problems. So, unless a child has hearing issues, the specialized training isn't significantly better than general training. Therefore, it's not indicated for every child, just those at risk, like with hearing loss. The answer should be No.
</think>

[No]",Incorrect
18049437,pubmedqa_pqa_l,Is there any relationship between streptococcal infection and multiple sclerosis?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if there's a relationship between streptococcal infection and multiple sclerosis (MS). The context provided is a study that measured two antibodies related to group A streptococcal infectionsâ€”ASO and ADNase Bâ€”in MS patients versus healthy controls.

First, I need to recall what these antibodies indicate. ASO (antistreptolysin O) and ADNase B (antideoxyribonuclease B) are markers of past streptococcal infections. Elevated levels suggest previous exposure to group A streptococcus.

The study found that ADNase B levels were significantly higher in MS patients compared to controls (p<0.001), while ASO levels were similar. A significant p-value here indicates that the difference in ADNase B is unlikely due to chance. Since ADNase B is a specific marker for streptococcal infection, this suggests a possible association between past streptococcal infection and MS. However, ASO levels not being different complicates things a bit. Maybe ADNase B is a more sensitive or specific marker in this context. The study's conclusion points towards a potential link, but the authors mention that there's not enough research yet. So while the results are suggestive, they aren't conclusive. The answer should reflect that there's some evidence pointing towards a relationship, but more research is needed. Therefore, the answer would be ""Yes"" based on the provided data, but with the caveat that it's not definitive.
</think>

[Yes]",Correct
15597845,pubmedqa_pqa_l,Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether combining 2-methoxyestradiol (2ME) with chemotherapeutics allows lower doses of the chemo drugs in treating ovarian cancer.

The context says they tested combinations of 2ME with various chemo agents on two ovarian cancer cell lines. They found a significant additive effect with epirubicine and carboplatin at lower concentrations of those drugs. An additive effect usually means that the combined effect is greater than either alone. If lower concentrations of the chemo drugs (like epirubicine and carboplatin) are effective when combined with 2ME, that suggests that you might not need as high a dose of the chemo drugs alone. So, using 2ME could let them reduce the chemo dosage while still getting the same or better effect. The study was in vitro, so it's cells in a lab, not actual patients, but the results point towards yes. The answer should be yes because the additive effect at lower concentrations implies dosage reduction is possible.
</think>

[Yes]",Correct
24996865,pubmedqa_pqa_l,Assessing joint line positions by means of the contralateral knee: a new approach for planning knee revision surgery?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if assessing joint line positions using the contralateral knee is a new approach for planning knee revision surgery. 

First, I need to understand the context provided. The study talks about how reconstructing the natural joint line in knee revision surgery is important but challenging when previous surgeries have removed cartilage and bone. They mention that using bony landmarks isn't reliable due to anatomical variations. Their hypothesis is that because the body is symmetrical, measuring distances from bony landmarks to the joint line on the contralateral knee via radiographs could work.

The methods involved scaled weight-bearing X-rays of both knees, measuring distances from specific landmarks (fibular head, epicondyles, adductor tubercle) to the joint line. The results showed a mean difference of 0.0 mm for the fibular head with tight confidence intervals. The p-value was significant.

The question is whether this approach is new. The study's hypothesis is presented as something they're testing, implying that this method of using the contralateral knee's joint line as a reference might not have been standard before. Since they're presenting it as a hypothesis and conducting a study to validate it, it suggests that this approach could be novel. Previous methods might have relied on the same knee's landmarks, which are unreliable after surgery. Using the contralateral side's symmetry is a different approach. The conclusion from their results supports the feasibility, which would be a new method in planning revision surgery. So the answer is likely Yes.
</think>

[Yes]",Correct
23361217,pubmedqa_pqa_l,Does the type of tibial component affect mechanical alignment in unicompartmental knee replacement?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether the type of tibial component (inlay vs. onlay) affects mechanical alignment in unicompartmental knee replacements (UKR). 

Looking at the context provided, the study compared two groups: Inlay (all-polyethylene) and Onlay (metal-backed). The results showed that the Onlay group had a mean postoperative mechanical alignment closer to neutral (2.8Â°) compared to the Inlay group (3.9Â°), with a significant p-value of 0.003. Additionally, when considering the tibial polyethylene insert thickness, the model's R-squared increased, and the effect remained significant.

The key points here are the comparison between the two component types and the statistically significant difference in alignment outcomes. The study adjusted for variables like gender, BMI, etc., which strengthens the validity. The mention of the tibial insert thickness further influencing alignment when added to the model suggests that component design (including material and type) plays a role. 

So, since the Onlay group had better alignment and the difference was significant, the answer should be yes. The type of tibial component does affect mechanical alignment in UKR.
</think>

[Yes]",Correct
17489316,pubmedqa_pqa_l,Is tumour expression of VEGF associated with venous invasion and survival in pT3 renal cell carcinoma?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if VEGF expression is linked to venous invasion and survival in pT3 renal cell carcinoma.

First, looking at the context provided. The study compared 78 patients with different pT3 stages. They looked at variables like VEGF expression and their impact on survival through univariate and multivariate analyses.

In the results, tumor size was different between groups, but the key points are the univariate and multivariate analyses. Univariate analysis showed that VEGF expression, along with other factors like lymph node involvement, was significantly associated with survival (p<0.01). Then, in the multivariate analysis, VEGF expression remained an independent predictor with an odds ratio of 6.07. That's a strong indicator that VEGF is linked to survival.

Now, the question also asks about venous invasion. The study mentions comparing groups with and without vena cava invasion. However, the results state that only tumor size was significantly different between the groups. VEGF expression wasn't highlighted as different in terms of venous invasion. So, VEGF is associated with survival but not directly with venous invasion based on the provided data.

Therefore, the answer should address both parts: venous invasion and survival. Since VEGF wasn't linked to venous invasion but was to survival, the answer would be that VEGF is associated with survival but not venous invasion. However, the question combines both aspects. The study's conclusion from multivariate analysis supports VEGF's role in survival, but not in venous invasion. So the answer should be Yes for survival, but maybe No for venous invasion. But the question is whether VEGF is associated with either. Since it's associated with survival, the answer is Yes. Even though venous invasion isn't linked, the presence of one association makes the answer Yes.
</think>

[Yes]",Incorrect
14518645,pubmedqa_pqa_l,Injury and poisoning mortality among young men--are there any common factors amenable to prevention?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if there are common factors in injury and poisoning deaths among young men that can be prevented.

Looking at the context provided, the study found high rates of poisoning by alcohol and drugs, unemployment, being single, and self-destructive behavior. These factors seem significant. Unemployment and substance abuse are modifiable through policy or programs. Being single might relate to social support, which could be addressed through community initiatives. Self-destructive behavior suggests mental health issues, which are preventable with better access to care. So, yes, there are factors here that can be targeted for prevention.
</think>

[Yes]",Correct
20337202,pubmedqa_pqa_l,Continuation of pregnancy after antenatal corticosteroid administration: opportunity for rescue?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if there's an opportunity for rescue antenatal corticosteroids (AC) based on the study's findings. The context provided is a retrospective analysis of women who received AC between 24-32 weeks. 

First, the study found that 35.7% delivered at â‰¥34 weeks, which is good because that's a more advanced gestational age. Then, 46.4% delivered within a week, with 13.3% within 24 hours. Only 17.9% remained pregnant after a week but delivered before 34 weeks. These women were compared to those who delivered â‰¥34 weeks after more than two weeks.

The factors associated with delivering before 34 weeks were PPROM, twins, and receiving AC before 28 weeks. The ORs here are significant. The question is about whether there's an opportunity for rescue AC. Rescue AC is typically considered if the initial course was given and the woman remains at risk of preterm birth beyond a certain period (like a week or two later). 

In the study, 17.9% stayed pregnant for over a week but still delivered before 34 weeks. That group might benefit from rescue steroids if they're still at risk. The study's conclusion might suggest that since a portion of women remain pregnant beyond a week but still deliver preterm, there's a window where rescue AC could be administered. However, the study itself is a retrospective analysis, so it's identifying associations, not proving effectiveness. But the presence of a group that could potentially benefit from rescue AC (those who didn't deliver within a week but still delivered preterm) suggests that there is an opportunity. The answer would be yes because the data indicates a subset of women who remained pregnant long enough after initial AC to possibly receive rescue therapy.
</think>

[Yes]",Incorrect
26449554,pubmedqa_pqa_l,Does either obesity or OSA severity influence the response of autotitrating CPAP machines in very obese subjects?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether obesity or OSA severity influences the response of autotitrating CPAP machines in very obese subjects. 

First, I need to recall the context provided. The study was conducted on a very obese population (median BMI 43) to see if previous correlations between autoCPAP pressure, OSA severity, and obesity hold. The previous work suggested that autoCPAP pressure correlated with both OSA severity and obesity, leading to an algorithm for fixed CPAP pressure. Now, they're testing this in a more obese group.

Looking at the results: the study found no significant correlation between autoCPAP pressure and measures of obesity (neck circumference, waist circumference, BMI). However, there was a moderate correlation with OSA severity (AHI and ODI). The p-values for OSA severity were significant (0.02 and <0.001), while for obesity measures, they weren't.

So, the question is whether obesity or OSA severity influences the machine's response. The answer hinges on the presence of significant correlations. Since obesity measures didn't show significant correlations, but OSA severity did, that suggests that OSA severity does influence the autoCPAP pressure (response), while obesity doesn't in this very obese group. 

Therefore, the answer would be that OSA severity influences the response, but obesity doesn't. The question is phrased as ""either... or..."", so the answer is yes, because one of them (OSA severity) does influence it. The study's conclusion supports that OSA severity is a factor, even in more obese subjects.
</think>

[Yes]",Correct
26215326,pubmedqa_pqa_l,Does the clinical presentation of a prior preterm birth predict risk in a subsequent pregnancy?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if the clinical presentation of a prior preterm birth (like ACD, PPROM, or PTL) can predict the risk in a subsequent pregnancy.

Looking at the context provided, the study compared three groups: those with prior ACD, PPROM, and PTL. The results show that the recurrence rates of preterm birth were highest in the ACD group (55.2%) compared to PPROM (27.2%) and PTL (32.2%). Also, the gestational age at delivery was lower for ACD, and their cervical length was shorter. The p-values are significant (P = .001), which suggests these differences aren't due to chance. The study used regression to control for confounders, which adds credibility. So, based on these findings, the clinical presentation does seem to predict the risk, especially if the prior presentation was ACD. Therefore, the answer should be yes.
</think>

[Yes]",Correct
29112560,pubmedqa_pqa_l,Is the Distance Worth It?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if the distance to a high-volume center is worth it for rectal cancer patients. The study compared outcomes between local low-volume and distant high-volume centers.

Looking at the results, the high-volume group had better lymph node yields, more neoadjuvant chemoradiation, lower 30-day and 90-day mortality, and better 5-year survival. Even though there's a travel burden, the outcomes are significantly better at high-volume centers. The study accounts for patient and hospital factors, which strengthens the conclusion. However, they mention lacking data on decision-making and surgeon factors, which could influence results. But the evidence provided leans towards the benefits outweighing the travel. So the answer should be yes.
</think>

[Yes]",Correct
24315783,pubmedqa_pqa_l,Aripiprazole: a new risk factor for pathological gambling?,yes,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking if aripiprazole is a new risk factor for pathological gambling based on the provided context.

First, the context mentions that dopamine replacement therapy (DRT) for Parkinson's is a known risk factor. Then it introduces aripiprazole, a dopamine agonist, as a potential new risk factor. The study analyzed 8 patients out of 166 who were on aripiprazole. 

These patients had schizophrenia or bipolar disorder, were mostly young men with prior addictive issues and regular gambling before starting aripiprazole. The causality assessment using an algorithm found ""possible"" in 7 cases and ""doubtful"" in one. 

So, the study suggests a possible link, but the sample size is small (only 8 patients). Also, the patients had pre-existing conditions and histories that could contribute to gambling. The causality is not certain, just possible. The answer should reflect that there's some evidence but not conclusive. The options are Yes, No, Maybe. Since the study indicates a possible association but isn't definitive, the answer is Maybe.
</think>

[Maybe]",Incorrect
9381529,pubmedqa_pqa_l,Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether there's synergy between lysosomotropic amines (like chloroquine and hydroxychloroquine) and cyclosporine in suppressing T-cell responses to minor (MiHC) and major (MHC) histocompatibility antigens.

Looking at the context provided, the study investigated the combination of cyclosporine with these amines. The key point here is in the results section: ""lysosomotropic amines in combination with cyclosporine result in synergistic suppression of a proliferative response to MiHC."" They also mention that similar synergy appears in an alloreactive response (which involves MHC). 

The term ""synergistic suppression"" directly indicates that the combination works better together than individually, which is the definition of synergy. Additionally, the study tested both MiHC and MHC responses, so the synergy exists for both types. The answer should be yes because the context explicitly states synergistic effects in both scenarios.
</think>

[Yes]",Correct
8985020,pubmedqa_pqa_l,Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if induction chemotherapy has a role in managing nasopharyngeal carcinoma (NPC) based on the provided study.

First, I need to look at the results presented. The study includes 122 patients, mostly Stage IV. They compared outcomes between those who received induction chemotherapy and those who didn't. 

Looking at the 5-year survival rates for Stage IV patients: 68% with induction chemo vs. 56% without. The p-value here is 0.02, which is statistically significant. That suggests induction chemo improves overall survival. 

Then there's freedom from relapse: 64% vs. 37%, p=0.01. Again, significant. Local control is 86% vs. 56%, p=0.009. Both of these are better with induction chemo. 

Also, in patients with UNPC (undifferentiated NPC) who had induction chemo and local control, the distant failure rate was 13% at 5 years. That's pretty low. 

For those not receiving chemo, local control rates with different radiotherapy methods were similar (66% vs. 67%), so the benefit seems tied to chemo. 

The study's conclusion would likely support the use of induction chemotherapy, especially in advanced stages (like Stage IV), as it shows significant improvements in survival, relapse rates, and local control. The p-values are all below 0.05, indicating the results aren't due to chance. 

However, the study is retrospective and from a single institution, which might have biases. But given the data presented, the answer should be yes.
</think>

[Yes]",Correct
26708803,pubmedqa_pqa_l,Treatment of contralateral hydrocele in neonatal testicular torsion: Is less more?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether treating a contralateral hydrocele in neonatal testicular torsion with a less invasive approach (just scrotal fixation without inguinal exploration) is effective.

First, I need to recall the context provided. The study looked at 37 patients with neonatal torsion. All had nonviable testicles, and 22 had a contralateral hydrocele. The approach was to address the hydrocele through a scrotal incision without inguinal exploration. The follow-up showed none developed hydrocele or hernia later, over an average of 7.5 years.

The key points here are that the hydroceles were managed via scrotal approach only, avoiding inguinal incision. The rationale was to prevent spermatic cord injury. The results showed no complications, suggesting that not doing an inguinal exploration (i.e., the ""less"" approach) was safe and effective. The study's conclusion supports that avoiding more invasive procedures (like inguinal) is better, hence ""less is more."" So the answer should be Yes.
</think>

[Yes]",Incorrect
22427593,pubmedqa_pqa_l,"Are normally sighted, visually impaired, and blind pedestrians accurate and reliable at making street crossing decisions?",maybe,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether normally sighted, visually impaired, and blind pedestrians are accurate and reliable in making street crossing decisions.

First, I need to refer back to the context provided. The study measured accuracy and reliability under three sensory conditions: visual plus auditory, visual only, and auditory only. The results mention that normally sighted and visually impaired individuals were accurate and reliable when using vision plus hearing or vision alone. However, when using hearing only, all subjects were reliable but inaccurate. Additionally, blind subjects were the least accurate under the hearing-only condition compared to the other groups.

So, the key points here are that under some conditions (vision involved), the normally sighted and visually impaired are accurate and reliable. But when relying solely on hearing, accuracy drops for everyone, especially for the blind. The question is a general one, not specifying the sensory condition. Since the answer depends on the condition, but the study shows that in some conditions they are accurate and reliable, and in others not. However, the question doesn't specify the condition, so the answer might be a ""maybe"" because it's conditional. But the study's conclusion might indicate that overall, the answer is no because under some conditions (hearing only) they aren't accurate. But the question is asking about all three groups collectively. Wait, the normally sighted and visually impaired are accurate in vision-based conditions, but blind individuals rely on hearing only, where they are less accurate. So the answer would be that it's not accurate across all groups and conditions. But the question is phrased as a general ""are they accurate and reliable?"" The answer would need to be ""No"" because in some conditions (hearing only), they are not accurate. However, the study says that in vision-based conditions, two groups are accurate. But the question groups all three together. So the answer is that it's not universally yes because some groups under some conditions are not accurate. Therefore, the answer is No. Wait, but the study says that normally sighted and visually impaired are accurate in vision conditions, but under hearing only, they are inaccurate. Blind subjects are least accurate in hearing only. So the answer would be that they are accurate and reliable in some conditions but not all. Since the question doesn't specify conditions, the answer is Maybe. Wait, the question is asking if they (all three groups) are accurate and reliable. The answer would be that it depends on the sensory condition. Since the study found that in some conditions they are, and in others not, the answer can't be a straightforward Yes or No. But the options are Yes, No, Maybe. The correct answer here is Maybe because the accuracy and reliability vary based on the sensory condition. However, the study's conclusion might suggest that overall, when considering all conditions, the answer is No because there are scenarios where they are not accurate. But the question is general. Hmm. Let me check again. The study's findings: normally sighted and visually impaired are accurate and reliable when using vision (with or without hearing). Under hearing only, all are reliable but inaccurate, and blind are least accurate. So, in some conditions, they are accurate, in others not. The question is whether they are accurate and reliable. Since the answer isn't a universal yes across all conditions, but the question doesn't specify, the answer would be Maybe. But the options are Yes, No, Maybe. The study shows that in some cases yes, others no. So Maybe. But the user might expect a No because under some conditions they aren't. However, the question is about their overall ability. The answer is Maybe because it's conditional. But the study's conclusion might indicate that the answer is No because in the hearing-only condition, which is crucial for blind individuals, accuracy is low. But the normally sighted and visually impaired are accurate in their respective conditions. So the answer is Maybe, as it's not a clear Yes or No for all groups in all conditions. But the question groups all three together. If the answer is that all three groups are accurate and reliable, then the answer would be No because blind individuals under hearing-only are less accurate. But the normally sighted and visually impaired are accurate in their conditions. However, the question is about all three groups collectively. Since one group (blind) is less accurate in a condition they rely on, the answer would be No. Wait, but the study says that under hearing only, all subjects (including normally sighted and visually impaired) were inaccurate. So all three groups are inaccurate in hearing-only. But normally sighted and visually impaired are accurate in vision conditions. So if the question is whether all three groups are accurate and reliable in general, the answer would be Maybe, because it depends on the condition. But the options are Yes, No, Maybe. The answer is Maybe because sometimes they are, sometimes not. But the study's conclusion might suggest that in the conditions where they use their primary senses (vision for sighted, hearing for blind), some are accurate, others not. But the question is general. Hmm. The answer is Maybe.
</think>

[Maybe]",Correct
11570976,pubmedqa_pqa_l,Is it Crohn's disease?,maybe,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's see. The question is asking if the patient's condition is Crohn's disease based on the provided context. The context describes a 21-year-old female with rheumatoid arthritis who had a severe systemic reaction to sulfasalazine. The reaction included eosinophilia, granulomatous enteritis, myelotoxicity, cholestatic hepatitis, and seizures.

First, I need to recall what Crohn's disease is. Crohn's is a type of inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract, which can involve any part from mouth to anus. It often presents with symptoms like abdominal pain, diarrhea, weight loss, and can have complications like strictures or fistulas. A key feature is granulomatous inflammation, which is seen in some cases.

The context mentions granulomatous enteritis, which is inflammation of the intestines with granulomas. That does align with Crohn's, as granulomas are a hallmark. However, the patient here is being treated with sulfasalazine, which is used for both IBD (like Crohn's) and rheumatoid arthritis. But the main issue here is a severe reaction to the drug. The adverse reactions listedâ€”eosinophilia, hepatitis, myelotoxicity, seizuresâ€”are part of a systemic reaction to sulfasalazine, not necessarily indicative of Crohn's itself.

The key point is that the granulomatous enteritis might be a result of the drug reaction rather than Crohn's. The patient's primary diagnosis is rheumatoid arthritis, and the severe reaction is a side effect of the medication. So even though granulomatous enteritis is present, the context is pointing towards a drug-induced condition rather than Crohn's disease. Therefore, the answer is probably No.
</think>

[No]",Incorrect
19757704,pubmedqa_pqa_l,Is Chaalia/Pan Masala harmful for health?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether Chaalia and Pan Masala are harmful for health based on the provided context.

First, I need to look at the context given. The study was conducted in schools in Karachi, Pakistan, to assess the students' practices and knowledge about these substances. The key points from the results are:

- 94% of students used Chaalia, and 73.8% used Pan Masala.
- 85% were regular users.
- 96% of the children considered Chaalia harmful, while 60% thought Pan Masala was harmful.
- The study mentions that knowledge about established harmful effects was variable, but high in both daily and less than daily users.

The question is whether these products are harmful. The context states that the students' knowledge about harmful effects was assessed, and a high percentage (96% for Chaalia, 60% for Pan Masala) believed they were harmful. However, the study itself is about the students' practices and their own knowledge, not an independent assessment of the actual harm. But the last line says ""Knowledge about established harmful effects was variable,"" implying that there are established harmful effects, which the students have varying awareness of. The fact that knowledge was high in both user groups suggests that there is some established harm, even if the students' awareness varies. So, the answer would be yes, based on the context provided, since the study refers to established harmful effects and a majority of the students recognize Chaalia as harmful, with a significant portion recognizing Pan Masala as harmful too.
</think>

[Yes]",Correct
27592038,pubmedqa_pqa_l,Does multi-modal cervical physical therapy improve tinnitus in patients with cervicogenic somatic tinnitus?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether multi-modal cervical physical therapy improves tinnitus in patients with cervicogenic somatic tinnitus (CST). 

First, I need to look at the context provided. The study is a randomized controlled trial, which is a strong design. They had two groups: immediate-start and delayed-start. Both groups received the same therapy over 6 weeks (12 sessions). The primary outcomes were the Tinnitus Functional Index (TFI) and Neck Bournemouth Questionnaire (NBQ) scores.

The results showed that TFI and NBQ scores decreased significantly after treatment. The TFI p-value was 0.04, which is statistically significant, and NBQ was p < 0.001. After follow-up, NBQ remained significant (p=0.001), but the TFI's long-term effect isn't mentioned. 

Also, 53% reported substantial improvement immediately after treatment, but only 24% maintained it at six weeks follow-up. The Global Perceived Effect (GPE) was positive right after treatment but dropped over time. 

So, the therapy does show a significant improvement in both tinnitus and neck complaints post-treatment. However, the effect on tinnitus specifically (TFI) might not be sustained as strongly as the neck issues (NBQ). The initial improvement is there, but the long-term effect is less pronounced. 

The question is whether the therapy improves tinnitus. The study says yes immediately after treatment, but the effect diminishes over time. Since the question doesn't specify time frame, the answer would be yes, but with the caveat that the improvement may not last. However, the answer options are Yes, No, Maybe. The study shows significant improvement post-treatment, so the answer is Yes. But the follow-up shows reduced effect. However, the question is about improvement, not maintenance. So based on the results, the answer is Yes.
</think>

[Yes]",Correct
27044366,pubmedqa_pqa_l,Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?,maybe,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether paucigranulocytic asthmatics are truly non-inflammatory based on the study's detailed analysis of sputum and systemic inflammation.

First, I need to recall the study's findings. The context mentions that all asthma phenotypes, including paucigranulocytic, had increased sputum eosinophils compared to healthy subjects. Even though paucigranulocytic asthma is typically considered to have low granulocyte levels, the study found higher absolute blood eosinophils in this group. Additionally, all asthma groups showed higher blood leukocytes than healthy subjects. However, systemic inflammatory markers like CRP and fibrinogen were raised in neutrophilic and eosinophilic phenotypes, but the text doesn't mention these markers for paucigranulocytic. 

So, even though paucigranulocytic asthma might have lower granulocytes in sputum, there's evidence of inflammation in blood parameters. The question is whether this means they are ""really non-inflammatory."" The study suggests some inflammation exists (blood eosinophils and leukocytes), so the answer might be No, they aren't non-inflammatory. But maybe there's ambiguity because systemic markers like CRP aren't mentioned for them. Wait, the study says paucigranulocytic had increased blood eosinophils compared to healthy, but not CRP or fibrinogen. So their systemic inflammation might be less pronounced. However, the presence of elevated blood eosinophils and leukocytes indicates some level of inflammation. Therefore, the answer is No, they are not really non-inflammatory.
</think>

[No]",Incorrect
9792366,pubmedqa_pqa_l,Is HIV/STD control in Jamaica making a difference?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if the HIV/STD control program in Jamaica is making a difference. The context provided includes data from various sources over several years.

First, looking at the AIDS incidence rate. It says there was only a marginal increase from 18.5 to 21.4 per 100,000 between 1994 and 1997. That's a small rise, which might suggest the program is preventing a larger increase. But I need to check other indicators.

HIV prevalence in the general population is about 1% or less. That's low, but high-risk groups like STD clinic attendees, prostitutes, and homosexuals have higher rates. For example, homosexuals have around 30% prevalence. However, the program's impact might be more about preventing spread in the general population rather than eliminating it in high-risk groups. 

Syphilis rates and congenital syphilis cases have declined. That's a positive sign, indicating that STD control measures are working for at least some diseases.

Then there's the KAP surveys. Men reporting sex with non-regular partners decreased from 35% to 26% between 1994 and 1996. That's a significant drop. Women's condom use increased from 51% in 1988 to 73% in 1996. Condom use with non-regular partners among women jumped from 37% to 73%. Men's condom use was already high but remained stable. Also, condom sales/distribution increased from 2 million to 10 million over a decade, showing more availability and usage.

Gay men, inner-city adults, and adolescents all reported increased condom use. These behavioral changes are key in controlling STD/HIV spread. The combination of reduced risky sexual behavior and increased condom use likely contributed to controlling the epidemic.

However, HIV rates in high-risk groups are still high. The program might not be as effective in those groups, or maybe they're harder to reach. But the overall trend in the general population and the decline in syphilis suggest the program is making a positive impact. The marginal increase in AIDS cases could be due to better reporting or longer survival with treatment, but the data here doesn't specify. 

Putting it all together: reductions in risky behavior, increased condom use, lower syphilis rates, and controlled HIV prevalence in the general population indicate the program is effective. So the answer is yes.
</think>

[Yes]",Correct
17562682,pubmedqa_pqa_l,Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK?,maybe,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether Panton-Valentine leucocidin (PVL) is associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK.

First, I need to recall the context provided. The study looked at 244 S. aureus bacteraemia isolates from the UK and Ireland. They found that only 4 out of 244 (1.6%) were PVL-positive, and all of these were methicillin-susceptible (MSSA). None of the methicillin-resistant (MRSA) isolates had PVL. The four PVL-positive cases had different infection foci and were from different locations. The genotypic analysis showed three distinct strains, with two from Ireland being related.

The key point here is the prevalence of PVL in bacteraemia cases. The study mentions that the importance of PVL in the pathogenesis of primary bacteraemia is uncertain. The low prevalence (1.6%) found in this study suggests that PVL is not a common factor in these cases in the UK. Since the majority of bacteraemia isolates were PVL-negative, especially all MRSA ones, it implies that PVL might not be a major contributor to the pathogenesis in this specific context. However, the presence of PVL in a few cases might indicate some association, but the study's conclusion seems to downplay its significance. The answer would likely be ""No"" because the low prevalence and uncertainty in the context suggest that PVL isn't a key factor here.
</think>

[No]",Incorrect
15800018,pubmedqa_pqa_l,Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?,yes,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking if even impaired fasting glucose (IFG) levels before surgery are linked to higher mortality after CABG.

First, I need to recall the context provided. The study looked at 1895 patients who had CABG, with data on fasting blood glucose (fB-glu) for 1375. They categorized non-diabetics into normal, IFG, and suspected DM based on fB-glu levels. The key here is the relative risks given for 30-day and 1-year mortality compared to normal fB-glu.

For IFG, the 30-day mortality relative risk is 1.7 with a 95% CI of 0.5-5.5. The 1-year is 2.9 (CI 0.8-11.2). The confidence intervals here are pretty wide and include 1, which means the results aren't statistically significant. So, even though the point estimates are above 1, the uncertainty is too high to be sure.

Then, looking at suspected DM (SDM), the 30-day risk is 2.8 (CI 1.1-7.2), which is significant since the CI doesn't include 1. But the 1-year risk is 1.9 (CI 0.5-6.3), which isn't significant. For clinical DM (CDM), both intervals include 1 as well.

The ROC area for fB-glu and 1-year mortality is 0.65, which is statistically significant (p=0.002), but the area under the curve is only moderate. This suggests some predictive value, but maybe not strong.

The question specifically asks about IFG. The study's results for IFG show increased relative risks, but the confidence intervals cross 1, so we can't reject the null hypothesis. However, the trend is there. The answer might hinge on whether the user is looking for statistical significance or a trend. Since the CIs include 1, the correct answer would be Maybe, but the study's data isn't conclusive. Alternatively, if considering the ROC result, there's some association, but it's not specific to IFG. The answer should be Maybe because the evidence isn't strong enough for a definitive yes, but there's a signal.
</think>

[Maybe]",Incorrect
14978612,pubmedqa_pqa_l,Does positron emission tomography change management in primary rectal cancer?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if positron emission tomography (PET) changes management in primary rectal cancer. The context provided is a study that looked into this.

First, the study involved 46 patients with advanced primary rectal cancer. The doctors recorded their initial treatment plans based on conventional imaging and then did PET scans. They compared the management before and after PET. 

The results: In 36 out of 46 patients (78%), the surgical management didn't change. However, PET did upstage or downstage the disease in some of these, but treatment stayed the same. Then, in 8 patients (17%), management was altered because of PET findings. For example, 6 had surgery canceled, and 2 had radiotherapy fields changed. Follow-up confirmed these changes were appropriate. Also, overall tumor stage changed in 39% of patients after PET. 

So even though most patients didn't have a change in management, a significant minority (17%) did. The question is whether PET changes management. The answer would be yes, because in 17% of cases, it did lead to a change. Even though the majority didn't change, the fact that some did means PET does have an impact. The answer should be yes.
</think>

[Yes]",Correct
18843057,pubmedqa_pqa_l,Can you deliver accurate tidal volume by manual resuscitator?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if accurate tidal volume can be delivered using a manual resuscitator. From the context provided, the study compared different methods: one-handed, two-handed, and two-handed half-compression. The results showed significant differences in the volumes delivered by each method. The mean volumes varied quite a bit, with standard deviations that are pretty large relative to the means. For example, the one-handed method had a mean of about 592 ml with an SD of 117, which means there's a lot of variability. The two-handed method had a higher mean but even higher SD. The two-handed half-compression was lower.

The study also mentions that physical characteristics like hand size and grip power didn't correlate with the volume delivered. Education and practice had slight increases but weak correlations. The p-values are all less than 0.01, indicating statistical significance, but the actual effect sizes (r values) are low for education and practice. 

So, the key points here are the variability in delivered volumes across different methods and the lack of strong correlation with user characteristics or training. Accurate tidal volume delivery would require consistency and minimal variability. However, the study shows that even trained individuals have significant variability, especially depending on the method used. Therefore, achieving accurate tidal volume consistently might be difficult with manual resuscitators as per this study. The answer would likely be No, because the results indicate high variability and lack of strong factors ensuring accuracy.
</think>

[No]",Correct
23076787,pubmedqa_pqa_l,Can increases in the cigarette tax rate be linked to cigarette retail prices?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether increases in the cigarette tax rate can be linked to retail prices. From the context provided, there's a specific example from China in 2009 where the excise tax was increased. However, the STMA used their authority to keep retail prices unchanged. The tax was collected at producer and wholesale levels, leading to higher government revenue and lower industry profits, but no price change for consumers.

So, the key point here is that even though the tax rate went up, the retail prices didn't because the STMA intervened. This suggests that in this case, the tax increase didn't affect retail prices. But the question is more general: can tax increases be linked to retail prices? The answer isn't a straightforward yes or no because it depends on other factors like government policies. In the example given, the answer would be no, but the question is broader. However, the context provided specifically shows a case where the link was broken by policy. So the answer here, based on the context, is that in this instance, the tax increase didn't lead to higher retail prices. Therefore, the answer is No.
</think>

[No]",Correct
9199905,pubmedqa_pqa_l,Vertical lines in distal esophageal mucosa (VLEM): a true endoscopic manifestation of esophagitis in children?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether vertical lines in the distal esophageal mucosa (VLEM) are a true endoscopic manifestation of esophagitis in children.

First, I need to look at the context provided. The study involved 255 esophageal biopsies performed between 1992 and 1994. They divided the patients into two groups: Group 1 had normal endoscopic appearance (160 studies), and Group 2 had VLEM as the only abnormality (41 endoscopies). 

The histology results are key here. In Group 1, 57.5% of biopsies were normal, which means a significant portion (42.5%) had some histologic changes despite normal endoscopy. However, in Group 2 (VLEM), only 2.4% had normal histology. That's a big difference. 

Most patients in Group 2 had eosinophilic esophagitis (83%), and the majority of those cases were moderate to severe. The specificity and sensitivity values are provided: specificity of 0.85 and sensitivity of 0.5 for VLEM in relation to eosinophilic esophagitis. The p-values are also significant (p<0.001), which suggests that the findings are statistically significant and not due to chance.

So, the presence of VLEM seems to be strongly associated with histologic esophagitis, especially eosinophilic esophagitis. The high specificity (0.85) means that when VLEM is present, it's a good indicator of the disease. The sensitivity is lower (0.5), meaning that not all cases of esophagitis will show VLEM, but when it's there, it's a reliable sign. The study's results support the idea that VLEM is a true endoscopic sign of esophagitis in children, particularly linked to eosinophilic esophagitis with moderate to severe inflammation.
</think>

[Yes]",Correct
23999452,pubmedqa_pqa_l,Does hypoglycaemia increase the risk of cardiovascular events?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if hypoglycemia increases the risk of cardiovascular events. The context provided is from the ORIGIN trial. Let me go through the details.

First, the trial had participants with dysglycemia and high CV risk. They were given either insulin glargine or standard care. The study looked at non-severe and severe hypoglycemia. Non-severe was defined as symptoms with glucose â‰¤54 mg/dL, and severe as needing assistance or glucose â‰¤36 mg/dL. The outcomes measured included CV events, mortality, etc.

The results showed that non-severe hypoglycemia wasn't associated with any outcomes after adjustment. However, severe hypoglycemia was linked to higher risks for the primary CV outcome, mortality, CV death, and arrhythmic death. The adjusted hazard ratios were all significant. Also, severe nocturnal hypoglycemia had similar associations. Importantly, the hazard for severe hypoglycemia was higher in the standard care group compared to insulin glargine.

So the key point here is that severe hypoglycemia, but not non-severe, was associated with increased CV events. The study differentiates between the two types. The question is general about hypoglycemia, but the answer depends on the severity. Since the study found that severe hypoglycemia does increase risk, the answer would be yes. But wait, the question doesn't specify severity. However, the context shows that severe hypoglycemia is linked, so the answer is yes. But maybe the user is considering all hypoglycemia. But the study says non-severe wasn't associated. So the answer is yes, because severe does, but maybe the user is conflating all hypoglycemia. Wait, the question is ""Does hypoglycaemia increase the risk..."" without specifying severity. The study shows that severe does, non-severe doesn't. So the answer would be yes, because part of hypoglycemia (severe) does. But maybe the answer is yes, but with the caveat of severity. However, the question is a yes/no/maybe. The study's conclusion is that severe hypoglycemia is associated, so the answer is yes. Therefore, the correct response is [Yes].
</think>

[Yes]",Correct
22534881,pubmedqa_pqa_l,Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if the radiographic transition zone correlates with the level of aganglionosis in Hirschsprung's disease. The context provided is a study that looked at this correlation.

The study had 79 patients, with 61 contrast enemas reviewed. They categorized the radiographic transition zones into four groups and compared them to the pathological findings. The results showed varying concordance rates: 42% for rectal, 57% for rectosigmoid, 100% for long-segment and total colonic. The overall agreement was 58.1% with a kappa coefficient of 0.39, which is considered fair agreement but not strong.

The kappa coefficient here is 0.39, which is between 0.21 and 0.40, indicating fair agreement. The confidence interval (0.24 to 0.57) doesn't cross into the moderate range (0.41-0.60) entirely. So, the correlation exists but isn't very strong. The study's conclusion might be that there's some correlation, but it's not highly accurate, especially in certain groups like rectal and rectosigmoid. However, in long-segment and total colonic cases, the correlation was perfect. 

The question is whether there's a correlation. The answer isn't a straightforward yes or no. The study shows that in some cases (like long-segment) there's a strong correlation, but overall, the agreement is only 58% with a fair kappa. So maybe the answer is ""Yes"" but with the caveat that it's not highly accurate in all cases. However, the user is asking if there's a correlation, not how strong it is. Since there is some level of agreement (even if moderate or fair), the answer would be yes. But the study's own conclusion might suggest that the correlation is not reliable, so maybe the answer is ""Maybe"". Wait, the abstract says the correlation is known to be inaccurate, and their study aimed to analyze it more precisely. Their results show partial agreement. So the answer is that there is a correlation, but it's not perfect. The question is phrased as ""Does the radiographic transition zone correlate..."" and the answer based on the study is yes, but with varying degrees. However, the kappa is 0.39, which is considered fair, so maybe the answer is ""Yes"" but the strength is weak. Alternatively, since the overall agreement is 58%, which is better than chance, but the kappa is low. The answer could be ""Yes"" because there is a correlation, even if it's not strong. The study's results do show some level of correlation, especially in certain groups. So the answer is [Yes].
</think>

[Yes]",Incorrect
24785562,pubmedqa_pqa_l,Is dexamethasone an effective alternative to oral prednisone in the treatment of pediatric asthma exacerbations?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if dexamethasone is an effective alternative to oral prednisone for pediatric asthma exacerbations.

First, I'll look at the context provided. The studies reviewed compared dexamethasone with prednisone. All six pediatric trials found that prednisone isn't superior to dexamethasone for mild to moderate cases. That suggests they're equally effective. The meta-analysis showed no significant differences in symptom resolution or revisits. Also, dexamethasone has benefits like better compliance because it's a shorter course (1-2 days vs. 5 days) and less vomiting. So, the evidence points to dexamethasone being a viable alternative. The answer should be yes.
</think>

[Yes]",Correct
22564465,pubmedqa_pqa_l,Mammographic screening in Sami speaking municipalities and a control group. Are early outcome measures influenced by ethnicity?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether early outcome measures of mammographic screening are influenced by ethnicity, specifically comparing Sami-speaking municipalities to a control group.

First, I need to look at the context provided. The study compared attendance rates, recall rates, and cancer detection rates between the Sami and non-Sami groups. The attendance rate was higher in the Sami group (78% vs 75%) with a significant p-value. The recall rate was lower in the Sami group (2.4% vs 3.3%), also significant. However, the rate of invasive screen-detected cancer wasn't significantly different (p=0.14), and the percentage of all breast cancers detected through the program was lower in the Sami group (67% vs 86%, p=0.06, which is close to but not below 0.05).

The question is about early outcome measures. Attendance and recall rates are early outcomes. Since these showed significant differences, ethnicity might influence these. However, the actual cancer detection rate (a later outcome) wasn't significantly different. The study's results suggest that ethnicity could affect early measures like attendance and recall, but maybe not the detection rate. The answer hinges on whether attendance and recall are considered early outcomes. Since they are part of the screening process's initial stages, the answer would be yes. But the user might be looking for a more nuanced answer. Wait, the percentage of cancers detected was lower in Sami but not statistically significant (p=0.06). So maybe the answer is yes for attendance and recall, but maybe not for others. The question is whether early outcome measures are influenced. Since attendance and recall are early, and they differ significantly, the answer is yes. But the study's conclusion might be that some measures are influenced. So the answer is yes.
</think>

[Yes]",Correct
27456836,pubmedqa_pqa_l,Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether electrochemiluminescence (ECL) assays improve the prediction of time to type 1 diabetes in TrialNet subjects who are autoantibody-positive.

First, I need to look at the context provided. The study analyzed TrialNet subjects positive for one or more autoantibodies. They had ECL-IAA and ECL-GADA data at their initial visit. Out of 1,287 subjects, 177 developed diabetes after a median follow-up of 24 months. 

The univariate analyses showed that several factors, including ECL-IAA and ECL-GADA, were significantly associated with progression. The key point here is that ECL-positive subjects had a 58% risk of progressing within 6 years versus 5% for ECL-negative. That's a huge difference and statistically significant (P<0.0001). 

Then, in multivariate models, the model including ECL positivity (along with other factors like C-peptide levels and RIA autoantibodies) was the best. Adding ECL to the existing DPTRS improved the AUC to 0.83, which is a good improvement and also significant. 

So, the evidence points towards ECL assays adding predictive value. The study directly compared models with and without ECL, and the one with ECL performed better. The improvement in the ROC curve's AUC when adding ECL to DPTRS suggests enhanced predictive accuracy. 

Therefore, the answer should be yes. The data supports that ECL assays do improve prediction in this context.
</think>

[Yes]",Correct
27287237,pubmedqa_pqa_l,Assessment of appropriate antimicrobial prescribing: do experts agree?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is asking whether experts agree on the assessment of appropriate antimicrobial prescribing. The context provided is a study where 24 infectious disease doctors (16 specialists and 8 residents) evaluated 56 cases. The reference standard was the modal opinion of the 16 specialists. The results showed that specialists agreed with the reference standard 80% of the time, with sensitivity and specificity around 75% and 84%. Also, interrater agreement between specialists and an index expert was 76%, and the index expert's intrarater agreement was 71%. 

So, the key points here are that the specialists' agreement with the reference (which is based on their own modal opinion) is 80%, which is pretty high but not perfect. The interrater agreement with a specific expert is lower at 76%, and even the same expert only agreed with themselves 71% of the time. This suggests that while there's a majority agreement, there's still variability among experts. The study also mentions that factors like specialty, hospital, or experience didn't affect the validity, and residents performed similarly.

The question is whether experts agree. The answer would depend on how we interpret the agreement percentages. 80% agreement with the reference (which is the majority opinion) indicates that most of the time they agree, but there's a 20% disagreement. The interrater and intrarater agreements being lower (76% and 71%) show that when comparing individual experts, the agreement isn't as strong. So, the answer isn't a straightforward yes or no. It's more like they agree to a certain extent but not completely. The study's conclusion might be that there's moderate agreement, but variability exists. Therefore, the answer would be ""Yes"" because there is a significant level of agreement, but the presence of variability might make someone think ""Maybe"". However, the question is phrased as ""do experts agree?"" and the data shows that in 80% of cases they do, so the answer leans towards ""Yes"". But the lower interrater and intrarater agreements could suggest some inconsistency. However, the reference standard is the modal expert opinion, so the 80% agreement with that implies that the majority do agree. Therefore, the answer is Yes.
</think>

[Yes]",Correct
14697414,pubmedqa_pqa_l,Is there a favorable subset of patients with prostate cancer who develop oligometastases?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if there's a favorable subset of prostate cancer patients who develop oligometastases. From the context provided, the study looked at patients with â‰¤5 metastatic lesions versus those with >5. The results showed that those with â‰¤5 lesions had better survival rates at 5 and 10 years (73% vs 45% and 36% vs 18%) with a p-value of 0.02, which is statistically significant. Also, metastasis-free survival and time to bone metastasis were better for the â‰¤5 group. However, once bone metastasis occurred, survival time didn't differ between the groups. Since oligometastases typically refer to a limited number of metastases, often â‰¤5, the study suggests that patients with â‰¤5 lesions have better outcomes, indicating a favorable subset. So the answer should be yes.
</think>

[Yes]",Correct
26686513,pubmedqa_pqa_l,Cycloplegic autorefraction in young adults: is it mandatory?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether cycloplegic autorefraction is mandatory in young adults. The context provided is a study comparing non-cycloplegic and cycloplegic measurements in young soldiers aged 18-21.

First, I need to recall what cycloplegic refraction does. Cycloplegic drops paralyze the ciliary muscle, preventing accommodation, which can affect the accuracy of the refraction, especially in younger people whose eyes can accommodate more. The study found a mean difference of 0.68D between the two methods, which is significant. Hypermetropes had a larger difference (1.30D) compared to myopes (0.46D). Also, moderate hypermetropes showed the greatest difference.

So, the question is whether cycloplegic refraction is mandatory. The study shows that there's a notable difference, especially in hypermetropic individuals. Since young adults can still have active accommodation, not using cycloplegia might lead to overestimating myopia or underestimating hyperopia. However, the study's population is specific (military personnel), but the age group is relevant. The conclusion would depend on the clinical implications of the differences found. If the difference is clinically significant, then cycloplegic refraction would be necessary. The study's results suggest that especially for hypermetropes, cycloplegia is important. But the answer isn't a straightforward yes or no. The study indicates that it's particularly important in hypermetropic cases, but maybe not for everyone. However, the question is about whether it's mandatory in general for young adults. Given that the mean difference is 0.68D, which could affect prescription accuracy, the answer might lean towards yes, but the study's conclusion isn't explicitly stated. The user is asking for a yes/no/maybe based on the provided data. Since the study shows significant differences, especially in hypermetropes, but the necessity might depend on the individual's refractive error, the answer could be ""Yes"" for hypermetropes and ""Maybe"" overall. But the question is general. The study's purpose was to compare, and the results suggest that cycloplegic refraction provides different measurements, so in cases where precise correction is crucial (as stated in the context), it might be mandatory. However, the answer options are only yes, no, maybe. The study doesn't explicitly state it's mandatory, but the implication is that there's a significant difference, so maybe the answer is yes. Alternatively, since the necessity is unclear (as per the context's first paragraph), but the study shows differences, maybe the answer is yes. Wait, the context says ""It is unclear whether cycloplegic refraction is necessary in this age group."" But the study's results show significant differences, so perhaps the conclusion is that it is necessary, hence the answer would be yes. But the study's own conclusion isn't provided here. The user is asking based on the given data. The key point is that the difference is significant, especially in hypermetropes, which suggests that cycloplegic refraction is important for accurate measurements. Therefore, the answer would be yes, it is mandatory, especially in hypermetropic young adults. But the question is general. However, the study's results support the necessity, so the answer is [Yes].
</think>

[Yes]",Incorrect
15530261,pubmedqa_pqa_l,Does screening or surveillance for primary hepatocellular carcinoma with ultrasonography improve the prognosis of patients?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether screening or surveillance for primary hepatocellular carcinoma (HCC) using ultrasonography improves patient prognosis. 

First, I need to look at the context provided. The study divided 680 cases into surveillance, opportunistic, and symptomatic groups. They compared outcomes like survival time, tumor morphology, and T staging using logistic regression.

The key results here are the adjusted odds ratios. For the screened vs. unscreened groups, the ORs for 1-, 2-, and 3-year survival are all below 1 (0.33, 0.33, 0.37), with confidence intervals not crossing 1. Similarly, surveillance vs. nonsurveillance also shows ORs less than 1 (0.58, 0.45, 0.44), again with significant CIs. The study mentions that when using tumor morphology or T stage as outcomes, the ORs are even smaller, which I think means even more favorable for the screened groups. All results are statistically significant, and there's a gradient relationship between screening history and prognosis.

Wait, odds ratios less than 1 here. Since the outcomes are survival time, tumor morphology, and T staging, which are likely coded in a way that higher values indicate better prognosis. So an OR <1 would mean that the screened group has lower odds of having worse outcomes. Wait, but survival time being the outcomeâ€”if the OR is for survival (like surviving 1, 2, 3 years), then a lower OR would actually be worse. But the way the study is phrased, the screened group has lower odds ratios compared to unscreened. Hmm, maybe I need to check how the outcome is defined. If the outcome is death within 1,2,3 years, then an OR <1 would mean lower odds of death in the screened group, which is better prognosis. Alternatively, if the outcome is survival (alive at 1,2,3 years), then OR <1 would be worse. The context says ""survival time, tumor morphology, and T staging as prognostic outcomes."" The exact coding isn't clear, but the study states that the odds ratios were even smaller when using tumor morphology or T stage as outcomes, and all results were significant. The conclusion mentions ""significant gradient relationships between prognostic outcomes and extent of screening history,"" implying that more screening leads to better outcomes.

Therefore, the answer should be Yes, because the screened and surveillance groups have significantly better odds (lower ORs indicating reduced risk of poor outcomes) compared to unscreened. The study supports that screening improves prognosis.
</think>

[Yes]",Correct
24160268,pubmedqa_pqa_l,"""Would a man smell a rose then throw it away?",maybe,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's try to figure out if the answer to the question ""Would a man smell a rose then throw it away?"" is Yes, No, or Maybe based on the given context.

First, I need to understand the context. The study is about Jordanian men's perspectives on breast cancer and their role in women's breast health. The themes identified include support for their wives, marital obligations, and cultural constraints like shame and destiny. The men feel responsible for family health, encourage seeking healthcare, but also have concerns about femininity post-mastectomy and cultural stigma (Eib/shame). There's mention of breast cancer being seen as an act of God or linked to improper behavior.

The question is metaphorical: ""Would a man smell a rose then throw it away?"" I need to relate this metaphor to the context. A rose is often a symbol of beauty or something valuable. Smelling it (appreciating) then throwing it away (discarding) might symbolize valuing something initially but then rejecting it. 

In the study, men support their wives' health (smelling the rose) but there's also a cultural stigma (Eib) and concerns about femininity after mastectomy, which might lead to rejection (throwing it away). The third theme mentions men's readiness to face the culture of shame, implying some might reject their wives due to breast cancer. The second theme talks about men's perceptions of diminished femininity and hereditary risks, which could lead to abandonment. However, the first theme shows support and responsibility. 

So, the answer isn't straightforward. Some men might support their wives (not throw away), while others might reject them due to cultural beliefs (throw away). Therefore, the answer is Maybe, as it depends on individual and cultural factors mentioned in the study.
</think>

[Maybe]",Correct
21823940,pubmedqa_pqa_l,Department of Transportation vs self-reported data on motor vehicle collisions and driving convictions for stroke survivors: do they agree?,no,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether the Department of Transportation (DOT) data and self-reported data from stroke survivors agree on motor vehicle collisions and driving convictions. 

First, I need to look at the context provided. The study compared government records (from the Ministry of Transportation of Ontario, MTO) with self-reports from stroke survivors. The key points here are the discrepancies found. 

The results mention that 13.5% of participants had mismatched collision reports, and 17.3% had mismatched conviction reports. The kappa coefficients are 0.52 and 0.47, which are considered moderate agreement. However, when combining both data sources, they found significantly more incidents than either source alone.

So, the question is about agreement between the two sources. The kappa values being moderate suggest there's some agreement, but not perfect. The fact that combining both sources reveals more incidents indicates that each source misses some data. Therefore, the answer is that they don't fully agree, but there's moderate agreement. The study's conclusion would be that there's moderate agreement, hence the answer is ""Maybe"" because it's not a clear yes or no. They agree to some extent but not completely.
</think>

[Maybe]",Incorrect
27217036,pubmedqa_pqa_l,"Neoadjuvant Imatinib in Locally Advanced Gastrointestinal stromal Tumours, Will Kit Mutation Analysis Be a Pathfinder?",yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether Kit mutation analysis will be a pathfinder for neoadjuvant Imatinib in locally advanced gastrointestinal stromal tumors (GIST). 

First, I need to recall the context provided. The study included 125 patients with LA or LR GIST treated with neoadjuvant Imatinib. Out of these, 45 had c-kit mutation testing. The results showed that exon 11 mutations were present in 55.5% of tested patients. The response rate (RR) was significantly higher in exon 11 mutants (84% vs. 40%), and disease stabilization rates (DSR) were also higher (92% vs. 75%). More exon 11 patients were surgical candidates, and surgery improved EFS and OS. However, there were no differences in outcomes between different exon variants.

The question is whether Kit mutation analysis will guide treatment (act as a pathfinder). The data shows that exon 11 mutants respond better to Imatinib, suggesting that mutation status could predict response. However, the study also mentions that there were no differences between exon variants in terms of outcomes and responses beyond exon 11 vs. non-exon 11. Also, only 36% of patients were tested, which might limit the generalizability. 

But the significant difference in RR and DSR between exon 11 and others implies that mutation analysis could help identify patients more likely to benefit from neoadjuvant Imatinib. However, the conclusion states that longer duration of neoadjuvant Imatinib isn't based on tumor biology (i.e., mutation analysis), which seems contradictory. Wait, the context says the longer duration isn't based on biology reflected by mutation analysis. But the study's results actually show that mutation status does affect response. So maybe the authors are saying that current practice doesn't use mutation analysis, but their data suggests it should. 

Therefore, the answer would be Yes, because the study shows that mutation status (specifically exon 11) correlates with better response and outcomes, implying that Kit mutation analysis could guide treatment decisions. However, the conclusion mentions that the duration isn't based on biology, which might suggest that current practice doesn't use it, but the data supports its use. So the answer is Yes.
</think>

[Yes]",Correct
18565233,pubmedqa_pqa_l,Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?,yes,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether bezafibrate, a PPAR ligand used for lipid-lowering, prevents colon cancer in patients with coronary artery disease based on the study provided.

First, I need to recall the study details. The BIP Study was a randomized, double-blind trial with 3011 patients. They were given either bezafibrate or placebo. The follow-up was 6 years, and cancer incidence was checked via the National Cancer Registry.

Looking at the results: For all cancers, 5.25% in the bezafibrate group vs. 6.51% in placebo. For colon cancer specifically, 0.53% vs. 1.13%. The p-value for colon cancer is one-sided 0.05, two-sided 0.07. The hazard ratio is 0.47 with a 95% CI of 0.2-1.1.

Now, interpreting these stats. The one-sided p-value of 0.05 is borderline significant, but the two-sided is 0.07, which is above the conventional 0.05 threshold. The confidence interval for the hazard ratio includes 1 (since 0.2 to 1.1 crosses 1), meaning the result isn't statistically significant at the 95% level. However, the point estimate (0.47) suggests a trend towards reduced risk. The study mentions the effect became noticeable after 4 years and increased with time, which might indicate a delayed effect.

But the question is about prevention. The study shows a trend but not a statistically significant result. The authors say the risk ""tended to be lower,"" which implies it's not conclusive. Also, the confidence interval is wide, indicating uncertainty. So, the answer isn't a clear yes. It's possible there's an effect, but the data isn't strong enough to confirm it definitively. Therefore, the answer should be Maybe.
</think>

[Maybe]",Incorrect
19694846,pubmedqa_pqa_l,Does self-efficacy mediate the relationship between transformational leadership behaviours and healthcare workers' sleep quality?,maybe,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether self-efficacy mediates the relationship between transformational leadership behaviors and healthcare workers' sleep quality. 

First, I need to recall the context provided. The study used a longitudinal design with two time points. They looked at transformational leadership, self-efficacy, and sleep quality. The analysis involved structural equation modeling to check cross-sectional and longitudinal relationships.

The key points from the context are: 
1. Direct relationships between transformational leadership and sleep quality were found. 
2. Cross-sectionally, the relationship was negative at both time points, but positive longitudinally from baseline to follow-up.
3. Importantly, the study states that the relationship between leadership and sleep quality was **not** mediated by self-efficacy. 

So the answer hinges on whether self-efficacy acts as a mediator. The context explicitly says there's no mediation by self-efficacy. Therefore, the answer should be ""No.""
</think>

[No]",Incorrect
27184293,pubmedqa_pqa_l,Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?,maybe,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether microbial contamination affects the success of hematopoietic cell transplantation (HCT) outcomes based on the provided study.

First, I need to look at the context given. The study analyzed contamination rates in HPC grafts from 2012 to 2015. They looked at autologous and allogeneic donors. The contamination rate was 1.15% in culture bottles and 1.3% on a sample basis in patients. Out of 248 HCT patients, 9 had contaminated products. Of these, 8 experienced febrile neutropenia, with the median onset at day 4. However, none of the patients died within 30 days post-transplant.

The key points here are the occurrence of febrile neutropenia in most patients with contamination, which is a complication, but no deaths in 30 days. The study's aim was to evaluate the success of HCT in patients who received contaminated products. The conclusion mentions that none died, but they did have complications like febrile neutropenia. However, the question is about the success of HCT outcomes. Success can be measured in various ways, including survival rates, engraftment success, complications, etc. The study doesn't mention other success metrics like engraftment time or long-term survival beyond 30 days. The absence of death in 30 days might suggest that contamination doesn't impact short-term survival, but the presence of complications like febrile neutropenia could affect overall success. However, the study doesn't provide a direct comparison between contaminated and non-contaminated groups in terms of HCT success rates. Without such a comparison, it's hard to definitively say contamination influences success. The answer might be Maybe, as there's an association with complications but no direct evidence of affecting survival or overall success here.
</think>

[Maybe]",Correct
19459018,pubmedqa_pqa_l,Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if very high serum CA 19-9 levels (specifically â‰¥900 IU/ml) are a contraindication to pancreaticoduodenectomy. 

First, I need to look at the context provided. The study compared patients with elevated CA 19-9 levels (>400 IU/ml after resolving jaundice) to a control group with normal levels. The elevated group was split into high (400-899) and very high (â‰¥900). The results showed that the elevated group had worse median survival (15 vs 22 months) and 3-year survival (14% vs 32%) compared to controls. However, there was no significant difference between the high and very high subgroups. Also, patients in the elevated group whose CA 19-9 normalized post-surgery had similar survival to controls.

A contraindication would mean that the procedure shouldn't be done because the risks outweigh the benefits. The study shows that even with very high levels, survival isn't worse than those with high levels (400-899), and some patients (those who normalized levels post-op) did as well as controls. So, while elevated CA 19-9 is a negative prognostic factor, the lack of difference between high and very high groups suggests that very high levels alone might not be a reason to avoid surgery. However, the study doesn't explicitly state that surgery is contraindicated; it just shows worse outcomes. But the answer here is whether it's a contraindication based on the data. Since the elevated group still underwent surgery and some had good outcomes, the answer is probably no. The key point is that the study didn't find a difference between high and very high, so even very high levels aren't a contraindication, especially if levels can normalize post-op.
</think>

[No]",Correct
22042121,pubmedqa_pqa_l,Perioperative care in an animal model for training in abdominal surgery: is it necessary a preoperative fasting?,no,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether preoperative fasting is necessary in the perioperative care of an animal model (specifically rabbits) used for training in abdominal surgery. The context provided is a study involving 32 rabbits undergoing various fasting periods before surgery. The study's results showed that despite extended fasting times, all animals still had some gastric content post-surgery and experienced increased blood glucose levels. The mortality and morbidity rates were low, but the presence of gastric content even after fasting suggests that fasting might not be fully effective in emptying the stomach.

The key points here are the correlation between fasting duration and gastric content. The study mentions a moderate negative correlation between fasting duration for liquids and solids and the quantity of solid gastric content. This implies that longer fasting times reduced the solid content but didn't eliminate it. However, since all animals had some gastric content regardless of fasting, the necessity of fasting is called into question. Additionally, the blood glucose levels increased post-surgery, which might be a stress response, but the study doesn't directly link this to fasting.

In human surgery, preoperative fasting is standard to reduce aspiration risk. But in this animal model, even with fasting, gastric content remained. The study's results might suggest that fasting as practiced here isn't fully effective, so maybe it's not necessary, or perhaps alternative methods are needed. However, the low mortality rate might indicate that despite some gastric content, complications are rare, so maybe fasting isn't critical here. But the presence of any gastric content could still pose a risk, so maybe it's still necessary but needs optimization. The answer isn't straightforward. The study shows that fasting didn't prevent gastric content, so maybe the answer is ""No,"" but the negative correlation suggests some benefit, so ""Maybe."" Alternatively, the necessity is questioned, so ""Yes"" but with modifications. Hmm. The question is whether it's necessary. The study's findings suggest that even with fasting, there's gastric content, so maybe it's not necessary, but the negative correlation implies that longer fasting reduces content. So perhaps fasting is necessary but the duration needs adjustment. The answer might be ""Yes"" because some fasting is needed, but the study shows it's not sufficient. Alternatively, since all had content despite fasting, maybe it's not necessary. The answer is probably ""Yes"" because some fasting is standard, but the study's results suggest maybe it's not fully effective. But the question is whether it's necessary. The study's data shows that even with fasting, there's content, so maybe it's not necessary. But the negative correlation means longer fasting helps, so maybe it is necessary. The answer is conflicting. The correct answer based on the study's conclusion might be that fasting is necessary but needs to be optimized. However, the user is asking if it's necessary. The study's results show that despite fasting, gastric content remains, which could imply that fasting isn't effective enough, hence not necessary. But the presence of a negative correlation suggests that longer fasting reduces content, so some fasting is beneficial. Therefore, the answer is ""Yes,"" but the study indicates that current fasting protocols may need adjustment. However, the question is a yes/no/maybe. The study's conclusion might lean towards ""Maybe"" because the necessity is questioned based on the results. Alternatively, since all animals had some content regardless, maybe fasting isn't necessary. But the negative correlation suggests that it does have an effect. So the answer is ""Maybe"" because the study shows that fasting reduces but doesn't eliminate gastric content, so its necessity is debatable. The authors might argue that fasting is necessary but not sufficient, hence maybe. So the answer is [Maybe].
</think>

[Maybe]",Incorrect
16100194,pubmedqa_pqa_l,Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if physicians are aware of the side effects of ACE inhibitors. The context provided is a study where they sent out a questionnaire to different types of doctorsâ€”cardiologists, allergists, and GPs. The results showed that the percentage of correct answers was pretty low across the board. GPs had the highest at 40%, which is still not great. The lowest correct answers were about when the cough starts and what to do about it. Also, cardiologists didn't know much about cross-reactivity with sartans.

So, the study is pointing out that even among these specialists, knowledge about ACE-I side effects is lacking. The question is whether physicians are aware. The data here suggests that their awareness is low since the correct answer rates are around 30-40%, which is not high. The conclusion in the context even mentions that the lower rate of correct answers indicates a lack of knowledge. Therefore, the answer would be that physicians are not sufficiently aware. The answer should be ""No"" because the study shows low correct response rates, indicating a lack of awareness.
</think>

[No]",Correct
25480629,pubmedqa_pqa_l,Residual fundus or neofundus after laparoscopic sleeve gastrectomy: is fundectomy safe and effective as revision surgery?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether fundectomy is safe and effective as revision surgery for residual fundus or neofundus after laparoscopic sleeve gastrectomy. 

First, I need to look at the context provided. The study included 19 patients divided into two groups. Group A had severe GERD, residual fundus/neofundus, hiatal hernia, and good weight loss. Group B had similar GERD issues but with inadequate weight loss or regain. The main outcomes were safety (complications) and efficacy (GERD improvement and weight loss).

For safety: The study mentions no mortality or intra-operative complications. However, there were 5 postoperative complications (2 bleeding, 1 stenosis, 2 leaks) which is 10.5% of the patients. That's a notable complication rate, but maybe acceptable in revision surgeries which can be riskier. The complications were managed, I assume, since they don't mention any long-term issues.

For efficacy: All patients had improved GERD symptoms and stopped PPIs. Group B also had an additional 53.4% EWL at 24 months. So in terms of resolving GERD and aiding weight loss in Group B, it seems effective. However, Group A already had good weight loss, so the main benefit there was GERD resolution.

The question is about both safety and effectiveness. The study shows effectiveness in GERD resolution and additional weight loss in Group B. Safety-wise, there were complications but no mortality. The complication rate is 10.5%, which might be considered acceptable depending on the risk-benefit analysis. The study is retrospective and small (19 patients), so larger studies might be needed, but based on the given data, the answer would lean towards yes. But the presence of complications might make someone hesitate. However, the conclusion here is that the authors state it's safe and effective, so maybe the answer is yes.
</think>

[Yes]",Incorrect
17453263,pubmedqa_pqa_l,Are physician estimates of asthma severity less accurate in black than in white patients?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if physician estimates of asthma severity are less accurate in black patients compared to white patients.

First, I need to look at the context provided. The study found that black patients were more likely to have their asthma severity underestimated by physicians. The odds ratio was 1.39, which is statistically significant since the confidence interval (1.08-1.79) doesn't include 1. Underestimation of severity would mean the physician's assessment is not matching the patient's reported symptoms, indicating inaccuracy. 

The study's first hypothesis was that underestimation is more frequent among black patients, and the results support that. Since accuracy here is about whether the physician's estimate aligns with the patient's actual symptoms (as reported by the patient), more underestimation in black patients implies lower accuracy. 

Additionally, the consequences of underestimation for black patients included poorer care outcomes, like less use of necessary medications and lower ratings of care and communication. This further suggests that the inaccuracy in severity assessment is more prevalent in black patients. 

So, the answer should be yes because the data directly shows that underestimation (a form of inaccuracy) is more common in black patients compared to white ones.
</think>

[Yes]",Correct
18322741,pubmedqa_pqa_l,Does laparoscopic surgery decrease the risk of atrial fibrillation after foregut surgery?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether laparoscopic surgery decreases the risk of atrial fibrillation (AF) after foregut surgery.

First, I need to look at the context provided. The study examined factors associated with new-onset AF in 154 patients who underwent major foregut surgeries. They used both univariate and multivariate analyses. 

In the results, they mention that laparoscopic surgeries were associated with a lower risk of AF (p = 0.004). The multivariate analysis adjusted for surgery type and found that laparoscopic surgery had an odds ratio (OR) of 0.09 with a 95% confidence interval (CI) of 0.01-0.95 and a p-value of 0.04. An OR less than 1 indicates a protective effect, meaning laparoscopic surgery is associated with reduced odds of developing AF. The CI here doesn't cross 1, which suggests statistical significance. 

The question is specifically about whether laparoscopic surgery decreases the risk. The study's findings support this, as both the univariate and multivariate analyses show a significant association. The OR of 0.09 is quite low, implying a strong effect. However, the confidence interval is wide (0.01-0.95), which might indicate some uncertainty, but since the upper bound is still below 1, the result remains significant. 

Other factors like age were also significant, but the question is focused on laparoscopic surgery. The answer should be yes based on the provided data. The study's conclusion in the context directly states that laparoscopic surgery was associated with lower risk, and the statistical analysis supports this.
</think>

[Yes]",Correct
19106867,pubmedqa_pqa_l,"The Main Gate Syndrome: a new format in mass-casualty victim ""surge"" management?",yes,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking if ""The Main Gate Syndrome"" represents a new format in managing mass-casualty victim surges. The context provided discusses a situation where a trauma center dealt with multiple casualties from suicide bombings. They mention two triage processes: one by the US Army Level I group before evacuation and another surgical triage with ultrasound. Four severe cases were re-categorized and had emergency surgery.

First, I need to understand what ""Main Gate Syndrome"" refers to. The term isn't explicitly defined in the context, but from the scenario, it might relate to the sudden influx of casualties arriving at the main gate of a trauma center, creating a surge. The article describes handling such a surge with dual triage steps and re-categorizing based on severity. 

The question is whether this scenario introduces a new management format. The context reports their experience and methods, suggesting they adapted triage processes to handle the surge. However, the term ""Main Gate Syndrome"" isn't a standard term I'm familiar with in mass-casualty management. The described approach might be a specific response to a particular scenario rather than an established new format. The answer hinges on whether the authors are proposing ""Main Gate Syndrome"" as a new term or framework. Since the context doesn't explicitly name it as such but describes their method, it's possible the user is inferring a new format from the case study. Without the authors explicitly coining the term as a new format, the answer might be Maybe or Yes if the implication is that this case study introduces a novel approach. However, since the term itself isn't defined here, Maybe seems safer.
</think>

[Maybe]",Incorrect
25691513,pubmedqa_pqa_l,Do communication disorders extend to musical messages?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if communication disorders extend to musical messages. The context provided is a study comparing children with different communication disorders (hearing loss using cochlear implants and autism spectrum disorder) to typically developing children in recognizing emotions or movements in music.

First, I need to understand what the study found. The results showed that the ASD group performed similarly to the TD-NH group, but the CI group was less accurate. The study mentions that communication disorders affecting transmission or decoding of structural features (like pitch, timbre) or symbolic representation can lead to atypical musical communication, impacting music therapy.

So, the key point here is that the CI group had difficulty identifying emotions and movements in music, which are aspects of musical messages. Even though ASD didn't show a significant difference, the CI group's impairment suggests that certain communication disorders (like hearing loss) do affect the ability to process musical messages. The study's conclusion implies that such disorders can indeed extend to musical communication, at least in some cases. Therefore, the answer should be yes because the CI group's results demonstrate that their communication disorder impacts their reception of musical messages.
</think>

[Yes]",Correct
11035130,pubmedqa_pqa_l,Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether RA patients on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long-term.

First, I need to look at the study described. It's a randomized, double-blind, placebo-controlled trial. They took 75 patients who were already on methotrexate (less than 20 mg weekly) and FA 5 mg daily. They stopped FA and randomized them to either placebo or continue FA. They monitored toxicity and efficacy over a year.

The results: 33% of patients dropped out early. The placebo group had a higher dropout rate (46% vs. 21%), which is statistically significant (P=0.02). Two placebo patients stopped due to neutropenia. At 9 months, nausea was more common in the placebo group (45% vs. 7%, P=0.001). Efficacy-wise, placebo had lower disease activity in some measures but not clinically significant.

So, stopping FA (placebo group) led to more dropouts, more side effects like nausea and neutropenia. But efficacy wasn't really affected much. The study suggests that discontinuing FA increases toxicity but doesn't significantly reduce methotrexate's effectiveness. 

The question is about long-term need. The study duration was 1 year. The increased toxicity in the placebo group implies that continuing FA helps reduce adverse effects. However, the study doesn't conclusively prove FA reduces all toxicities, as mentioned in the context. Also, the theoretical risk of FA reducing methotrexate efficacy wasn't observed here, but the study might not be long enough or large enough to detect all effects.

So, based on the study, stopping FA leads to more toxicity. Therefore, patients might need to continue FA long-term to mitigate these side effects. But the answer isn't a clear yes because the study has limitations (only 1 year, 75 patients, some toxicities not conclusively proven to be reduced by FA). However, the significant increase in adverse events when stopping FA suggests that continuing is beneficial. The answer is probably yes, but the study's context mentions there's no conclusive proof. Wait, the context says ""there is no conclusive proof that it decreases the toxicity of methotrexate"" but the study here shows that stopping FA increases toxicity. So maybe the study provides some evidence in favor of FA reducing toxicity, even if not conclusive. The conclusion here is that stopping FA leads to more adverse effects, so continuing FA is beneficial. Therefore, the answer is yes, they need to continue. But the study's own conclusion might be that FA helps with toxicity but not efficacy. The question is whether they need to continue long-term. Since the study shows increased toxicity upon discontinuation, the answer would be yes. But the context also mentions that there's no conclusive proof. However, the study here provides evidence supporting FA use. So maybe the answer is yes. But the study's results are mixed in terms of statistical vs. clinical significance. The increased nausea and dropouts are significant, so the answer is yes. So the answer should be [Yes].
</think>

[Yes]",Correct
19409117,pubmedqa_pqa_l,Can infundibular height predict the clearance of lower pole calyceal stone after extracorporeal shockwave lithotripsy?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether infundibular height can predict the clearance of lower pole calyceal stones after SWL.

Looking at the context provided, the study analyzed several renal anatomical factors. They compared two groups: those who were stone-free (NR) and those with residual fragments (R). The results showed no significant differences in most factors like infundibulopelvic angle, width, length, etc. However, the height of the infundibulum was significantly different between the groups with a p-value of 0.002. 

Since the p-value is less than 0.05, this indicates that infundibular height is a statistically significant predictor. The study concludes that height was the only parameter with significant differences. Therefore, the answer should be yes because the data supports that infundibular height can predict treatment success.
</think>

[Yes]",Correct
21900017,pubmedqa_pqa_l,Does lung ischemia and reperfusion have an impact on coronary flow?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if lung ischemia and reperfusion (IR) affects coronary flow. The context provided is a study using a swine model.

First, I need to look at the results from the IR group versus the control. The study measured total coronary flow (TCF) as the sum of LAD, Cx, and RCA blood flow. In the IR group, TCF decreased significantly from baseline during IR, with the lowest point at 60 minutes of reperfusion, a 37.1% drop. The p-values here are all less than 0.05, which indicates statistical significance. The control group didn't show changes in coronary flow. 

Additionally, there were increases in cardiac Troponin and IL-6 in the IR group, suggesting myocardial injury and inflammation, which might be related to reduced coronary flow. The hemodynamic changes like drops in left ventricular pressure and increased right ventricular pressure during ischemia also support that there's a systemic effect impacting the heart. 

The control group had no IR and their coronary flow remained stable. Since the experimental group showed a significant decrease in coronary flow during IR compared to their baseline and the control group, the answer should be yes. The data directly links lung IR injury to reduced coronary flow in the study.
</think>

[Yes]",Correct
16968876,pubmedqa_pqa_l,Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if a patient's self-reported health-related quality of life (HRQOL) is a prognostic factor for survival in non-small-cell lung cancer (NSCLC) patients. 

Looking at the context provided, the study aimed to determine if HRQOL provides independent prognostic information. They measured HRQOL using specific tools (EORTC QLQ-C30 and QLQ-LC13) in 391 advanced NSCLC patients. The analysis used Cox regression models and bootstrap validation.

In the results, the multivariate analysis retained four factors: male gender, performance status, pain score, and dysphagia. Both pain and dysphagia are part of the self-reported HRQOL measures. The hazard ratios for these were significant, with a 10-point worsening leading to increased risk of death. 

The question is whether self-reported HRQOL is a prognostic factor. The study includes components of HRQOL (pain and dysphagia) as significant factors. However, the term ""HRQOL"" itself isn't listed as a single factor; instead, specific symptoms from the HRQOL scales are. The user might be conflating overall HRQOL with its components. Since the study found that specific self-reported symptoms (which are part of HRQOL) are prognostic, the answer would be yes. But if the question is about HRQOL as a composite score, maybe not. However, the context says the aim was about HRQOL providing independent info, and the results support that through its components. So the answer is yes.
</think>

[Yes]",Incorrect
18540901,pubmedqa_pqa_l,Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether there's a role for polymorphisms in the ADRB genes in transient tachypnea of the newborn (TTN). 

First, I need to look at the context provided. The study collected DNA from 73 TTN cases and 55 controls. They found several differences between the groups, like gender, birthweight, gestational age, and delivery method. But the key part here is the genetic analysis.

The beta1Ser49Gly polymorphism showed a significant difference between cases and controls. The multivariate analysis gave an odds ratio of 18.5 for beta1Gly49 homozygotes, which is a strong association, even though the confidence interval is wide (1.5-229). The p-value is 0.023, which is below 0.05, so statistically significant. 

Additionally, the ADRB2 gene's T-47C, A46G, C79G, and C491T haplotype (TACC) was associated with TTN with a p-value of 0.048. That's just under 0.05, so also significant. 

The question is whether these polymorphisms in ADRB genes (beta1 and ADRB2) play a role in TTN. The study found significant associations for both specific polymorphisms and a haplotype in ADRB2. The OR for beta1Gly49 is quite high, even with the wide CI, suggesting a strong effect. The other haplotype in ADRB2 also shows significance. 

So, based on the data presented, the answer should be yes. The study provides evidence that polymorphisms in ADRB genes are associated with TTN. The answer is [Yes].
</think>

[Yes]",Correct
27448572,pubmedqa_pqa_l,Is duration of psychological treatment for depression related to return into treatment?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if the duration of psychological treatment for depression is related to returning to treatment. The context provided is a study from the Netherlands with a large sample size.

First, the study's main aim was to check if treatment duration and relapse (returning to care) are connected. They looked at patients from 2009-2010 and followed up until 2013. The key findings mention that most patients (86%) didn't return. But those with shorter treatment durations (like 5-250 minutes, 251-500, and 751-1000) had a higher likelihood of returning compared to the reference group of over 1000 minutes. The hazard ratios are all above 1, indicating increased risk. The study adjusted for demographic and clinical factors, which adds credibility.

So, the data shows a correlation where shorter treatments are associated with higher return rates. The answer should be yes, but I need to make sure I'm not misinterpreting. The hazard ratios are statistically significant since the confidence intervals don't cross 1. Even though the effect sizes are modest (like 1.19), they still indicate a relationship. The answer is yes because the study found a significant association, even if it's not a massive effect.
</think>

[Yes]",Correct
17621202,pubmedqa_pqa_l,Does shaving the incision site increase the infection rate after spinal surgery?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether shaving the incision site before spinal surgery increases the infection rate. The context provided is a study where they randomly assigned patients into shaved and unshaved groups. The shaved group had 371 patients, and 4 got infections. The unshaved group had 418 patients, with 1 infection. The p-value for the infection rate comparison is less than 0.01, which is statistically significant.

So, the study found a higher infection rate in the shaved group. The p-value being <0.01 suggests that this result is unlikely due to chance. However, I should check if the sample sizes are appropriate. The shaved group is smaller (371 vs. 418), but the difference in infection numbers is 4 vs. 1. Even though the absolute numbers are low, the statistical significance is there. The study design is randomized, which helps control for confounding variables. The conclusion here seems to support that shaving increases infection rates. But wait, maybe there's something else. Did they control for other factors like surgical duration? The context mentions the duration of anesthesia didn't differ, so that's accounted for. So, based on the data, the answer should be yes. But wait, maybe the effect size is small? 4 vs. 1, but with the p-value being significant. So the study's conclusion is that shaving increases infection rate. Therefore, the answer is yes.
</think>

[Yes]",Incorrect
25987398,pubmedqa_pqa_l,The influence of atmospheric pressure on aortic aneurysm rupture--is the diameter of the aneurysm important?,maybe,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether the diameter of an aortic aneurysm is important in the context of atmospheric pressure influencing its rupture.

First, I need to recall the context provided. The study looked at 223 patients with ruptured abdominal aneurysms in the Silesia region over a decade. They compared atmospheric pressures on the day of rupture, days before, and between events, considering aneurysm size.

The results mentioned that there were no statistically significant differences in pressure between rupture days and other days. However, they noted a higher frequency of admissions in winter and spring when atmospheric pressure was higher, but this wasn't statistically significant. Importantly, there was a non-significant trend suggesting that larger aneurysms (>7 cm) might rupture more when pressure increased from the day before to the day of rupture, especially in hypertensive patients (p=0.1).

The question is whether aneurysm diameter matters in the effect of atmospheric pressure on rupture. The study's findings indicate a trend for larger aneurysms being more affected by pressure changes, even though it's not statistically significant. The key here is that the trend exists, particularly in hypertensive patients, which suggests that diameter might play a role, but the evidence isn't strong enough to be conclusive. Since the question is about importance, and the study points to a possible association (albeit not statistically confirmed), the answer would lean towards ""Maybe"" because the data hints at a relationship but doesn't confirm it definitively.
</think>

[Maybe]",Correct
16816043,pubmedqa_pqa_l,Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from an STD.

First, I need to look at the context provided. The study was conducted in France with 144 lay people, 10 psychologists, and 7 physicians. They evaluated 48 scenarios combining different factors. The key points here are the mean ratings: lay people had 11.76, psychologists 9.28, and physicians 2.90 on a 0-22 scale. Higher numbers mean more acceptance. 

Lay people and psychologists have higher means compared to physicians, which suggests they are more accepting. The scale goes up to 22, so 11.76 is about the midpoint, but the exact interpretation of the scale's anchors isn't given. However, the study mentions that lay people and psychologists favored breaching confidentiality more than physicians. 

The cluster analysis for lay people shows that 14 out of 144 found it ""always acceptable,"" 87 depended on circumstances, 30 required expert consultation, and 13 never. So, a majority (87) are conditional, but 14 are fully in favor. Adding the 14 and maybe the 30 who require consultation (if that's a form of conditional acceptance), but the exact breakdown isn't clear. However, the main point is that lay people and psychologists have higher mean ratings than physicians. 

The question is whether they find it acceptable. The answer isn't a simple yes or no because it's conditional. But the study's conclusion is that lay people and psychologists are more favorable than physicians. The mean ratings are significantly higher for lay people and psychologists. So, the answer would be yes, they do find it acceptable, especially compared to physicians. But the answer needs to be based on the data provided. The mean for lay people is 11.76, which is over the midpoint (11), so leaning towards acceptable. Psychologists at 9.28 are below the midpoint but still higher than physicians. However, the scale's interpretation isn't fully clear. But the context states that lay people and psychologists favored it more. So the answer is yes, they do find it acceptable, but with varying degrees. The question is phrased as ""find it acceptable,"" not ""always acceptable."" Since the means are higher and the clusters show some groups finding it acceptable, the answer is yes.
</think>

[Yes]",Incorrect
12920330,pubmedqa_pqa_l,Do somatic complaints predict subsequent symptoms of depression?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether somatic complaints predict subsequent symptoms of depression. The context provided is a study from the RENO Diet-Heart Study.

First, I need to parse the key points from the context. The study used prospective data, which is better than retrospective or cross-sectional designs because it can suggest causality. They assessed somatization with the SCL-90-R and depression with CES-D five years later in a community cohort that was initially healthy.

The results mention gender-stratified analysis. For both men and women, baseline CES-D (depression) scores were the best predictors of later depression. However, the SCL-90-R somatization subscale did predict subsequent depressive symptoms, but only in women. The study also notes that somatic complaints were less powerful predictors than income and age.

So the question is whether somatic complaints (somatization) predict later depression. The answer here is yes, but with caveats. The study found that in women, somatic complaints did predict later depressive symptoms, though not as strongly as other factors. For men, it wasn't a significant predictor. So the answer isn't a straightforward yes for everyone, but in the context of the study, there is a predictive relationship in women. The user's question doesn't specify gender, so the answer should reflect that it does predict, but only in a specific group. However, the question is phrased generally. The study's finding is that somatic complaints do predict subsequent depression in women, so the answer would be yes, but with the caveat that it's gender-specific. However, the user is asking if somatic complaints predict, and the answer in the study is yes for women. Since the question doesn't limit to gender, but the study found a significant prediction in women, the answer is yes, but maybe the user should be aware of the gender difference. But according to the instructions, the response should be Yes, No, or Maybe in brackets. The study does show that somatic complaints predict subsequent depression in women, so the answer is Yes. Even though it's only in women, the presence of a predictive relationship exists. The answer is [Yes].
</think>

[Yes]",Incorrect
23497210,pubmedqa_pqa_l,Are women with major depression in pregnancy identifiable in population health data?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if women with major depression during pregnancy can be identified in population health data. The context provided is a study that uses two datasets: hospital admission records and pharmaceutical dispensing claims.

First, the study linked data from Western Australia, including hospital admissions and antidepressant dispensing. They identified depression in two ways: through antidepressant prescriptions (N06A category) and hospital records noting depression as a comorbidity. 

The results showed that 4.6% of pregnant women were dispensed antidepressants, and 3.1% had a hospital record of depression. However, there was only a 13.6% overlap between the two groups. Most women on antidepressants (80%) didn't have depression noted in their hospital records. The capture-recapture method estimated a higher prevalence of around 16%, suggesting that using both datasets together captures more cases than either alone.

So, the study demonstrates that while each dataset alone misses some cases, combining them allows for better identification. But there's a significant discrepancy between the two sources. The answer hinges on whether using both methods counts as identifiable in population data. Since the study used linked data to identify more cases than either method alone, the answer is likely yes, but with limitations. However, the question is whether they are identifiable, not perfectly captured. The presence of both datasets allows identification, even if incomplete. Hence, the answer should be Yes.
</think>

[Yes]",Incorrect
21952349,pubmedqa_pqa_l,Remote ischemic postconditioning: does it protect against ischemic damage in percutaneous coronary revascularization?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether remote ischemic postconditioning (RIPC) protects against ischemic damage during percutaneous coronary revascularization (PCI). 

First, I need to look at the context provided. The study described is a randomized trial where patients undergoing elective PCI were assigned to either RIPC (three 5-min cycles of arm ischemia) or a placebo. The primary outcome was the maximum troponin increase in 24 hours, which is a marker of myocardial damage. Secondary outcomes included heart failure readmission or cardiovascular mortality after one year.

The results mentioned in the context suggest that RIPC might reduce myocardial lesions from PCI, but the effect could be less in diabetics. The study's aim was to evaluate the protective effect specifically in this patient population. The primary outcome focuses on troponin levels, which directly relate to myocardial injury. If RIPC reduces troponin elevation, that would indicate protection against ischemic damage. The secondary outcomes look at longer-term effects, which could support the primary findings.

However, the answer isn't a straightforward yes. The context mentions ""might reduce"" and ""perhaps less so in diabetics,"" indicating that the effect isn't universal. The study's results would determine the answer. Since the user hasn't provided the actual results, but the study's design is to test this hypothesis, the answer hinges on whether the study found a significant difference in troponin levels between the RIPC and placebo groups. 

Given that the study is designed to evaluate this protective effect, and the question is whether RIPC does protect, the answer would depend on the study's conclusion. If the primary outcome (troponin increase) was lower in the RIPC group, then yes. If not, then no. But since the context doesn't state the results, but the study's aim is to assess this, the answer is likely yes based on the hypothesis presented, but with a caveat about diabetic patients. However, the question doesn't specify subgroups, just the general effect. The context says ""might reduce,"" which suggests a possible positive effect. Therefore, the answer is probably yes, but with a maybe if considering the diabetic subgroup. But the main question is general, so based on the context provided, the answer is yes.
</think>

[Yes]",Correct
21712147,pubmedqa_pqa_l,Does combining antiretroviral agents in a single dosage form enhance quality of life of HIV/AIDS patients?,no,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking if combining antiretroviral agents into a single dosage form enhances the quality of life for HIV/AIDS patients.

First, I need to look at the context provided. The study mentioned is a cost-utility analysis comparing fixed-dose (FXD) combinations versus free-dose combinations (FRC). The key points here are the utility measured using SF-6D scores from the SF-12 questionnaire, which relates to quality of life. 

The study found that the mean utility gained by using FXD over FRC was 0.085. However, it's noted that this difference wasn't statistically significant. Even though there's a numerical increase in utility, the lack of statistical significance means we can't be confident that this difference isn't due to random chance. 

Additionally, the incremental cost-utility ratio (ICUR) was calculated, and probabilistic sensitivity analysis suggested that FXD becomes cost-effective above a $40,000 threshold with over 50% probability. But the question isn't about cost-effectiveness; it's specifically about quality of life enhancement. 

Since the utility gain wasn't statistically significant, the answer hinges on that. Even though there's a mean increase, without statistical significance, we can't definitively say it enhances quality of life. The answer would be Maybe, considering the numerical gain but uncertainty due to statistical insignificance.
</think>

[Maybe]",Incorrect
25311479,pubmedqa_pqa_l,The inverse equity hypothesis: does it apply to coverage of cancer screening in middle-income countries?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether the inverse equity hypothesis applies to coverage of cancer screening in middle-income countries based on the study provided.

First, I need to recall what the inverse equity hypothesis states. It suggests that new health interventions are first adopted by the wealthier groups, leading to initial inequalities, but as the intervention becomes more widespread, the poorer groups catch up, reducing the inequality.

Looking at the context provided, the study examines four middle-income countries: China, Mexico, Russia, and South Africa. They looked at breast and cervical cancer screening coverage and measured economic inequalities using methods like Adjusted OR, RII, and Slope Index.

The coverage rates vary. For breast cancer, South Africa has the lowest coverage (10.5%), followed by China (19.3%), Russia (33.8%), and Mexico (43%). For cervical cancer, South Africa is 24%, China 27.2%, Mexico 63.7%, and Russia 81.5%. 

The key part here is the RII values. For breast cancer, RII decreases as coverage increases: South Africa (14.57), China (4.90), Mexico (2.01), Russia (1.04). Similarly, cervical cancer RII also decreases with higher coverage: China (3.60), South Africa (2.47), Mexico (1.39), Russia (1.12). Lower RII means less inequality. 

So, countries with higher coverage (like Russia and Mexico) have lower RII, indicating less economic inequality in screening participation. This aligns with the inverse equity hypothesis because as coverage increases (implying the intervention is diffusing more widely), the economic inequalities narrow. Therefore, the hypothesis seems to hold in these middle-income countries for cancer screening.
</think>

[Yes]",Correct
20602784,pubmedqa_pqa_l,Identification of racial disparities in breast cancer mortality: does scale matter?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether the geographic scale (like census tract, zip code, county) affects the identification of racial disparities in breast cancer mortality. The context provided is a study in Texas from 1995-2005 looking at African-American, Hispanic, and White non-Hispanic women.

The study found that disparities were detected differently based on the scale. For example, using census tracts with RD (absolute difference) showed more significant results. Also, areas with higher poverty rates had more disparities. The key points here are that the scale (tract vs. zip vs. county) and the type of statistic (RR vs. RD) influenced the detection of disparities. Since the results varied depending on the geographic level and the statistical method, the answer would be that scale does matter. The study's conclusion seems to support that the choice of scale affects the identification of these disparities. So the answer should be yes.
</think>

[Yes]",Correct
12836106,pubmedqa_pqa_l,Does the leukocyte count correlate with the severity of injury?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether the leukocyte (white blood cell) count correlates with the severity of injury in blunt trauma patients. 

First, I need to recall the context provided. The study mentioned evaluated 713 blunt trauma patients, looking at ISS, GCS, RTS, and WBC count. The statistical analysis showed that WBC was positively correlated with ISS and negatively with GCS and RTS. 

Now, ISS (Injury Severity Score) is a measure where higher scores indicate more severe injuries. GCS (Glasgow Coma Scale) and RTS (Revised Trauma Score) are scores where lower values typically indicate worse condition (like lower consciousness for GCS). 

The study found a positive correlation between WBC and ISS. Since higher ISS means more severe injury, a positive correlation here would mean that as injury severity increases, WBC count also increases. Then, a negative correlation with GCS and RTSâ€”since lower GCS/RTS scores indicate worse conditionâ€”so if WBC is negatively correlated, that means higher WBC counts are associated with lower GCS/RTS, which again points to more severe injury.

So putting this together: higher WBC correlates with higher injury severity (as per ISS) and with lower GCS/RTS (which also indicate more severe injury). Therefore, the answer should be yes, leukocyte count does correlate with injury severity.
</think>

[Yes]",Correct
25588461,pubmedqa_pqa_l,Can transcranial direct current stimulation be useful in differentiating unresponsive wakefulness syndrome from minimally conscious state patients?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether transcranial direct current stimulation (tDCS) can help differentiate between patients with unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS). 

First, I need to recall the study details. The study used a-tDCS on the orbitofrontal cortex in DOC patients. Baseline tests showed that MCS patients had some preserved cortical connectivity and excitability, while UWS patients didn't. After applying a-tDCS, MCS and healthy controls showed boosted connectivity/excitability. Importantly, some UWS patients showed these responses after stimulation, which weren't present at baseline.

So the key point here is that a-tDCS was able to ""unmask"" connectivity in some UWS patients. That suggests that even though they were clinically diagnosed as UWS (no purposeful behavior), there might be residual networks that only become detectable with stimulation. 

The question is about differentiation. If a-tDCS can elicit a response in some UWS patients that wasn't there before, then maybe it can help distinguish between UWS and MCS. But wait, the baseline already differentiates them (MCS had partial preservation, UWS didn't). However, after a-tDCS, some UWS patients showed connectivity similar to MCS. So perhaps the stimulation helps identify a subset of UWS patients who have residual networks, which might mean they are actually in a more conscious state than their clinical diagnosis suggests. 

Therefore, using a-tDCS could help in differentiating UWS patients who have hidden connectivity (possibly indicating some level of consciousness) from those who don't. This would refine the diagnosis beyond clinical observations. So the answer would be yes, because the stimulation revealed differences in UWS patients that baseline couldn't, aiding in distinguishing subgroups within UWS and possibly reclassifying some as MCS if they show connectivity post-stimulation.
</think>

[Yes]",Correct
19299238,pubmedqa_pqa_l,Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms?,yes,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether preventing osteoporosis is the key to eliminating aromatase inhibitor (AI)-related musculoskeletal symptoms.

First, I need to recall the context provided. The study looked at patients on AIs and factors like BMD, previous tamoxifen use, and calcium/bisphosphonate (Ca/Bis) therapy. The results showed a significant association between musculoskeletal symptoms and BMD. Lower BMD (indicating osteoporosis or osteopenia) was linked to more symptoms. Also, patients who took tamoxifen before AIs had fewer symptoms and fractures. Additionally, those on Ca/Bis with AIs had fewer symptoms and fractures. The type of AI (steroidal vs. nonsteroidal) also affected symptom incidence.

The question is about whether preventing osteoporosis (which would improve BMD) would eliminate these symptoms. The study found that lower BMD correlates with more symptoms, so improving BMD through osteoporosis prevention (like with Ca/Bis) might reduce symptoms. The study's results support that interventions targeting bone health (Ca/Bis) are associated with fewer symptoms. However, the study also mentions that even with Ca/Bis, some patients still had symptoms, and the type of AI influenced outcomes. So while preventing osteoporosis (via maintaining BMD) seems important, it might not completely eliminate symptoms, as other factors like the specific AI used also play a role. Therefore, the answer might be ""Maybe"" because while improving BMD helps, it's not the only factor.
</think>

[Maybe]",Incorrect
22706226,pubmedqa_pqa_l,Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is asking if different follow-up methods could affect the diagnosis of asymptomatic endometrial cancer relapses. The context provided is a study that looked at 282 women with recurrent endometrial cancer. They found that 58.5% of the patients were asymptomatic at recurrence, and their relapses were detected through planned visits or exams. Among these asymptomatic patients, most were detected via imaging (62.4%) or clinical visits (36.4%). The study also mentions that asymptomatic patients had a longer median survival compared to symptomatic ones.

So, the key points here are that a significant portion of relapses were found in asymptomatic patients through scheduled procedures like imaging and clinical visits. The fact that different modalities (clinical visit, imaging, cytology) were used and detected these cases suggests that varying follow-up methods do play a role in identifying asymptomatic relapses. The study also implies that using these modalities helps in early detection, which correlates with better survival outcomes. Therefore, the answer should be yes because the data shows that different follow-up methods (like imaging vs. clinical exams) were instrumental in diagnosing asymptomatic cases.
</think>

[Yes]",Incorrect
12913878,pubmedqa_pqa_l,Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if locoregional opening of the rodent BBB using Nd:YAG LITT allows paclitaxel to pass through, as a new adjuvant therapy for glioma.

First, the context says they did LITT on rats' left forebrains. They checked BBB disruption with Evans blue and IH, which showed extravasation of markers like Evans blue, C3C, fibrinogen, IgM. Then they gave paclitaxel and used HPLC to find it in brain and plasma. The results showed that paclitaxel crossed the disrupted BBB.

So the study's conclusion is that LITT-induced BBB opening allowed paclitaxel to enter the brain. The question is phrased as whether this is a new concept for adjuvant glioma therapy. The study's results support that the method works in rodents. Since the question is about the possibility, the answer would be yes based on the provided data. But maybe the user is looking for confirmation that the study's findings support the concept. The answer should be yes because the study demonstrated both BBB opening and drug passage.
</think>

[Yes]",Correct
16769333,pubmedqa_pqa_l,Preoperative tracheobronchoscopy in newborns with esophageal atresia: does it matter?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether preoperative tracheobronchoscopy (TBS) in newborns with esophageal atresia (EA) makes a difference. The context provided is a study that evaluated the influence of preoperative TBS.

First, I need to understand the study's findings. The study included 62 patients. Before TBS, they were classified using the Gross system: 9 type A, none type B, 51 type C. After TBS, 3 of the type A patients actually had a proximal fistula (type B), which wasn't suspected before. That's a significant finding because type B requires a different surgical approach. Also, 2 H-type fistulas were found, leading to a cervical approach. Additionally, TBS detected respiratory malformations in 4 patients and allowed occlusion of carinal fistulas in 14, improving ventilation during surgery. Overall, TBS was useful in 45.2% of cases and crucial in modifying surgery for 24.2%.

The question is whether TBS matters. The study shows that TBS changed the diagnosis (finding unexpected fistulas and malformations) and altered surgical management in a significant portion of patients. Since these changes could prevent complications and improve outcomes, the answer would lean towards yes. The study also mentions no complications from TBS, supporting its safety. Therefore, the answer is likely yes because TBS provided critical information that affected treatment decisions.
</think>

[Yes]",Correct
22497340,pubmedqa_pqa_l,Is horizontal semicircular canal ocular reflex influenced by otolith organs input?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if the horizontal semicircular canal ocular reflex is influenced by otolith organs input. The context provided is a study where they tested this by stimulating the right ear with ice water and positioning subjects in different orientations. They observed that the nystagmus (eye movements) weren't symmetric when comparing supine vs prone or left-ear-down vs right-ear-down positions. The conclusion drawn is that the axis of eyeball rotation was affected by gravity direction changes, which relates to the otolith organs (since they detect linear acceleration and head position relative to gravity).

So, the horizontal semicircular canals are responsible for detecting rotational movements (like turning the head left/right), and the ocular reflex helps stabilize gaze during such movements. The otolith organs (utricle and saccule) sense linear acceleration and head position. The study's results show that changing the head's position relative to gravity (which affects otolith input) altered the eye movement patterns, implying that the otolith input does influence the reflex mediated by the horizontal canal. Therefore, the answer should be yes because the asymmetry in nystagmus when changing positions (and thus otolith input) indicates that the otoliths are modulating the reflex.
</think>

[Yes]",Correct
10223070,pubmedqa_pqa_l,Is perforation of the appendix a risk factor for tubal infertility and ectopic pregnancy?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if appendiceal perforation is a risk factor for tubal infertility and ectopic pregnancy.

First, I need to look at the context provided. The study analyzed articles from 1966 to 1997, found 23 articles, but only 4 had original data with control groups. The key findings mention a risk estimate of 4.8 for tubal infertility from perforation, with a 95% CI that doesn't include 1, which suggests statistical significance. For ectopic pregnancy, the risk is 1.6, also with a CI that doesn't include 1. 

However, the studies have issues like recall bias and poor adjustment for confounders. The Evidence-Based Medicine criteria were used, which might point to some methodological weaknesses. Despite the limitations, the risk estimates are elevated. The answer should probably be yes, but with a note about the study limitations. But the question just asks if it's a risk factor, not the strength or certainty. So based on the provided data, the answer is yes.
</think>

[Yes]",Incorrect
8566975,pubmedqa_pqa_l,Serovar specific immunity to Neisseria gonorrhoeae: does it exist?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user wants to know if there's serovar-specific immunity to Neisseria gonorrhoeae based on the provided context.

First, the study looked at 508 episodes of gonorrhea over four years, with 22 patients having multiple infections. They analyzed the serovars from initial and subsequent infections in those with recurrences. The key findings were that there was no significant difference in the prevalence of serovars between those with repeat infections and those without. Also, the initial infection site didn't affect the subsequent serovar.

So, if there were serovar-specific immunity, you'd expect that after an infection with a particular serovar, the immune system would protect against the same serovar in the future. That would mean that repeat infections would be more likely with different serovars. But the study found that the serovars in repeat infections weren't significantly different from the initial ones. That suggests that the immune response isn't effectively targeting specific serovars to prevent reinfection. 

Additionally, the fact that the site of initial infection didn't influence subsequent serovar might imply that local immune responses aren't providing protection either. If immunity were serovar-specific, you might see some pattern where prior exposure to a serovar reduces the chance of the same one recurring. But the data here doesn't support that. 

However, the sample size of 22 patients with multiple infections is quite small. Maybe the study wasn't powered enough to detect a significant difference. But the conclusion drawn from the data presented is that there's no significant evidence of serovar-specific immunity. 

So, putting it all together, the answer would be that the study's findings don't support the existence of serovar-specific immunity. Therefore, the response should be ""No.""
</think>

[No]",Correct
25186850,pubmedqa_pqa_l,May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether student examiners (SE) can be reasonable substitutes for faculty examiners (FE) in an undergraduate OSCE focused on medical emergencies.

First, I need to look at the study results. The context mentions that students in the SE track scored significantly higher in three stations (TM, AM, OE) and the overall OSCE score. However, they scored lower in the PE station when with FE. The effect sizes are mostly small, which suggests that while there are differences, they might not be very large in practical terms.

Then, in the post-assessment evaluation, students rated the ACS station and overall OSCE higher in the FE track. So even though SEs led to higher scores in some areas, students might perceive the FE track more positively. But the effect sizes here are also small.

The key points here are the mixed results. Some stations showed better performance with SEs, one with FEs, and the overall score was higher with SEs. However, evaluations were better for FEs in some aspects. The small effect sizes mean the differences, while statistically significant, might not be educationally significant. 

But the question is about whether SEs can be reasonable substitutes. The study shows that in terms of performance, SEs can lead to comparable or even better scores in some areas. However, the perception of students might favor FEs. Since the effect sizes are small, the practical impact might be minimal. Also, the study is in a specific context (emergency medicine OSCE for third-year students), so generalizability might be a consideration. 

Potential limitations: The study's sample size is moderate (207 students), and the OSCE stations are specific. The fact that some stations had better performance with SEs could be due to various factors, like SEs being less intimidating, leading to better performance. But the PE station's better performance with FEs might indicate areas where faculty expertise is more critical. 

The conclusion would hinge on whether the primary goal is student performance or their perception. If performance is the main metric, SEs might be reasonable substitutes, especially since the overall score was higher. However, if student confidence in the assessment's validity (as indicated by their evaluations) is important, FE might be preferred. But given the small effect sizes, the differences might not be substantial enough to dismiss SEs as substitutes. 

So, considering the mixed but generally positive performance outcomes with SEs, the answer would lean towards yes, but with caveats. However, the question is phrased as ""may student examiners be reasonable substitute,"" which doesn't require them to be better, just acceptable. The study shows they can be, especially since in most stations there's no significant difference, and some even favor SEs. The answer would be yes, but maybe with a note that in certain stations faculty might be better. But according to the guidelines, the response should be only Yes, No, or Maybe. The study's results are mixed but show that SEs can lead to comparable or better performance in some areas, so the answer is likely Yes.
</think>

[Yes]",Correct
9427037,pubmedqa_pqa_l,Are endothelial cell patterns of astrocytomas indicative of grade?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if endothelial cell patterns in astrocytomas are indicative of the tumor grade. From the context provided, the study looked at vascular patterns using GFAP and vWF staining. The control tissues had few vessels. Pilocytic astrocytomas (grade I) had lacy clusters but intact vessel walls. Low-grade diffuse astrocytomas (probably grade II) were similar to controls. Intermediate (grade III) and high-grade tumors (anaplastic astrocytoma and glioblastoma, grades III and IV) showed increased vessel density, glomeruloid clusters, loss of vessel integrity, and more vWF-positive cells.

So, higher grades had more abnormal endothelial patterns. The presence of features like glomeruloid clusters and increased vessel density correlates with higher malignancy grades. The study's findings suggest that vascular patterns, which involve endothelial cells, do vary with tumor grade. Therefore, the answer should be yes.
</think>

[Yes]",Correct
28359277,pubmedqa_pqa_l,Do healthier lifestyles lead to less utilization of healthcare resources?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if healthier lifestyles lead to less use of healthcare resources. The context provided is a study from Taiwan in 2005 that looked at various health behaviors and their impact on outpatient visits, health exams, and seeing the same doctor.

First, the study found that four health behaviorsâ€”exercise, diet, regular blood pressure checks, and drinking habitsâ€”were significantly correlated with healthcare utilization. The P-value was less than 0.05, which means the results are statistically significant. 

Now, the key here is understanding the direction of the correlation. If healthier behaviors (like exercising, good diet, regular check-ups) are linked to fewer doctor visits and exams, then the answer would be yes. But the study's details mention that these behaviors have a ""significant correlation,"" but the abstract doesn't specify if it's a negative or positive correlation. However, intuitively, healthier habits should reduce the need for medical care. For example, regular exercise and good diet might prevent illnesses, leading to fewer doctor visits. Regular blood pressure checks could be part of preventive care, which might increase some healthcare use (like check-ups) but prevent more serious issues later. Drinking habits, if referring to excessive alcohol use, could lead to more health problems, so not drinking would be healthier and reduce usage.

The study's regression models showed that gender, age, and education also played roles, but the main focus is on the four health behaviors. Since the question is about healthier lifestyles (which include those four behaviors) leading to less utilization, and the study found a significant correlation, even though the direction isn't explicitly stated here, the implication is that healthier behaviors reduce usage. But wait, the study includes health examinations as part of the utilization. If people with healthier lifestyles get more regular check-ups, that could increase that particular resource use. However, the question is about overall healthcare resources. If the study found that despite more check-ups, the total utilization (like outpatient visits) is lower, then the answer is yes. The abstract says ""healthcare utilization"" includes outpatient visits and exams, and the four behaviors are correlated with this. But without seeing the exact data, it's a bit ambiguous. However, the standard assumption is that healthier lifestyles reduce the need for treatment, even if they increase preventive care. So the answer is likely yes. But the study's exact findings might have nuances. Since the user provided that the regression model showed significant correlations and the question is phrased as ""healthier lifestyles lead to less utilization,"" the answer is probably yes based on the context given.
</think>

[Yes]",Incorrect
11411430,pubmedqa_pqa_l,Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether antral follicle assessment (AFC) is a better predictor of IVF outcomes than age and FSH levels.

First, I need to look at the context provided. The study compared pregnancy rates and cancellation rates based on AFC (â‰¤6 vs >6), age (â‰¤35 vs >35), and FSH (â‰¤10 vs >10). The results showed that the group with AFC >6 had a significantly higher pregnancy rate (51% vs 19%) even when controlling for age and FSH. Also, cancellation rates were higher with lower AFC, older age, and higher FSH. 

The key points here are that AFC was a significant predictor even after adjusting for age and FSH. The study suggests that AFC has an independent effect on outcomes. However, the question is whether AFC is ""better"" than age and FSH. The study doesn't directly compare the predictive power statistically (like AUC in ROC curves or regression coefficients), but it does show that AFC is a strong predictor even when controlling for the others. 

But since the study includes age and FSH as variables and AFC still stands out, it implies that AFC might be a better or at least an additional useful predictor. However, without direct statistical comparisons between the predictors (like which has a higher odds ratio), we can't definitively say it's better. The answer might be ""Yes"" based on the context, but the study is a preliminary one, so maybe there's a need for more research. Wait, the study says it's a prospective, descriptive preliminary study. So maybe the evidence isn't conclusive yet. But the results do show significant associations even when controlling for age and FSH, which suggests AFC adds predictive value beyond those factors. 

So the answer would be Yes, because even when accounting for age and FSH, AFC still had a significant impact. But the question is if it's a better predictor. The study's results support that AFC is a strong predictor, possibly better, but the study design might not allow for a definitive conclusion. However, based on the given data, the answer leans towards Yes.
</think>

[Yes]",Incorrect
16956164,pubmedqa_pqa_l,Do all ethnic groups in New Zealand exhibit socio-economic mortality gradients?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if all ethnic groups in New Zealand exhibit socio-economic mortality gradients. The context provided is a study that looked into this.

First, the study's first aim was to check if a deprivation gradient exists in all-cause mortality across all ethnic groups. The methods mention constructing lifetables for four ethnic groups: Asian, Pacific, Maori, and European. They used deprivation quintiles and sex. Then, they fitted models to estimate the gradients.

The results state that all four ethnic groups have deprivation gradients in life expectancy. Specifically, Maori had the steepest gradients, steeper than Europeans. Asian and Pacific groups had shallower gradients compared to Europeans. 

So, the key point here is that the study found gradients in all four groups. The answer should be yes, since the question is whether all groups exhibit such gradients, and the answer is explicitly given in the results.
</think>

[Yes]",Correct
15687156,pubmedqa_pqa_l,Can normal knee kinematics be restored with unicompartmental knee replacement?,no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if normal knee kinematics can be restored with a unicompartmental knee replacement. 

First, I need to recall the context provided. The study compared knee kinematics before and after unicompartmental and tricompartmental replacements. The key findings were that unicompartmental replacement didn't significantly change tibial axial rotation or femoral rollback, and quadriceps tension was similar to the intact knee. In contrast, the tricompartmental replacement did affect tibial rotation.

So, the question is about whether unicompartmental replacement restores normal kinematics. The study's results show that in the unicompartmental condition, tibial rotation wasn't significantly different from the intact knee, and femoral rollback wasn't affected either. Quadriceps tension was also the same. These findings suggest that the kinematics remain similar to normal after the unicompartmental procedure. Therefore, the answer should be yes because the data indicates no significant differences from the intact state.
</think>

[Yes]",Incorrect
28127977,pubmedqa_pqa_l,Are serum leptin levels a prognostic factor in advanced lung cancer?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if serum leptin levels are a prognostic factor in advanced lung cancer based on the provided context.

First, I need to recall what a prognostic factor is. A prognostic factor is something that can predict the likely outcome or course of a disease when diagnosed. So, if leptin levels are prognostic, they should be associated with survival outcomes like overall survival.

Looking at the context, the study measured leptin levels in lung cancer patients versus controls. They found lower leptin in cancer patients. But when they looked at clinicopathological parameters (like ECOG PS, weight loss, histology, stage, TNM), there was no significant difference in leptin levels. However, there was a correlation with BMI in cancer patients. 

The key part here is the last sentence: ""The analysis of serum leptin values did not show any association with the overall survival of the patients."" Since overall survival is a primary endpoint for prognosis, and there's no association found, that suggests leptin levels aren't a prognostic factor. Even though they looked at advanced stages (since disease stage is mentioned as a parameter), the lack of association with survival means it's not prognostic. The question specifically asks about advanced lung cancer, but the study didn't find a link in any stage, including advanced. So the answer should be No.
</think>

[No]",Correct
16809243,pubmedqa_pqa_l,Is fetal gender associated with emergency department visits for asthma during pregnancy?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if fetal gender is associated with emergency department (ED) visits for asthma during pregnancy.

First, I need to recall the context provided. The study linked two databases to look at ED visits for asthma and pregnancy outcomes. The sample included women with live singleton births from 2003-2004. Cases were those with at least one ED visit for asthma, controls were the rest. They used logistic regression to model the risk of an ED visit, including fetal gender as a predictor.

The results mentioned that having an ED visit for asthma was associated with factors like teenage pregnancy and low income, but not with fetal gender. The odds ratio (OR) was 1.01 with a confidence interval (CI) of 0.85-1.19. Since the CI includes 1, the result isn't statistically significant. That means there's no evidence here that fetal gender affects the risk of ED visits for asthma.

Additionally, when looking at adverse pregnancy outcomes among the cases (those with ED visits), fetal gender wasn't a significant predictor either. So both parts of the study's aims found no association between fetal gender and the outcomes in question.

The question specifically asks about the association between fetal gender and ED visits. The study's conclusion directly addresses this, stating no association. The OR being close to 1 and the CI crossing 1 supports that. Therefore, the answer should be No.
</think>

[No]",Correct
17276182,pubmedqa_pqa_l,Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if the study shows a stretch-sensitive KCNQ1 mutation linking genetic and environmental factors in atrial fibrillation (AF) pathogenesis.

First, the context mentions that AF can be genetic, but the interaction between inherited mutations and acquired factors like atrial stretch wasn't explored before. The study found a KCNQ1 mutation (R14C) in a family with high hypertension. AF occurred in older members with atrial dilation and the mutation. 

The key part is the electrophysiological results. Normally, the mutant and wild-type channels didn't differ. But when exposed to hypotonic solution (causing cell swelling/stretch), the mutant channels showed increased current, altered activation, and shorter action potential. This suggests that the mutation's effect is only apparent under stretch conditions, which is an environmental factor (like hypertension leading to atrial stretch). 

So, the mutation (genetic) interacts with stretch (environmental) to cause AF. That links both factors. The answer should be Yes.
</think>

[Yes]",Correct
21123461,pubmedqa_pqa_l,Are adult body circumferences associated with height?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if adult body circumferences are associated with height based on the provided study.

First, I need to recall the context. The study examined how weight, waist circumference (WC), and hip circumference (HC) scale to height. They used allometric models adjusted for age, race, and health status. 

The results mention that after adjusting for age and race, WC and HC scaled to height with specific powers. For men, WC scaled with a power of 0.76 and HC 0.45. For women, WC was 0.80 and HC 0.53. All these were statistically significant (p<0.001). Even though the univariate models (without adjustments) were weak, the adjusted models showed significant scaling. Additionally, the incremental increases per cm in height were 0.2-0.5 cm for circumferences. 

The fact that the scaling exponents are positive (even if less than 1) indicates that as height increases, WC and HC also increase, but not proportionally (since 1 would mean direct proportionality). The negative scaling of WC/height and HC/height ratios to height suggests that taller individuals have slightly lower ratios, but the original question is about the association between circumferences and height, not the ratios. 

So, even though the scaling isn't as strong as weight (which scales with height squared), there's still a significant positive association between height and both WC and HC when adjusted for age and race. Therefore, the answer should be yes.
</think>

[Yes]",Correct
22428608,pubmedqa_pqa_l,Would corrected QT dispersion predict left ventricular hypertrophy in hypertensive patients?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether corrected QT dispersion (QTcD) can predict left ventricular hypertrophy (LVH) in hypertensive patients. 

First, I need to look at the context provided. The study involved 100 hypertensive patients and 30 normotensive controls. They used echocardiography to determine LVH and measured QTcD via ECG. The results showed that 42% of the hypertensive group had LVH, and none in the control group. 

Hypertensive patients had higher LVH indices and QTcD compared to controls, with significant p-values. Within the hypertensive group, those with LVH had higher QTcD than those without. The Pearson's correlation showed strong positive correlations between QTcD and LVH indices, all with p<0.001.

The ROC analysis identified 60 ms as the optimal cutoff for QTcD to predict LVH, with high sensitivity (92.9%) and specificity (98.2%). 

So, the study's findings directly support that QTcD is a good predictor of LVH in hypertensives. The statistical significance, correlation, and ROC metrics all point to a strong predictive value. Therefore, the answer should be yes.
</think>

[Yes]",Correct
27858166,pubmedqa_pqa_l,Traumatic aortic injury: does the anatomy of the aortic arch influence aortic trauma severity?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if the anatomy of the aortic arch influences the severity of aortic trauma in traumatic aortic injury (TAI). 

First, I need to look at the context provided. The study they mention is retrospective, looking at 22 cases treated with TEVAR for TAI. They classified the injuries using the Society of Vascular Surgery's recommendations. The key measurements here are the aortic arch angle and aortic arch index.

The results show that the mean aortic arch index and angle decrease as the injury type becomes more severe (from type I to IV). For example, type I had 6.8 cm and 58.3Â°, type III 4.4 cm and 45.9Â°, and type IV 3.3 cm and 37Â°. The differences in these measurements between type III and IV groups were substantial. Additionally, the multivariate analysis found that a smaller aortic arch angle was significantly associated with type III injury (OR 1.5; CI 1.03-2.2). 

So, the study's findings suggest that a smaller aortic arch angle (and possibly a lower aortic arch index) correlates with more severe injuries. The statistical analysis supports the association, especially for type III. However, the sample size is small (22 cases), which might affect the generalizability. But based on the data presented, the answer seems to lean towards yes. The anatomy, specifically the angle and index, does influence the severity. The answer should be [Yes].
</think>

[Yes]",Correct
23791827,pubmedqa_pqa_l,Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether risk stratification is useful for deciding between inpatient or outpatient management of neutropenic fever (NF) in gynecologic oncology patients.

First, I need to recall the study details. The study used the MASCC risk index score, where a score â‰¥21 is low risk. They found that 76% of patients were low risk. High-risk patients had significantly higher rates of severe complications, ICU admissions, and mortality. The MASCC score's negative predictive value (NPV) was 90%, meaning 90% of those classified as low risk didn't have bad outcomes. The positive predictive value (PPV) was 50%, so half of high-risk patients did have complications.

For outpatient management, a high NPV is crucial because you want to be confident that sending someone home (low risk) won't result in complications. Here, the NPV is 90%, which is pretty good. However, the study's population was all inpatients, so it's not directly testing outpatient vs. inpatient. But the results suggest that low-risk patients (most of whom didn't have severe issues) might be candidates for outpatient care. The high-risk group clearly had worse outcomes, so they'd need inpatient care. The MASCC score seems effective in distinguishing these groups. The answer would lean towards yes, risk stratification is useful here.
</think>

[Yes]",Correct
18243752,pubmedqa_pqa_l,Should chest wall irradiation be included after mastectomy and negative node breast cancer?,maybe,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether chest wall irradiation should be included after mastectomy in patients with node-negative breast cancer. The context provided is a study that looked at local failure patterns in such patients who received post-mastectomy radiotherapy targeting the internal mammary chain.

First, I need to understand the study's findings. The study included 92 patients with internal or central breast tumors that were node-negative. They were treated with mastectomy and radiotherapy to the internal mammary chain at 50 Gy. The local recurrence rate was 5%, with all recurrences occurring at the operative scar and chest wall. Factors like age â‰¤40 and tumor size >20mm were associated with higher risk, but not statistically significant.

The question is about whether adding chest wall irradiation would be beneficial. The study's patients didn't receive chest wall irradiation, only the internal mammary chain. The recurrences happened in the chest wall and scar area, which suggests that the current approach (not irradiating the chest wall) might be missing those areas. However, the recurrence rate was low (5%), which might be considered acceptable. But if the chest wall isn't being irradiated and that's where the recurrences are happening, maybe adding chest wall irradiation could reduce that rate further. 

But wait, standard practice for post-mastectomy radiotherapy (PMRT) in node-negative patients might not always include chest wall irradiation. PMRT is more commonly recommended for patients with positive nodes or other high-risk features. The study's patients were node-negative, so maybe they were considered lower risk. However, the presence of factors like young age and larger tumor size (even if not statistically significant) might indicate a subset that could benefit. 

The study's conclusion might imply that even with internal mammary chain irradiation, the chest wall remains a site of recurrence. Therefore, including chest wall irradiation could potentially lower the recurrence rate. However, the study is retrospective and has a small sample size (92 patients), so the evidence might not be strong enough to make a definitive recommendation. Also, the lack of statistical significance in the risk factors means we can't be certain about their impact.

In clinical practice, decisions are often based on risk-benefit analysis. Adding chest wall irradiation could increase toxicity, so the benefit in terms of reducing a 5% recurrence rate needs to be weighed against potential side effects. If the study's results suggest that the chest wall is a common site of recurrence despite not being irradiated, then maybe including it would help. But without a control group that didn't receive any radiotherapy, it's hard to say. The study only compared different factors within the same treatment group.

So, considering all this, the answer might lean towards ""Yes"" because the recurrences were in areas not targeted by the radiotherapy they received. However, the study's limitations and the fact that current guidelines might not support it for node-negative patients could make the answer ""Maybe."" The user is looking for a yes/no/maybe, so I need to decide based on the provided context. The study shows that even with internal mammary chain irradiation, chest wall recurrences occur, suggesting that adding chest wall irradiation might be beneficial. But since the study doesn't directly compare with or without chest wall irradiation, it's not definitive. Hence, ""Maybe"" could be appropriate.
</think>

[Maybe]",Correct
17279467,pubmedqa_pqa_l,Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?,maybe,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The case is about a child with osteogenesis imperfecta type IV who was treated with pamidronate. The treatment improved his BMD and vertebral fractures, but after stopping, his BMD dropped and he had new fractures. The question is whether bisphosphonates can be stopped in such cases.

First, I need to recall what bisphosphonates do. They inhibit bone resorption, so they help increase bone density. In kids with OI, they're often used long-term. But stopping them might lead to bone loss again, especially during growth spurts. The case here shows that after stopping, BMD decreased and new fractures occurred. That suggests that discontinuation might not be safe. However, maybe there are factors like duration of treatment, age, or other therapies. The child here had treatment for 4 years, stopped, and then problems arose. The study uses different densitometry methods, and all showed improvement during treatment but decline after. The vertebral fractures remodeled, but new stress fractures happened post-treatment. The question is about stopping in a growing child. The key issue is whether the benefits of continuing outweigh the risks. Since stopping led to negative outcomes, the answer might be no, but maybe there's a possibility of intermittent therapy or other factors. But based on the case presented, the data suggests that stopping leads to deterioration. So the answer is probably no, but maybe there's a maybe if there are other considerations. But the case here clearly shows a problem when stopped. So the answer is [No].
</think>

[No]",Incorrect
22758782,pubmedqa_pqa_l,"Regional anesthesia as compared with general anesthesia for surgery in geriatric patients with hip fracture: does it decrease morbidity, mortality, and health care costs?",no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether regional anesthesia, compared to general anesthesia, decreases morbidity, mortality, and healthcare costs in geriatric hip fracture patients.

First, I need to look at the context provided. The study is a retrospective cohort review comparing regional and general anesthesia. The key points from the context are:

1. **Morbidity**: The study mentions that in-hospital mortality and readmission rates were not statistically different between the two groups. However, it doesn't specify other morbidity aspects like complications, recovery time, or post-op issues. The abstract says ""postoperative morbidity"" was analyzed, but the results only state that mortality and readmission weren't different. So maybe there's no significant difference in morbidity either, but the details aren't provided.

2. **Mortality**: The study explicitly states that in-hospital mortality wasn't statistically different between the two anesthesia groups. So regional anesthesia doesn't decrease mortality compared to general here.

3. **Healthcare Costs**: The average hospitalization costs were almost identical ($16,789 vs $16,815) with a p-value of 0.9557, which is not significant. So no difference in costs. However, factors like ICU admission and surgery delay did increase costs, but those aren't directly related to the type of anesthesia.

The question is whether regional anesthesia decreases these three outcomes. The study found no significant differences in mortality and costs. For morbidity, the study mentions ""postoperative morbidity"" was analyzed but doesn't report the results except for readmission rates (which are part of morbidity). Since readmission rates were not different, and the abstract doesn't mention other morbidity metrics showing a difference, it's possible that morbidity wasn't reduced either. However, the exact morbidity outcomes (like complications) aren't detailed, so there's a bit of uncertainty. But based on the given data, the answer would be that regional anesthesia does not decrease morbidity, mortality, or costs compared to general. The answer should be ""No"" for all three, but the question combines them. The study's conclusion is that there's no difference, so the answer is No.
</think>

[No]",Correct
15223725,pubmedqa_pqa_l,Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if blood pressure (BP) in treated hypertensive patients changes depending on whether it's measured by a physician or a nurse. 

First, I'll look at the context provided. The study compared systolic BP measured by nurses (NBP), physicians (PBP), and self-measured. The key data here is the difference between physician-systolic BP and nurse-systolic BP, which is 5.16 mmHg with a 95% confidence interval of 2.62-7.7 and a p-value less than 0.001. Since the p-value is below the typical alpha level of 0.05, this indicates a statistically significant difference. The confidence interval doesn't include zero, reinforcing that the difference is real.

The diastolic BP didn't show significant differences, but the question specifically asks about blood pressure in general. However, the significant systolic difference is enough to answer the question. The sensitivity and specificity values provided for NBP and PBP might relate to how well each method detects hypertension, but the main point here is the actual BP measurements differing between nurse and physician.

So, based on the significant difference in systolic BP between physician and nurse measurements, the answer should be yes. The diastolic not being different doesn't negate the systolic finding, and the question doesn't specify systolic or diastolic. Therefore, the answer is yes.
</think>

[Yes]",Correct
19482903,pubmedqa_pqa_l,Treadmill testing of children who have spina bifida and are ambulatory: does peak oxygen uptake reflect maximum oxygen uptake?,yes,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether peak oxygen uptake (VO2peak) measured during treadmill testing in ambulatory children with spina bifida reflects their maximum oxygen uptake (VO2max). 

First, I need to recall the context provided. The study aimed to determine if VO2peak from a treadmill test truly represents VO2max in these children. They used a cross-sectional design with 20 participants. The methods included measuring VO2peak during a graded treadmill test and comparing it to VO2 during a supramaximal protocol (VO2supramaximal).

The results showed that average VO2peak was 1.23 L/min and 34.1 mL/kg/min. Fifteen children met at least two of the three criteria for maximum effort, but one didn't meet any. There was no significant difference between VO2peak and VO2supramaximal, but five children had higher values in the supramaximal test.

So, the key points here are that most children met the criteria for maximum testing, but some didn't. Also, even though there was no significant difference overall, a subset showed improvement in the supramaximal test. This suggests that for some individuals, VO2peak might not capture their true VO2max. However, since the majority met the criteria and the overall difference wasn't significant, the study's conclusion might lean towards VO2peak being a valid measure in most cases, but with exceptions.

The question is whether VO2peak reflects VO2max. The answer isn't a straightforward yes or no. The study shows that in most cases, it does, but there are exceptions where the supramaximal test showed higher values. Therefore, the answer would be ""Maybe"" because while it generally reflects, there are instances where it might not.
</think>

[Maybe]",Incorrect
25752912,pubmedqa_pqa_l,Is the probability of prenatal diagnosis or termination of pregnancy different for fetuses with congenital anomalies conceived following assisted reproductive techniques?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether the probability of prenatal diagnosis (PND) or termination of pregnancy for fetal anomaly (TOPFA) is different for fetuses with congenital heart defects (CHD) conceived via assisted reproductive techniques (ART) compared to those conceived spontaneously.

First, I need to refer back to the context provided. The study compared ART-conceived and spontaneously conceived fetuses with CHD. The key findings mentioned are the probabilities of PND and TOPFA. 

Looking at the results: For PND, the percentages were 28.1% for ART vs. 34.6% for spontaneous, with a p-value of 0.077. Since the p-value is above 0.05, this isn't statistically significant. Similarly, for TOPFA, the rates were 36.2% vs. 39.2% with a p-value of 0.677, which is also not significant. The study adjusted for confounders and still found no significant differences. The gestational age at PND was slightly earlier for ART, but after adjustment, that difference wasn't significant either. 

The question is whether there's a difference in probability. The study's conclusion states that there's no statistical difference in both PND and TOPFA probabilities between the two groups. Even though the raw numbers for PND are somewhat different (28.1% vs. 34.6%), the p-value isn't below the significance threshold. Therefore, the answer should be that there's no significant difference. The answer is No.
</think>

[No]",Correct
21946341,pubmedqa_pqa_l,Is there a relationship between complex fractionated atrial electrograms recorded during atrial fibrillation and sinus rhythm fractionation?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if there's a relationship between complex fractionated atrial electrograms (CFAEs) during atrial fibrillation (AF) and sinus rhythm fractionation (SRF). 

First, I need to recall the context provided. The study compared CFAE and SRF maps in 20 patients with persistent AF and 9 controls. They looked at the overlap between regions with CFAEs and SRF in the AF group. The results mentioned that there was no significant correlation between the two maps (r = 0.2, P = NS). Also, when comparing AF patients to controls, there was no significant difference in SRF distribution. Additionally, regions of SRF overlapped with wave-front collision areas 75% of the time.

So, the key points here are the correlation coefficient (r = 0.2) which is low and not statistically significant (P = NS). The lack of difference in SRF between AF patients and controls further suggests that SRF might not be specifically related to AF substrate. The overlap with wave-front collision might explain some SRF, but that's a different aspect. Since the question is about the relationship between CFAEs during AF and SRF, the study directly states there's no significant correlation. Therefore, the answer should be No.
</think>

[No]",Correct
16428354,pubmedqa_pqa_l,Does rural or urban residence make a difference to neonatal outcome in premature birth?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether rural or urban residence affects neonatal outcomes in premature births. The context provided is a study from NSW and ACT that compared outcomes between rural and urban very premature infants.

First, I need to recall the key findings from the study. The study found that rural mothers had different risk factors compared to urban mothers, like being younger, Indigenous, and having previous preterm births. Urban mothers had higher rates of assisted conception and C-sections. Importantly, more urban infants were born in tertiary hospitals (93% vs 83%), which are better equipped for high-risk births.

The study's main result was that rural infants had a higher mortality rate, with an adjusted odds ratio of 1.26. This was significant, as the confidence interval didn't cross 1. The trend was consistent across subgroups, especially in those born in tertiary hospitals and the 30-31 weeks gestation group. Additionally, rural areas had higher stillbirth rates.

So, the study directly addresses the question. The data shows that rural residence is associated with worse neonatal outcomes, specifically higher mortality and stillbirth rates. Even though there's a coordinated transport system, rural infants still fared worse. The answer should be yes because the study's findings support that rural residence makes a difference, leading to poorer outcomes.
</think>

[Yes]",Correct
19302863,pubmedqa_pqa_l,Is the use of cyanoacrylate in intestinal anastomosis a good and reliable alternative?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user wants to know if cyanoacrylate glue is a good and reliable alternative to sutures for intestinal anastomosis based on the study described.

First, I need to recall the study details. They used rats divided into groups E and L, with subgroups using either Vicryl sutures (A) or cyanoacrylate glue (B). The outcomes measured were bursting pressure, hydroxyproline levels, and operation time. The results showed no significant difference in bursting pressures between the subgroups on days 2 and 6. However, hydroxyproline levels (which relate to collagen and thus healing) and the anastomosis time (AT) were significantly better in the B subgroups (cyanoacrylate).

So, bursting pressure is a measure of how well the anastomosis holds under pressure, indicating mechanical strength. No difference there suggests that both methods are equally strong initially and after a few days. Hydroxyproline being higher in the glue groups implies better collagen deposition, which is good for healing. The operation time being shorter with glue is a practical advantage.

The question is about whether cyanoacrylate is a good and reliable alternative. The study's results support that it's at least as good as sutures in terms of strength (since bursting pressure was the same) and better in terms of healing markers and operation time. However, since this is an animal study, there might be limitations in directly applying the results to humans. Also, the study only looked at two time points (days 2 and 6), so long-term outcomes aren't assessed. But based on the data provided, the answer would lean towards yes. The conclusion in the study probably supports cyanoacrylate as a viable alternative, given the positive findings in hydroxyproline and operation time without compromising strength.
</think>

[Yes]",Correct
24245816,pubmedqa_pqa_l,Is trabecular bone related to primary stability of miniscrews?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if trabecular bone is related to the primary stability of miniscrews.

Looking at the context provided, the study compared primary stability using various metrics like insertion torque, mobility, and pull-out strength. They found that lower BMD in trabecular bone correlated with lower primary stability. Also, trabecular properties like number, thickness, separation, BV/TV, and BMD were correlated with the stability measures. The Pearson test showed these correlations were statistically significant. So, since trabecular characteristics directly influenced the outcomes, the answer should be yes.
</think>

[Yes]",Correct
24666444,pubmedqa_pqa_l,"Is there any evidence of a ""July effect"" in patients undergoing major cancer surgery?",no,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if there's evidence of a ""July effect"" in patients undergoing major cancer surgery. The context provided discusses a study that looked into this.

First, the July effect is about new medical staff starting in July, potentially leading to worse patient outcomes. The study used data from 1999 to 2009, focusing on eight major cancer surgeries at academic centers. They checked complications and mortality.

In the univariate analysis, they found higher overall complications in July, especially genitourinary and hematologic. But when they did multivariate analysis controlling for other factors, only hematologic complications remained significantly higher. There was no difference in overall complications or mortality when looking at all surgeries together or separately.

So, the key here is that multivariate analysis is more rigorous because it accounts for variables like patient and hospital characteristics. The fact that only hematologic complications were higher suggests some effect, but not across the board. The study's conclusion seems to be that there's a limited July effect in this context. The question is asking for any evidence, and even a specific complication (hematologic) counts as evidence. Therefore, the answer should be yes, there is some evidence, even if it's not comprehensive.
</think>

[Yes]",Incorrect
19913785,pubmedqa_pqa_l,Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether it's necessary to routinely insert a nasobiliary drainage (ENBD) tube after clearing the common bile duct in patients with cholangitis caused by choledocholithiasis.

First, I need to look at the context provided. The study mentioned is a prospective, randomized trial comparing two groups: one with ENBD and one without. The primary outcomes were recurrence of cholangitis and hospital stay length. The results showed no significant differences in recurrence rates at 24 weeks (3.9% vs 3.8%) and similar hospital stays (7.9 days each). However, the ENBD group had longer procedure times and higher discomfort scores.

The study's conclusion seems to suggest that routine ENBD insertion doesn't improve clinical outcomes like reducing cholangitis recurrence or shortening hospital stays. Instead, it adds to procedure time and patient discomfort. Since there's no benefit in the main outcomes but some downsides, the answer would lean towards ""No,"" routine insertion isn't necessary. But I should check if there are any caveats. The study is a single-center trial, which might limit generalizability, but the results are pretty clear. The authors probably concluded that routine use isn't needed. So the answer should be No.
</think>

[No]",Correct
1571683,pubmedqa_pqa_l,Storage of vaccines in the community: weak link in the cold chain?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if the storage of vaccines in the community is a weak link in the cold chain based on the provided context.

First, I need to recall what the cold chain refers to. The cold chain is the system of storing and transporting vaccines at recommended temperatures from manufacture to administration. Any break in this chain can reduce vaccine efficacy.

Looking at the context: The study was done in Manchester and Bradford. They surveyed practices and clinics, checked refrigerators. Only 40 out of 50 responded. 16 out of 40 knew the correct storage conditions. Only 8 had min/max thermometers, and only one monitored daily. Then, in 6 out of 8 monitored fridges, temperatures were either too low (subzero) or too high (up to 16Â°C). Some of these were specialized fridges with thermostats and gauges, but still had issues.

So, the data shows that most places aren't following guidelines. Many don't know the correct storage conditions, don't have proper thermometers, and even when they do, they don't check them daily. The temperature monitoring showed that most fridges weren't maintaining the correct temps. Since the cold chain requires consistent proper storage, these failures indicate that storage in the community is indeed a weak link. The answer should be Yes.
</think>

[Yes]",Incorrect
15631914,pubmedqa_pqa_l,Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether a clinically positive axilla in breast cancer is truly a contraindication for sentinel lymph node (SLN) biopsy. From the context provided, the study challenges the common belief that palpable, suspicious axillary nodes should prevent SLN biopsy.

The study found that clinical exams were wrong 41% of the time overall. Specifically, 53% of moderately suspicious nodes and 23% of highly suspicious nodes were actually negative upon biopsy. That's a significant number of false positives. So even when nodes feel suspicious, many patients might not have metastases, meaning SLN biopsy could still be useful to avoid unnecessary axillary lymph node dissections (ALND), which are more invasive.

The data here suggests that relying solely on clinical examination might lead to overtreatment. Factors like tumor size and histologic grade affected false positives, but age and BMI didn't. The conclusion seems to be that clinical positivity isn't a strict contraindication because the exam isn't reliable enough. Therefore, the answer would lean towards ""No,"" since the evidence contradicts the mandate against SLN biopsy in these cases.
</think>

[No]",Correct
11970923,pubmedqa_pqa_l,Convulsions and retinal haemorrhage: should we look further?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The context is a study looking at retinal hemorrhages in children after convulsions. They studied 153 kids aged 2 months to 2 years who had a convulsive episode. The main point is that retinal hemorrhages are often linked to child abuse, so they wanted to see if after a convulsion, these hemorrhages occur, which might mean abuse or another issue.

The study found that only one child had unilateral retinal hemorrhages after a simple febrile convulsion. They did a thorough investigation and found no other cause. The question is asking if, when convulsions and retinal hemorrhage are present, should further investigation be done.

So, the study's conclusion seems to suggest that since only one case out of 153 had retinal hemorrhage without any other cause found, maybe it's rare. But since retinal hemorrhages are a red flag for abuse, even if it's rare, the presence should prompt further checks. The answer would be yes, because even though it's not common after convulsions, the possibility of abuse can't be ignored. The study's recommendation would be to investigate further to rule out abuse or other systemic issues.
</think>

[Yes]",Correct
20121683,pubmedqa_pqa_l,Are patients willing participants in the new wave of community-based medical education in regional and rural Australia?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if patients are willing participants in community-based medical education in regional and rural Australia based on the provided context.

First, I need to look at the data from the study. The context mentions that 118 out of 122 patients consented to student involvement, which is a high consent rate (about 96.7%). That's a strong indicator of willingness. Then, 99% of those who consented completed a pre-consultation survey, and 85% completed a post-consultation survey. 

In the pre-consultation phase, patients were positive about their doctor and practice being involved in teaching. They felt they played an important role. However, they were initially reluctant to let students conduct parts of the consultation independently. But after the consultation, their willingness increased; they reported they would have accepted more student involvement than what actually happened. 

So, even though there was initial hesitation about certain aspects, the overall consent rate and post-consultation feedback suggest that patients are willing. The key points are the high consent rate and the positive shift in acceptance after the experience. The answer should be ""Yes"" because the majority consented and their acceptance increased post-consultation, indicating willingness.
</think>

[Yes]",Correct
27281318,pubmedqa_pqa_l,Can Flexible Instruments Create Adequate Femoral Tunnel Lengths at 90Â° of Knee Flexion in Anterior Cruciate Ligament Reconstruction?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if flexible instruments can create adequate femoral tunnel lengths at 90Â° of knee flexion in ACL reconstruction. The context provided is a study on cadaveric knees.

First, I need to recall the study's findings. The study measured intra-osseous lengths at different flexion angles: 70Â°, 90Â°, and 120Â°. The mean length at 90Â° was 32.1 mm, with a range from 22 to 45 mm. The goal was to see if lengths over 20 mm could be achieved. Since 32.1 mm is well above 20 mm, that's a point in favor of ""Yes.""

The statistical significance here is important. The p-value was less than 0.05 when comparing 70Â° to 90Â°, which means the increase in length at 90Â° is not due to chance. So, the study supports that 90Â° flexion with flexible reamers can create tunnels longer than 20 mm.

Also, the distances to lateral structures like the LCL and common peroneal nerve were considered. The study found no significant differences in distance to LCL across angles, and while there was a trend towards safer distances to the nerve with higher flexion, the main point here is that at 90Â°, the tunnel length is adequate without compromising safety.

The question specifies ""adequate"" length. Since 20 mm is the threshold mentioned in the study's purpose, and the mean at 90Â° is 32.1 mm, which is above 20 mm, the answer should be yes. Even though individual specimens had a minimum of 22 mm at 90Â°, which is still above 20, so all samples met or exceeded the threshold. Therefore, the answer is yes.
</think>

[Yes]",Correct
12846929,pubmedqa_pqa_l,Quality of life in lung cancer patients: does socioeconomic status matter?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether socioeconomic status (SES) affects the quality of life (QoL) in lung cancer patients based on the provided study.

First, I need to recall the context. The study measured QoL at baseline and three months post-treatment using three instruments. SES was determined via the Carstairs and Morris Deprivation Categories (1-7). There were 129 patients initially, but only 82 had complete data. 

At baseline, 57% were lower SES, and they had more health issues, lower functioning, and more symptoms. Specific domains like physical mobility, energy, role functioning, physical functioning, and breathlessness were significant with p-values ranging from 0.05 to 0.02. However, at follow-up, there were no significant differences between SES groups, and no consistent pattern emerged.

So the key points are: significant differences at baseline in several QoL aspects between lower and higher SES groups, but these differences disappeared at follow-up. The question is whether SES matters for QoL. The answer hinges on the timing. At baseline, yes, SES is associated with QoL. But after treatment (follow-up), the effect isn't significant anymore. 

The study's conclusion seems to suggest that SES impacts initial QoL but not after treatment. However, the question is general, not specifying a time frame. The user might be looking for whether SES is a factor overall. Since the baseline shows significance but follow-up doesn't, the answer isn't straightforward. Maybe the effect is present initially but not sustained, or perhaps the treatment mitigated SES-related disparities. Alternatively, the sample size at follow-up (82) might be underpowered. 

The answer could be ""Yes"" because there was a significant baseline association. But since the follow-up didn't show differences, maybe the effect is temporary. However, the question doesn't specify time, so the study's findings are mixed. Therefore, the answer might be ""Yes"" for baseline but not after, leading to a ""Maybe"" overall. But the user might want a direct answer. The study's results are conflicting depending on the time point. The correct approach is to say ""Yes"" because the baseline shows SES matters, but the follow-up complicates it. However, the question is general, so the answer is ""Yes"" because there was an initial significant effect. Alternatively, since the follow-up didn't show differences, maybe SES doesn't matter in the longer term. But the user's question is whether SES matters, not when. The study shows that at least at baseline, it does. So the answer is Yes. Wait, but the user might consider the follow-up as part of the overall QoL assessment. If the differences disappear, then maybe SES doesn't have a lasting impact. But the study's conclusion is that at follow-up, there's no difference. So the answer could be ""Yes"" because there's an initial impact, but the follow-up complicates it. However, the question is phrased as ""does socioeconomic status matter?"" without specifying time. The study found that SES was associated with QoL at baseline but not after treatment. Therefore, the answer is that SES matters at baseline but not after. But the question is general. If the user is asking whether SES is a factor in QoL for lung cancer patients, the answer would be ""Yes"" because there's evidence from baseline. However, the follow-up results might suggest that the effect is temporary. But the study's overall conclusion might be that SES is a factor at diagnosis but not post-treatment. Since the question is general, the answer could be ""Yes"" because there is a significant association at some point. Alternatively, if the follow-up is considered more important, maybe ""No"". But the study's results are mixed. The correct answer here is ""Yes"" because the baseline shows significant differences, and the question doesn't specify time. Therefore, the answer is [Yes].
</think>

[Yes]",Correct
26505821,pubmedqa_pqa_l,Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?,maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women. 

First, I need to recall the context provided. The study involved 371 postmenopausal osteoporotic women. They measured both biochemical markers (like bone ALP, PINP, sCTX) and histomorphometric parameters from bone biopsies. The results showed significant correlations between the biochemical markers and the histomorphometric parameters. For example, bone ALP and PINP correlated with formation parameters, and sCTX with resorption parameters. The correlation coefficients (r') ranged from 0.18 to 0.36, which are statistically significant but not very strong.

Now, the question is about representativeness. The key here is understanding what ""representative"" means. If biochemical markers correlate significantly with histomorphometry, does that mean they are representative? Well, the study found significant correlations, but the strength of the correlations is moderate. So while there is a statistical association, the biochemical markers might not fully capture all the details that histomorphometry provides. However, the fact that there are significant correlations suggests that they do reflect some aspects of bone turnover as seen in histomorphometry. 

The study's conclusion would likely support that biochemical markers are useful as systemic indicators, even if they can't replace histomorphometry for detailed tissue-level analysis. Since the question is whether they are representative, and the answer in the context is that there are significant correlations, the answer should be yes. But wait, the correlations are moderate, so maybe there's a nuance. However, the question is about being representative, not about perfect correlation. So given the significant p-values and the presence of correlations, the answer is probably yes.
</think>

[Yes]",Incorrect
25156467,pubmedqa_pqa_l,Should early extubation be the goal for children after congenital cardiac surgery?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether early extubation should be the goal for children after congenital cardiac surgery. The context provided is a study analyzing the feasibility and outcomes of an early extubation strategy in this population.

First, I need to understand the key findings from the study. The study included 613 children, 97 of whom were neonates. They achieved intraoperative extubation in 71% of cases and early extubation (within 24 hours) in 89%. The mortality rate was low overall (1.5%), and early extubation was associated with even lower mortality (1% vs. 9%) and lower reintubation rates (4% vs. 23%). Neonates had a 63% early extubation rate, including specific procedures like arterial switch operations. The Norwood procedure was the only one where no early extubation occurred. Predictors of delayed extubation included preoperative ventilation, low weight, longer surgery time, and need for inotropes. Early extubation also correlated with fewer complications and shorter ICU/hospital stays.

The question is whether early extubation should be the goal. The study's results are positive, showing better outcomes with early extubation. However, there are exceptions, like the Norwood procedure. The answer might depend on patient-specific factors. But overall, the data supports aiming for early extubation when feasible. The answer is likely ""Yes,"" but I should check if there's any reason to doubt this. The study's design is a linked database analysis, which is observational, so there might be confounding factors. However, the multivariable analysis adjusted for predictors, which strengthens the conclusion. The benefits in mortality, reintubation, and length of stay are significant. So, the answer is probably ""Yes.""
</think>

[Yes]",Correct
22023714,pubmedqa_pqa_l,Does delivery mode affect women's postpartum quality of life in rural China?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether the delivery mode (vaginal vs. cesarean) affects postpartum quality of life for women in rural China.

Looking at the context provided, the study was a cross-sectional survey of women 0-12 months postpartum in rural areas. They used a specific scale to measure quality of life across six dimensions. The key findings mentioned are that the C-section rate was 70%, mostly by maternal request. The results showed no significant differences in any of the six dimensions or the total quality of life score between vaginal delivery and cesarean groups. Additionally, factors like postnatal home visits, husband's education level, and infant's gender were associated with quality of life, but delivery mode wasn't.

So, the study's conclusion is that delivery mode doesn't have a significant impact on postpartum quality of life in this population. The answer should be ""No"" based on the provided data.
</think>

[No]",Correct
16046584,pubmedqa_pqa_l,Menopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is asking whether there's a potential role for uterine natural killer (uNK) cells in menopausal hormone therapy (HT) and irregular endometrial bleeding.

Looking at the context provided, the study's main objective was to explore the role of uNK cells and their cytokine IL-15 in irregular bleeding among HT users. The results showed that endometrial CD56+ uNK cells were significantly increased during bleeding episodes compared to non-bleeding HT users. Additionally, IL-15 expression was highest during bleeding. The study didn't find a clear link with killer Ig-like receptor genotypes and bleeding.

So, the findings directly indicate that uNK cells (specifically CD56+) and IL-15 are associated with bleeding episodes in HT users. Since the question is about a potential role, the answer would be yes because the study provides evidence supporting their involvement.
</think>

[Yes]",Correct
16155169,pubmedqa_pqa_l,Percutaneous ethanol injection for benign cystic thyroid nodules: is aspiration of ethanol-mixed fluid advantageous?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking whether aspiration of ethanol-mixed fluid is advantageous in percutaneous ethanol injection for benign cystic thyroid nodules.

First, I need to look at the context provided. The study compared two groups: Group A without aspiration and Group B with aspiration. The main outcomes were success rates (complete disappearance of the cyst), side effects, and procedure time.

Looking at the success rates, both groups had high successâ€”29 in Group A and 28 in Group B. The statistical analysis showed no significant difference (P > 0.05). So, aspiration doesn't seem to improve success rates.

Next, side effects. Pain was common but similar between groups. However, Group B had more intracystic hemorrhage (P < 0.05) and all Group B patients complained about double puncture (P < 0.001). These are negatives for aspiration.

Procedure time was nearly double in Group B because of the extra steps like evacuating fluid and compression. Longer procedure time is a disadvantage.

So, the study found that adding aspiration didn't improve success, caused more complications, and took longer. Therefore, aspiration doesn't seem advantageous. The answer should be No.
</think>

[No]",Correct
19398929,pubmedqa_pqa_l,Can the growth rate of a gallbladder polyp predict a neoplastic polyp?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if the growth rate of a gallbladder polyp can predict whether it's neoplastic.

First, I need to look at the context provided. The study they mentioned involved 145 patients who had gallbladder polyps and underwent follow-up ultrasounds before getting a cholecystectomy. They looked at factors like age, polyp size, and growth rate. 

The results showed that neoplastic polyps were more common in patients over 60, those with hypertension, polyps larger than 10mm, and a rapid growth rate (>0.6 mm/month). However, when they did the multivariate analysis, the growth rate wasn't significantly associated with neoplastic polyps anymore. Instead, older age and larger size were the significant factors.

So, even though a rapid growth rate was observed in neoplastic polyps initially, the multivariate analysis suggests that growth rate isn't an independent predictor. The key predictors were age and size. Therefore, the answer would be that growth rate alone can't reliably predict a neoplastic polyp when considering other factors. The study's conclusion points to age and size being more important.
</think>

[No]",Correct
28143468,pubmedqa_pqa_l,Are performance measurement systems useful?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if performance measurement systems (PMS) are useful based on the provided context.

First, I need to recall the context details. The prior literature says PMS is crucial for improving care processes. The study tested direct and indirect models linking strategic PMS use to improved processes. The results showed a direct significant positive effect (p<0.001) of strategic PMS use on improved processes. Also, strategic PMS use positively affects perceived managerial discretion, but the mediation effect wasn't significant.

The question is whether PMS are useful. The context mentions that strategic use of PMS enhances quality compared to non-strategic use. The direct link is significant, so that supports usefulness. Even though the mediation through managerial discretion isn't significant, the direct effect is strong. The response rate is high (77.6%), which adds credibility. The answer should be yes because the study found a direct positive impact. The answer is [Yes].
</think>

[Yes]",Correct
9483814,pubmedqa_pqa_l,Does para-cervical block offer additional advantages in abortion induction with gemeprost in the 2nd trimester?,yes,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user wants to know if a paracervical block provides extra benefits when using gemeprost for second-trimester abortions.

First, I'll look at the study details. They had 20 women divided into two groups: one with just pethidine and butylscopolamine, and the other adding paracervical anesthesia (bupivacaine) once the cervix was 2-3 cm dilated. The main outcomes were induction-to-abortion time, pain levels, and medication requirements.

The results showed that the median time from induction to abortion was 20 hours without the block and 13 hours with it. But the range was wide (8-44 vs. 8-36), and it's noted as not significant (NS). So the difference in time isn't statistically significant. 

Looking at other intervals, like last gemeprost dose to abortion and 3 cm dilation to abortion, they were slightly shorter in the block group but again not significant. Pain intensity, measured by a scale, didn't differ between groups, especially in the late first stage. However, the block group needed more butylscopolamine (p<0.05), which is interesting. More of that might indicate more uterine spasms or discomfort, but the study doesn't specify why. Pethidine use was similar. No side effects from the block were reported.

So, the main points: the block didn't significantly reduce the time to abortion or pain. It did increase the need for butylscopolamine. Since the key outcomes (time and pain) didn't show significant improvement, the additional advantage isn't clear. Maybe there's a slight trend, but without statistical significance, it's not conclusive. The answer would be Maybe, but leaning towards No because the benefits aren't proven here.
</think>

[No]",Incorrect
22720085,pubmedqa_pqa_l,Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's try to figure out if insulin resistance is driving the association between hyperglycemia and cardiovascular risk based on the study described.

First, the context says that hyperglycemia (high blood glucose) is linked to higher cardiovascular disease (CVD) risk and mortality, but treating high glucose doesn't really reduce that risk. The researchers wanted to see if insulin resistance explains this link.

They studied 60 middle-aged people without diabetes. They measured fasting glucose, 2-hour post-glucose levels, insulin sensitivity (via clamp method), body fat percentage, and used the Framingham risk score for CVD risk. 

The results showed that both fasting and 2-hour glucose levels were positively associated with higher Framingham scores (rÂ²=0.21 and 0.24, both significant). Insulin sensitivity had a stronger inverse association (rÂ²=0.36), meaning higher insulin sensitivity was linked to lower CVD risk. 

When they adjusted for insulin sensitivity and 2-hour glucose, fasting glucose's effect became non-significant (p=0.06). Similarly, adjusting for insulin sensitivity and fasting glucose made 2-hour glucose's effect non-significant (p=0.143). However, insulin sensitivity remained significant even after adjusting for glucose levels. Body fat wasn't significant when considering insulin sensitivity.

So, the key point here is that when they controlled for insulin sensitivity, the association between glucose levels (both fasting and post-glucose) and CVD risk went away. But insulin sensitivity's association with CVD risk stayed strong. This suggests that insulin resistance (lower insulin sensitivity) might be the underlying factor that explains why hyperglycemia is linked to CVD risk. In other words, hyperglycemia's association with CVD risk is not independent of insulin resistance; once you account for insulin resistance, the glucose levels don't add significant risk. Therefore, insulin resistance is likely driving the association.
</think>

[Yes]",Correct
24748473,pubmedqa_pqa_l,Are there risk factors that increase the rate of staple line leakage in patients undergoing primary sleeve gastrectomy for morbid obesity?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if there are risk factors that increase the rate of staple line leakage in patients undergoing primary sleeve gastrectomy for morbid obesity.

First, I need to look at the context provided. The study analyzed data from 5,400 LSG procedures over seven years. They found that the leak rate decreased from 6.5% to 1.4% during the study period. 

The context mentions several factors associated with higher leakage rates: male gender, higher BMI, concomitant sleep apnea, conversion to laparotomy, longer operation time, use of both buttresses and oversewing, and intraoperative complications. However, on multivariate analysis, only operation time and year of procedure were significant. 

So, even though some factors were significant in univariate analysis, the multivariate analysis narrowed it down to operation time and year. But the question is about risk factors in general. The presence of any factors that increase the risk, even if some were not significant in multivariate analysis, would mean the answer is yes. The study does identify several factors, even if only two remained significant after adjusting for others. Therefore, the answer should be yes.
</think>

[Yes]",Correct
15588538,pubmedqa_pqa_l,Chronic functional somatic symptoms: a single syndrome?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if chronic functional somatic symptoms represent a single syndrome. The study compared patients with these symptoms to controls over 10 years. The findings show that patients had more symptoms across multiple body systems, higher medication use, more GP visits, psychiatric issues, and referrals. But the study's goal was to see if these features support specific somatic syndromes. The conclusion might suggest that the clustering of symptoms and associated factors could indicate distinct syndromes, but the abstract doesn't explicitly confirm a single syndrome. The answer hinges on whether the data supports a unified syndrome or multiple. The authors mention testing the hypothesis of specific syndromes, which implies they might have found evidence for distinct ones rather than a single. So maybe the answer is No, but I need to check if the data points to multiple syndromes or just features of one. The study found patients had symptoms in multiple systems, which could suggest multiple syndromes. However, the question is whether it's a single syndrome. Since the study's results show varied presentations and comorbidities, maybe the answer is No, indicating it's not a single syndrome. Alternatively, the features might support a single syndrome with varied manifestations. The abstract states the aim was to determine if symptoms support specific syndromes (plural), but the results might not confirm a single. The conclusion isn't clear here, but the data shows heterogeneity. So the answer is Maybe, as the study provides evidence for distinguishing features but doesn't conclusively confirm a single syndrome. Wait, the question is phrased as ""a single syndrome?"" The study's purpose was to see if the symptoms support the existence of specific (i.e., multiple) syndromes. If they found distinctive features, that might support multiple specific syndromes, hence the answer would be No. But the abstract's conclusion isn't fully provided. Based on the results, the presence of varied symptoms across systems and higher comorbidities might suggest multiple underlying syndromes rather than one. Therefore, the answer is No.
</think>

[No]",Correct
22211919,pubmedqa_pqa_l,"Actinobaculum schaalii, a cause of urinary tract infections in children?",maybe,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The user is asking if Actinobaculum schaalii is a cause of urinary tract infections (UTIs) in children based on the provided context.

First, I need to parse the context. The study examined urine samples using different methods: wet smear microscopy, culture in CO2, and real-time PCR specific for A. schaalii. 

In 5 out of 29 samples, A. schaalii was detected only by PCR with levels between 10^4 to 10^5 CFU/mL. Then, in two children with UTIs and high leukocytes, A. schaalii was found at â‰¥10^6 CFU/mL by both culture and PCR. 

High CFU counts, especially when detected by both culture and PCR, are significant. Typically, in UTIs, a threshold like â‰¥10^5 CFU/mL is considered indicative of infection. The two cases here had higher counts (â‰¥10^6) along with symptoms (UTI) and leukocytes, which are signs of infection. 

The fact that it was detected by both methods in symptomatic patients strengthens the association. The other five cases with lower counts only by PCR might be colonization or asymptomatic bacteriuria, but the two cases with higher counts and symptoms suggest causation. 

So, the context provides evidence that A. schaalii was found in children with UTIs, meeting the diagnostic criteria. Therefore, the answer should be yes.
</think>

[Yes]",Incorrect
24433626,pubmedqa_pqa_l,Prevalence of chronic conditions among Medicare Part A beneficiaries in 2008 and 2010: are Medicare beneficiaries getting sicker?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking whether Medicare Part A beneficiaries are getting sicker based on the prevalence of chronic conditions between 2008 and 2010.

First, I need to look at the context provided. The study found that the average number of chronic conditions per beneficiary increased from 2008 to 2010. That suggests that, on average, beneficiaries had more chronic conditions in 2010. However, the answer isn't straightforward because some conditions decreased in prevalence while others increased.

The study mentions that conditions like congestive heart failure, ischemic heart disease, and stroke/transient ischemic attack decreased. But other conditions like chronic kidney disease, depression, diabetes, osteoporosis, and rheumatoid arthritis/osteoarthritis increased. The overall average number of chronic conditions went up, which the study attributes to the increase in these other conditions. Additionally, there were differences in trends for Alzheimer's, cancer, and COPD based on sex or dual eligibility.

So, the key point here is that while some conditions became less common, the overall number of chronic conditions per person increased. The study refers to this as a ""deterioration of average health."" However, the answer might depend on how ""sicker"" is defined. If having more chronic conditions is considered being sicker, then yes. But if some major conditions decreased, maybe the answer is more nuanced. The study's conclusion seems to lean towards the average health deteriorating, so the answer is likely yes. But I should check if the increase in conditions is significant enough to conclude they are getting sicker overall.
</think>

[Yes]",Correct
9542484,pubmedqa_pqa_l,Does successful completion of the Perinatal Education Programme result in improved obstetric practice?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The study is looking at whether completing the PEP improves obstetric practice. They used two MOUs that enrolled in PEP and one that didn't. The design is a before-and-after study, which usually compares outcomes before and after an intervention.

Looking at the results: Eight out of 13 midwives completed PEP and showed improved knowledge. But when they checked the case notes of 303 patients, most of the measured practices didn't improve. For example, syphilis testing rates were similar across groups, hemoglobin measurement was low and didn't change, and appropriate actions for detected problems were rarely taken, with no significant improvement post-PEP. Even in areas like fetal weight estimation and pelvimetry, there was no difference. The only slight improvement was in actions during labor, but it wasn't significant.

So even though knowledge improved, actual practice didn't show meaningful changes. The third MOU (control) didn't have changes either, suggesting that external factors weren't influencing the results. The answer is probably No because the data doesn't support a significant improvement in practice despite knowledge gains.
</think>

[No]",Correct
17008699,pubmedqa_pqa_l,Do patients with localized prostate cancer treatment really want more aggressive treatment?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if patients with localized prostate cancer really want more aggressive treatment. The context provided is a study where patients were given two radiotherapy options: 70 Gy vs 74 Gy. The higher dose (74 Gy) is more aggressive, offering better cure rates but more toxicity.

The study found that 75% of the 119 patients who chose their treatment opted for the lower dose (70 Gy). The choice was consistent with their importance weightsâ€”they valued survival and cure (high odds ratios) but were concerned about adverse effects (low odds ratios for GI and genitourinary issues). Also, older patients, low-risk individuals, those not on hormone therapy, and those with lower anxiety/depression scores more often chose the lower dose.

So, the majority didn't choose the more aggressive option. The answer hinges on the data showing most patients preferred the less aggressive treatment. The question is phrased as ""do they really want more aggressive treatment?"" The answer would be No because the majority chose the less aggressive option. But wait, maybe the phrasing is tricky. The study's conclusion is that patients made a reasoned choice based on their priorities. So the answer is No, they don't want more aggressive treatment; they prefer the less aggressive one when given the choice, considering the trade-offs.
</think>

[No]",Correct
23228527,pubmedqa_pqa_l,Does music influence stress in mechanically ventilated patients?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if music influences stress in mechanically ventilated patients based on the provided study.

First, I need to understand the study's setup. It's a randomized controlled trial with three groups: patient-directed music (PDM), headphones only, and usual ICU care. The primary outcome measured was urinary free cortisol (UFC), a stress biomarker. The study included 65 patients from 12 ICUs. The analysis controlled for illness severity, gender, and baseline UFC levels. The result was no significant differences in UFC among the groups over the duration of ventilatory support.

The key here is the outcome measure. UFC is a reliable biomarker for stress, so if there were a reduction in stress due to music, we'd expect lower UFC in the music group compared to the others. However, the study found no significant differences. That suggests that, according to this particular measure, music didn't influence stress levels. But wait, the study mentions that patients could self-initiate music whenever they wanted. Maybe adherence or the amount of music listened to wasn't sufficient? The abstract doesn't provide details on compliance, so I can't assume that. The main result is the lack of significant difference. 

Also, the sample size for the UFC analysis was 65, which might be underpowered. But the study controlled for several variables, which strengthens the analysis. The conclusion here is that, based on UFC levels, music didn't have a significant effect. However, the question is whether music influences stress. The study's answer is no, but maybe there are other stress indicators not measured here. But according to the data provided, the answer would be no. So the response should be [No].
</think>

[No]",Correct
15489384,pubmedqa_pqa_l,Does reducing spasticity translate into functional benefit?,yes,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking whether reducing spasticity leads to functional benefits, based on the provided study.

First, the context mentions that botulinum toxin is used to reduce spasticity, but functional benefits are less clear. The study did a meta-analysis to see if there's a link between reduced spasticity and improved arm function.

Looking at the results: They found a significant correlation (rho = -0.2822, p = 0.0008) between maximum changes in spasticity and function, independent of treatment. That negative correlation suggests that as spasticity decreases, function improves. However, when looking at specific doses, the 500 and 1000 units groups showed stronger correlations (rho around -0.44 to -0.56, significant p-values), but the placebo and 1500 units didn't show this. 

So, the answer isn't straightforward. The overall data shows a relationship, but the effect varies with treatment type and dosage. The study is exploratory, so it's not definitive. Some patients had concurrent improvements, others had spasticity reduction first, and some the reverse. 

The question is whether reducing spasticity translates to functional benefit. The study shows a correlation, but causation isn't proven. Also, the benefit is present in certain treatment groups but not others. So the answer might be ""Maybe"" because it's context-dependent on treatment specifics and individual variation.
</think>

[Maybe]",Incorrect
17444776,pubmedqa_pqa_l,Is the holmium:YAG laser the best intracorporeal lithotripter for the ureter?,yes,deepseek-ai/deepseek-r1,maybe,"<think>
Okay, let's tackle this question. The user is asking if the holmium:YAG laser is the best intracorporeal lithotripter for the ureter based on the provided study.

First, the study shows a high success rate of 92.7% initially and 96.7% at 3 months. The main issue was retropulsion in 3.3% of cases, and there were minimal complications like one stricture and no perforations. Stenting was common, but that's typical in these procedures.

However, the study only compares the outcomes of using the holmium:YAG laser without mentioning other lithotripters like pneumatic or ultrasonic devices. To determine if it's the ""best,"" we need comparative data on efficacy, safety, and outcomes against other methods. The study's results are positive for the holmium laser, but without direct comparison, it's hard to claim superiority. Also, the time frame (2003-2005) might mean newer technologies or studies could have emerged since then. The answer should reflect that while the results are good, the study alone doesn't conclusively prove it's the best compared to others. So the answer would be Maybe, since the data supports its effectiveness but lacks comparison to alternatives.
</think>

[Maybe]",Incorrect
8422202,pubmedqa_pqa_l,Metered-dose inhalers. Do health care providers know what to teach?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if healthcare providers know what to teach regarding metered-dose inhalers based on the provided context.

First, the context mentions that healthcare providers (house staff, nurses, respiratory care practitioners) were surveyed. Their performance scores on knowledge about proper inhaler use were assessed. The results showed that house staff and nurses were less proficient, while respiratory care practitioners were the most knowledgeable. 

So, the question is whether healthcare providers know what to teach. The answer isn't a straightforward yes or no because it varies among the different groups. Respiratory care practitioners do know, but house staff and nurses are less proficient. Since the question groups all healthcare providers together, but the context shows mixed proficiency, the answer should reflect that not all are proficient. However, the study's conclusion might imply that overall, there's a deficiency except for respiratory practitioners. The options are Yes, No, Maybe. Since some know and others don't, Maybe could be appropriate. But the context states that a significant percentage of providers (house staff and nurses) were less proficient, which are parts of the healthcare providers. So the answer might lean towards No, because the majority (except respiratory) aren't proficient. But Maybe could also be considered if the answer is uncertain. However, the context clearly states that respiratory care practitioners are the most knowledgeable, implying others aren't. So the answer is No, because the majority (house staff and nurses) don't know enough to teach properly.
</think>

[No]",Correct
23794696,pubmedqa_pqa_l,Does the bracket-ligature combination affect the amount of orthodontic space closure over three months?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The study is looking at whether different bracket-ligature combinations affect how much space closes in orthodontic treatment over three months. They had three groups: conventional brackets with regular elastomeric ligatures, the same brackets with low-friction ligatures, and Damon self-ligating brackets. The primary outcome was mean space closure measured over three months.

The results from the ANOVA showed that the mean space closure was about 1 mm per 28 days across all groups, which is pretty similar. The P-value was 0.718, which is way above the typical significance threshold of 0.05. That means the differences between the groups weren't statistically significant. Even though there was individual variation, the study didn't find a meaningful difference based on the bracket-ligature type. So, the answer should be no, the combination doesn't affect the amount of closure in this timeframe.
</think>

[No]",Correct
20549895,pubmedqa_pqa_l,Health habits and vaccination status of Lebanese residents: are future doctors applying the rules of prevention?,no,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if the health habits and vaccination status of Lebanese residents (specifically first-year medical residents) indicate that future doctors are following prevention rules.

First, I need to look at the context provided. The study reviewed 109 residents from 2005 to 2008. Their physical activity is lowâ€”only 5.5% meet guidelines. Many skip meals, leading to a significant number being overweight, especially males. Smoking and alcohol use are present, though alcohol is mostly occasional. Vaccination status: only 23% are fully up-to-date, with gaps in MMR and dT Polio. However, 90% have hepatitis B immunization, with 71% having an adequate response.

So, the key points are poor health habits (low exercise, poor diet, smoking) and incomplete vaccinations. The question is whether they're applying prevention rules. Since doctors are expected to model healthy behaviors and ensure their own vaccinations to prevent disease spread, the data shows they're not fully complying. High rates of skipping meals, low exercise, and incomplete vaccinations suggest they aren't following the prevention guidelines they're supposed to advocate. The answer would be No, as the majority aren't meeting the standards.
</think>

[No]",Correct
18714572,pubmedqa_pqa_l,Does vaginal intraepithelial neoplasia have the same evolution as cervical intraepithelial neoplasia?,maybe,deepseek-ai/deepseek-r1,no,"<think>
Okay, let's tackle this question. The user is asking if vaginal intraepithelial neoplasia (VAIN) has the same evolution as cervical intraepithelial neoplasia (CIN). 

First, I need to recall the context provided. The study compared patients with vaginal lesions and synchronous cervical lesions. They looked at the rates of mild vs. severe cervical lesions in those with mild or severe vaginal lesions. 

In the results, patients with mild vaginal lesions had more mild cervical lesions (like koilocytosis, warts, CIN I) than severe ones (CIN II/III, carcinoma). Also, ""active"" vaginal lesions (with koilocytosis) correlated with more ""active"" cervical lesions. However, when comparing high-grade VAIN vs. low-grade VAIN, there wasn't a significant difference in the rates of mild vs. severe cervical lesions.

So, the study suggests that mild vaginal lesions are associated with mild cervical lesions, and active vaginal lesions with active cervical ones. But when it comes to the severity (low vs. high-grade VAIN), there's no significant difference in cervical lesion severity. This implies that while there's some correlation in activity (koilocytosis as a marker), the progression (evolution) might not be the same, especially since high-grade VAIN doesn't correlate with more severe cervical lesions. Therefore, the natural history might not be similar. The answer would be No, but wait, the conclusion says the differences weren't significant, so maybe the study didn't find enough evidence to say they evolve the same. The authors aimed to see if they have similar natural histories, but the results don't strongly support that. So the answer is No.
</think>

[No]",Incorrect
2224269,pubmedqa_pqa_l,Should general practitioners call patients by their first names?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether GPs should call patients by their first names. The study found that most patients either liked it or didn't mind, except those over 65 who mostly disliked it. But most patients didn't want to call the doctor by their first name. So, the majority are okay with being called by their first name, but there's a significant minority, especially older patients, who don't like it. The answer probably depends on considering the majority preference but also respecting the minority. Since the majority are okay, the answer might lean towards yes, but with a caveat for older patients. However, the question is a straightforward ""should they"" based on the data. The study shows that most are okay, so the answer is yes, but maybe with exceptions. But the options are Yes, No, Maybe. Since the majority are in favor or neutral, the answer is Yes. But wait, the study says 223 liked, 175 didn't mind, 77 disliked. So 223+175=398 out of 475 are okay with it. That's a majority. So the answer is Yes. But the question is ""should"" they do it. The data supports that it's acceptable, so the answer is Yes.
</think>

[Yes]",Correct
8910148,pubmedqa_pqa_l,Transesophageal echocardiographic assessment of left ventricular function in brain-dead patients: are marginally acceptable hearts suitable for transplantation?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's tackle this question. The user is asking if marginally acceptable hearts, as assessed by transesophageal echocardiography (TEE) in brain-dead donors, are suitable for transplantation. 

First, I need to understand the context provided. The study looked at 55 potential donors, using TEE to measure fractional area change (FAC). They divided the harvested hearts into two groups: H1 (FAC â‰¥50%) and H2 (FAC <50%). Out of 40 harvested hearts, 36 were successfully transplanted. The success criteria included the recipient being alive without certain complications by the fifth day.

In group H2 (FAC <50%), 9 hearts were transplanted. The results mention that two deaths in H1 were due to hemorrhage, unrelated to heart function. In H2, two deaths were due to ventricular dysfunction. The FAC improved post-transplant in 18 cases. Survival rates at 1 and 2 years were higher in H1 (86.2%) vs. H2 (64.6%), but the p-value wasn't significant (p = NS), meaning the difference might be due to chance.

So, even though H2 had lower survival rates, the lack of statistical significance suggests that hearts with lower FAC (marginally acceptable) can still be suitable. The study implies that using TEE could expand donor criteria, as some hearts with initially lower function can recover post-transplant. However, there's a higher risk of ventricular dysfunction-related deaths in H2. The answer hinges on whether the benefits (more donors) outweigh the risks (possible lower survival). Since the study shows that some of these hearts were successfully used, the answer is likely Yes.
</think>

[Yes]",Correct
23899611,pubmedqa_pqa_l,Attenuation of ischemia/reperfusion-induced ovarian damage in rats: does edaravone offer protection?,yes,deepseek-ai/deepseek-r1,yes,"<think>
Okay, let's see. The question is whether edaravone offers protection against ischemia/reperfusion-induced ovarian damage in rats based on the study described.

First, the context mentions that the study had four groups of rats. The sham group had a catheter but no pneumoperitoneum. Group 2 got saline, and groups 3 and 4 received different doses of edaravone before pneumoperitoneum. After the procedure, they looked at various markers like histology, caspase-3, and oxidative stress markers (GSH, MDA, TAC).

The results showed that the saline group had worse follicular degeneration and edema compared to sham. Edaravone groups had significantly less degenerative changes. Caspase-3 expression was lower in treatment groups, especially dose-dependent. Also, oxidative stress markers like MDA (which is a marker of lipid peroxidation) were reduced, and GSH and TAC (antioxidant markers) were better in edaravone groups.

So, all the measured outcomesâ€”histological damage, apoptosis (via caspase-3), and oxidative stressâ€”improved with edaravone. The study's conclusion in the context says that edaravone attenuated oxidative stress from I/R injury, which supports the protective effect. Therefore, the answer should be yes.
</think>

[Yes]",Correct
